[
  {
    "id": 1,
    "question": "Which organelle is primarily responsible for degrading unwanted cellular components using hydrolytic enzymes?",
    "options": {
      "A": "Mitochondria",
      "B": "Lysosome",
      "C": "Smooth Endoplasmic Reticulum",
      "D": "Ribosome",
      "E": "Golgi apparatus"
    },
    "answer": "B",
    "explanation": "Lysosomes contain hydrolytic enzymes that degrade cellular waste. Mitochondria generate ATP, the smooth ER synthesizes lipids, and ribosomes synthesize proteins.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 2,
    "question": "What is the main function of the rough endoplasmic reticulum?",
    "options": {
      "A": "Lipid breakdown",
      "B": "Glycogen storage",
      "C": "Protein synthesis",
      "D": "Fatty acid oxidation",
      "E": "Cell membrane structure support"
    },
    "answer": "C",
    "explanation": "The rough ER has ribosomes attached and synthesizes proteins destined for secretion or membrane insertion.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 3,
    "question": "Which structure pulls chromosomes apart during cell division?",
    "options": {
      "A": "Microtubules",
      "B": "Intermediate filaments",
      "C": "Actin filaments",
      "D": "Golgi vesicles",
      "E": "Centrosome matrix"
    },
    "answer": "A",
    "explanation": "Microtubules form the mitotic spindle, which separates chromosomes. Actin and intermediate filaments play structural and motility roles but not chromosome separation.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 4,
    "question": "Which component of the cytoskeleton is most involved in muscle contraction?",
    "options": {
      "A": "Intermediate filaments",
      "B": "Microtubules",
      "C": "Actin filaments",
      "D": "Centrosomes",
      "E": "Ribosomes"
    },
    "answer": "C",
    "explanation": "Actin filaments (microfilaments) interact with myosin to enable muscle contraction.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 5,
    "question": "Which of the following statements best describes the nucleus?",
    "options": {
      "A": "It synthesizes ATP",
      "B": "It breaks down old proteins",
      "C": "It stores genetic material and contains the nucleolus",
      "D": "It produces hydrogen peroxide",
      "E": "It modifies glycoproteins"
    },
    "answer": "C",
    "explanation": "The nucleus stores DNA and includes the nucleolus, where ribosomes are assembled. ATP is made in mitochondria; protein breakdown is done by proteasomes.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 6,
    "question": "What is the function of the Golgi apparatus?",
    "options": {
      "A": "Synthesizing fatty acids",
      "B": "Assembling ribosomes",
      "C": "Sorting and modifying proteins",
      "D": "Producing hydrogen peroxide",
      "E": "DNA replication"
    },
    "answer": "C",
    "explanation": "The Golgi modifies, sorts, and packages proteins and lipids for transport. Ribosomes are assembled in the nucleolus, and fatty acids are made in the smooth ER.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 7,
    "question": "Which cytoskeletal component provides mechanical strength and resists shearing forces?",
    "options": {
      "A": "Actin filaments",
      "B": "Microtubules",
      "C": "Intermediate filaments",
      "D": "Nuclear pores",
      "E": "Ribosomes"
    },
    "answer": "C",
    "explanation": "Intermediate filaments provide mechanical stability. Actin and microtubules are more involved in movement and transport.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 8,
    "question": "Which organelle is most associated with detoxifying harmful substances and generating hydrogen peroxide?",
    "options": {
      "A": "Lysosome",
      "B": "Mitochondrion",
      "C": "Peroxisome",
      "D": "Rough ER",
      "E": "Golgi apparatus"
    },
    "answer": "C",
    "explanation": "Peroxisomes contain oxidase enzymes that generate hydrogen peroxide for detoxification.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 9,
    "question": "Where are ribosomes assembled within the eukaryotic cell?",
    "options": {
      "A": "Cytosol",
      "B": "Nucleolus",
      "C": "Rough ER",
      "D": "Mitochondria",
      "E": "Lysosome"
    },
    "answer": "B",
    "explanation": "The nucleolus, found within the nucleus, is the site of ribosomal subunit assembly.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 10,
    "question": "Which organelle contains enzymes for fatty acid oxidation and houses the citric acid cycle?",
    "options": {
      "A": "Peroxisome",
      "B": "Smooth ER",
      "C": "Mitochondrion",
      "D": "Golgi",
      "E": "Lysosome"
    },
    "answer": "C",
    "explanation": "The mitochondrial matrix is where the citric acid cycle and fatty acid oxidation occur. Peroxisomes also oxidize fatty acids but not in the same metabolic pathway.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 11,
    "question": "Which of the following features is unique to eukaryotic cells?",
    "options": {
      "A": "Plasma membrane",
      "B": "DNA as genetic material",
      "C": "Membrane-bound organelles",
      "D": "Ribosomes",
      "E": "Cell wall"
    },
    "answer": "C",
    "explanation": "Only eukaryotes have membrane-bound organelles like mitochondria and Golgi. Both prokaryotes and eukaryotes have DNA, membranes, and ribosomes.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 12,
    "question": "What is the key structural difference between cytoplasm and cytosol?",
    "options": {
      "A": "Cytosol contains DNA",
      "B": "Cytosol excludes membrane-bound organelles",
      "C": "Cytoplasm only refers to the nucleus",
      "D": "Cytoplasm refers to extracellular fluid",
      "E": "Cytosol is only found in bacteria"
    },
    "answer": "B",
    "explanation": "Cytoplasm = everything inside the plasma membrane (organelles + fluid), while cytosol = just the fluid portion without organelles.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 13,
    "question": "What describes a polarised epithelial cell?",
    "options": {
      "A": "Has cilia on both surfaces",
      "B": "Contains only cytosol",
      "C": "Has distinct structural and functional regions",
      "D": "Contains circular DNA",
      "E": "Does not undergo mitosis"
    },
    "answer": "C",
    "explanation": "Epithelial cells are polarised with apical and basal domains, important for directional transport and barrier functions.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 14,
    "question": "Which structure plays a central role in vesicle-mediated transport between ER and Golgi?",
    "options": {
      "A": "Actin filaments",
      "B": "Nucleolus",
      "C": "Transport vesicles",
      "D": "Smooth ER",
      "E": "Centrosome"
    },
    "answer": "C",
    "explanation": "Transport vesicles bud from the ER and fuse with the Golgi. This trafficking is essential for protein sorting and modification.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 15,
    "question": "Which pathway correctly describes protein targeting for secretion?",
    "options": {
      "A": "Cytosol \u2192 Nucleus \u2192 Golgi \u2192 Lysosome",
      "B": "Ribosome \u2192 Cytosol \u2192 ER \u2192 Peroxisome",
      "C": "Rough ER \u2192 Golgi apparatus \u2192 Plasma membrane",
      "D": "Nucleolus \u2192 Golgi \u2192 Mitochondria",
      "E": "Ribosome \u2192 Actin filament \u2192 Plasma membrane"
    },
    "answer": "C",
    "explanation": "Secretory proteins are synthesized in the rough ER, processed in the Golgi, then sent to the membrane via vesicles.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 16,
    "question": "Which of the following is a key feature of the cristae in mitochondria?",
    "options": {
      "A": "Sites of DNA storage",
      "B": "Enclose peroxisomal enzymes",
      "C": "Increase surface area for oxidative phosphorylation",
      "D": "Store calcium for muscle contraction",
      "E": "Connect directly to ribosomes"
    },
    "answer": "C",
    "explanation": "Cristae are folds in the inner mitochondrial membrane that increase surface area for electron transport and ATP production.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 17,
    "question": "What role does ubiquitin play in the cell?",
    "options": {
      "A": "Tags proteins for glycosylation",
      "B": "Assembles ribosomes",
      "C": "Directs proteins to proteasomes for degradation",
      "D": "Exports mRNA from the nucleus",
      "E": "Forms microvilli on epithelial cells"
    },
    "answer": "C",
    "explanation": "Ubiquitin marks damaged or misfolded proteins for degradation by the proteasome \u2014 a key step in cellular quality control.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 18,
    "question": "Which form of amino acid is found in human proteins?",
    "options": {
      "A": "D-isomer",
      "B": "R-isomer",
      "C": "L-isomer",
      "D": "Alpha-keto form",
      "E": "Beta-barrel form"
    },
    "answer": "C",
    "explanation": "Proteins in humans are composed exclusively of L-isomers of amino acids. D-isomers are found in some bacterial cell walls, but not in human proteins.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 19,
    "question": "What type of bond links amino acids together in a protein chain?",
    "options": {
      "A": "Hydrogen bond",
      "B": "Peptide bond",
      "C": "Ionic bond",
      "D": "Disulfide bond",
      "E": "Phosphodiester bond"
    },
    "answer": "B",
    "explanation": "Peptide bonds are covalent bonds that form between the carboxyl group of one amino acid and the amino group of another, forming the backbone of a protein chain.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 20,
    "question": "Which amino acid is coded by the start codon AUG?",
    "options": {
      "A": "Alanine",
      "B": "Cysteine",
      "C": "Threonine",
      "D": "Methionine",
      "E": "Tryptophan"
    },
    "answer": "D",
    "explanation": "AUG is the start codon in mRNA and codes for the amino acid methionine, which is the first amino acid incorporated into a newly synthesized protein.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 21,
    "question": "Which level of protein structure describes the overall 3D shape of a single polypeptide chain?",
    "options": {
      "A": "Primary structure",
      "B": "Secondary structure",
      "C": "Tertiary structure",
      "D": "Quaternary structure",
      "E": "Isomeric structure"
    },
    "answer": "C",
    "explanation": "Tertiary structure refers to the 3D conformation of a single polypeptide chain formed by interactions among side chains of amino acids.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 22,
    "question": "What type of interaction primarily stabilizes alpha helices and beta sheets in proteins?",
    "options": {
      "A": "Peptide bonds",
      "B": "Disulfide bonds",
      "C": "Hydrogen bonds",
      "D": "Van der Waals forces",
      "E": "Ionic bonds"
    },
    "answer": "C",
    "explanation": "Secondary structures such as alpha helices and beta sheets are stabilized by hydrogen bonds between the backbone atoms (C=O and N-H groups).",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 23,
    "question": "What does a low KM value indicate about an enzyme?",
    "options": {
      "A": "The enzyme has a low affinity for its substrate",
      "B": "The enzyme is a competitive inhibitor",
      "C": "The enzyme binds its substrate tightly and is efficient even at low substrate levels",
      "D": "The enzyme permanently inactivates its target",
      "E": "The enzyme catalyses irreversible reactions"
    },
    "answer": "C",
    "explanation": "A low KM means the enzyme binds the substrate tightly and can function efficiently even at low concentrations. High KM implies low affinity.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 24,
    "question": "Which of the following is an example of a non-competitive reversible inhibitor?",
    "options": {
      "A": "Penicillin",
      "B": "Doxycycline",
      "C": "Indinavir",
      "D": "NADH",
      "E": "Glucose"
    },
    "answer": "B",
    "explanation": "Doxycycline is a non-competitive inhibitor of bacterial collagenase. It binds to a site other than the active site and reduces Vmax without affecting KM.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 25,
    "question": "Which enzyme class catalyses oxidation-reduction reactions?",
    "options": {
      "A": "Hydrolase",
      "B": "Lyase",
      "C": "Oxidoreductase",
      "D": "Isomerase",
      "E": "Polymerase"
    },
    "answer": "C",
    "explanation": "Oxidoreductases catalyse redox reactions, commonly named dehydrogenase, oxidase, or reductase. Polymerase is not one of the six main enzyme classes.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 26,
    "question": "What effect does a competitive inhibitor have on enzyme kinetics?",
    "options": {
      "A": "Decreases Vmax",
      "B": "Increases KM without affecting Vmax",
      "C": "Decreases KM and Vmax",
      "D": "Increases both KM and Vmax",
      "E": "Has no impact on KM or Vmax"
    },
    "answer": "B",
    "explanation": "Competitive inhibitors increase KM because they compete with substrate for the active site. Vmax remains unchanged since the inhibition can be overcome with more substrate.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 27,
    "question": "Which of the following best describes allosteric regulation?",
    "options": {
      "A": "Substrate binds at the active site to activate the enzyme",
      "B": "Product of a reaction permanently deactivates the enzyme",
      "C": "Regulator binds at a separate site, inducing a conformational change",
      "D": "Enzyme is destroyed after catalysis",
      "E": "Gene transcription is halted"
    },
    "answer": "C",
    "explanation": "Allosteric regulators bind to sites other than the active site, changing enzyme conformation and toggling between active/inactive states.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 28,
    "question": "Which of the following best describes how enzymes affect a chemical reaction?",
    "options": {
      "A": "They increase the overall free energy change (\u0394G)",
      "B": "They consume substrate irreversibly",
      "C": "They lower the activation energy without changing \u0394G",
      "D": "They increase the rate by increasing temperature",
      "E": "They make reactions thermodynamically favorable"
    },
    "answer": "C",
    "explanation": "Enzymes lower the activation energy of reactions, speeding them up without altering the overall free energy change (\u0394G).",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 29,
    "question": "What does the enzyme-substrate complex model suggest?",
    "options": {
      "A": "The enzyme undergoes degradation after the reaction",
      "B": "The substrate is permanently bound to the enzyme",
      "C": "The substrate binds reversibly to the enzyme\u2019s active site",
      "D": "The enzyme forms an irreversible bond with the product",
      "E": "All substrates are transformed into enzymes"
    },
    "answer": "C",
    "explanation": "The enzyme-substrate complex (ES) is a reversible interaction where the substrate binds to the active site before being converted to product.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 30,
    "question": "Why does alcohol intolerance occur in individuals with defective ALDH enzyme?",
    "options": {
      "A": "The enzyme breaks down alcohol too quickly",
      "B": "The enzyme has a low Vmax",
      "C": "The enzyme has a high KM, so it only functions at high aldehyde levels",
      "D": "The enzyme is blocked by competitive inhibitors",
      "E": "The alcohol cannot reach the liver"
    },
    "answer": "C",
    "explanation": "Defective ALDH has a high KM, indicating low affinity for acetaldehyde. It only becomes active at high substrate concentrations, causing buildup and toxicity.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 31,
    "question": "What is the significance of Vmax in enzyme kinetics?",
    "options": {
      "A": "It is the rate at which all enzymes are denatured",
      "B": "It is the substrate concentration at which the enzyme is half-saturated",
      "C": "It is the maximum rate of reaction when all enzymes are saturated",
      "D": "It reflects how many active sites are phosphorylated",
      "E": "It marks the point at which enzyme inhibition begins"
    },
    "answer": "C",
    "explanation": "Vmax is the maximum velocity of an enzyme-catalyzed reaction when all enzyme active sites are saturated with substrate.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 32,
    "question": "Which of the following is true of irreversible enzyme inhibitors?",
    "options": {
      "A": "They bind reversibly to the enzyme active site",
      "B": "They increase the KM without affecting Vmax",
      "C": "They can be outcompeted by increasing substrate concentration",
      "D": "They bind covalently and permanently disable the enzyme",
      "E": "They switch the enzyme between active and inactive states"
    },
    "answer": "D",
    "explanation": "Irreversible inhibitors bind covalently to enzymes, rendering them permanently inactive. Cells must synthesize new enzyme to restore activity.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 33,
    "question": "How does feedback inhibition regulate enzyme activity?",
    "options": {
      "A": "The product activates a different metabolic pathway",
      "B": "The enzyme is broken down after every reaction",
      "C": "The product inhibits an earlier enzyme in the same pathway",
      "D": "The enzyme stops working when gene transcription halts",
      "E": "The enzyme exports the product to another cell"
    },
    "answer": "C",
    "explanation": "In feedback inhibition, the product of a pathway inhibits an earlier enzyme to prevent unnecessary accumulation.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 34,
    "question": "Which of the following is an example of post-translational modification of enzymes?",
    "options": {
      "A": "Splicing of pre-mRNA",
      "B": "Transcriptional silencing",
      "C": "Phosphorylation on serine or threonine residues",
      "D": "mRNA export from the nucleus",
      "E": "ATP synthesis"
    },
    "answer": "C",
    "explanation": "Post-translational modifications like phosphorylation on serine, threonine, or tyrosine residues can rapidly alter enzyme activity.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 35,
    "question": "Which statement best defines an allosteric enzyme?",
    "options": {
      "A": "An enzyme that is permanently inhibited by its product",
      "B": "An enzyme with multiple active sites that all bind substrate",
      "C": "An enzyme regulated by molecules binding outside the active site",
      "D": "An enzyme that catalyses peptide bond formation",
      "E": "An enzyme degraded by proteolysis"
    },
    "answer": "C",
    "explanation": "Allosteric enzymes are regulated by effectors that bind to sites other than the active site, causing a conformational change.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 36,
    "question": "Which of the following is *not* a function of lipids in the human body?",
    "options": {
      "A": "Storage of energy",
      "B": "Forming membranes",
      "C": "DNA replication",
      "D": "Signalling within cells",
      "E": "Intercellular signalling"
    },
    "answer": "C",
    "explanation": "Lipids are not involved in DNA replication. Their roles include energy storage, membrane structure, and signalling.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 37,
    "question": "Which lipid molecule is the main storage form of fat in the human body?",
    "options": {
      "A": "Cholesterol",
      "B": "Triacylglycerol",
      "C": "Phosphatidylcholine",
      "D": "Prostaglandin",
      "E": "Glycogen"
    },
    "answer": "B",
    "explanation": "Triacylglycerol is the main storage lipid found in adipose tissue.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 38,
    "question": "Which fatty acid is essential and must be obtained from the diet?",
    "options": {
      "A": "Oleic acid",
      "B": "Linoleic acid",
      "C": "Stearic acid",
      "D": "Palmitic acid",
      "E": "Lauric acid"
    },
    "answer": "B",
    "explanation": "Linoleic acid is an essential fatty acid that cannot be synthesized and must be obtained from food.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 39,
    "question": "What type of bond is *absent* in saturated fatty acids?",
    "options": {
      "A": "Single bond",
      "B": "Covalent bond",
      "C": "Double bond",
      "D": "Carbon-hydrogen bond",
      "E": "Carbon-carbon bond"
    },
    "answer": "C",
    "explanation": "Saturated fatty acids contain only single carbon-carbon bonds; no double bonds are present.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 40,
    "question": "Which molecule reduces membrane fluidity by packing between phospholipids?",
    "options": {
      "A": "Cholesterol",
      "B": "Triacylglycerol",
      "C": "Linolenic acid",
      "D": "Vitamin D",
      "E": "Phosphatidylserine"
    },
    "answer": "A",
    "explanation": "Cholesterol decreases membrane fluidity by inserting between other lipids.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 41,
    "question": "Which lipid derivative is involved in inflammation and derived from arachidonic acid?",
    "options": {
      "A": "Bile salts",
      "B": "Steroid hormones",
      "C": "Vitamin D",
      "D": "Eicosanoids",
      "E": "Phosphatidylinositol"
    },
    "answer": "D",
    "explanation": "Eicosanoids like prostaglandins are derived from arachidonic acid and play roles in inflammation.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 42,
    "question": "Which sugar is a ketose?",
    "options": {
      "A": "D-glucose",
      "B": "D-mannose",
      "C": "D-galactose",
      "D": "D-fructose",
      "E": "D-ribose"
    },
    "answer": "D",
    "explanation": "Fructose is a ketose sugar with a ketone group.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 43,
    "question": "Which of the following is a pentose sugar found in nucleic acids?",
    "options": {
      "A": "D-glucofuranose",
      "B": "D-fructofuranose",
      "C": "D-mannose",
      "D": "D-deoxyribose",
      "E": "D-galactose"
    },
    "answer": "D",
    "explanation": "D-deoxyribose is a pentose sugar and a component of DNA.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 44,
    "question": "Which disaccharide is made from glucose and fructose?",
    "options": {
      "A": "Maltose",
      "B": "Lactose",
      "C": "Cellobiose",
      "D": "Sucrose",
      "E": "Galactose"
    },
    "answer": "D",
    "explanation": "Sucrose is formed by \u03b1-glucose and \u03b2-fructose linked via a 1-2 glycosidic bond.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 45,
    "question": "Which polysaccharide contains \u03b21-4 glycosidic bonds and is indigestible by humans?",
    "options": {
      "A": "Glycogen",
      "B": "Starch",
      "C": "Cellulose",
      "D": "Amylopectin",
      "E": "Chitin"
    },
    "answer": "C",
    "explanation": "Cellulose is composed of \u03b21-4 linked glucose and is indigestible by human enzymes.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 46,
    "question": "Which statement best describes the fluid mosaic model of membrane structure?",
    "options": {
      "A": "Phospholipids form rigid sheets embedded with DNA",
      "B": "Membrane proteins are immobile once embedded",
      "C": "Membranes are composed of a bilayer with fluid phospholipids and mobile proteins",
      "D": "Membranes are only made of cholesterol and glycolipids",
      "E": "Cell membranes contain only protein without lipids"
    },
    "answer": "C",
    "explanation": "The fluid mosaic model describes the cell membrane as a flexible lipid bilayer with proteins that move laterally.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 47,
    "question": "Which of the following is TRUE regarding membrane proteins?",
    "options": {
      "A": "They are always composed of beta sheets",
      "B": "They are fully hydrophilic to match the membrane surface",
      "C": "Most form alpha helices that span the membrane and contain hydrophobic regions",
      "D": "They are never involved in transport processes",
      "E": "They are only found in intracellular membranes"
    },
    "answer": "C",
    "explanation": "Membrane proteins often form alpha helices that span the lipid bilayer with hydrophobic regions interacting with the membrane core.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 48,
    "question": "Which of the following correctly describes the typical intracellular vs extracellular concentration of K\u207a?",
    "options": {
      "A": "Higher outside the cell (145 mM)",
      "B": "Equal on both sides",
      "C": "Higher inside the cell (140 mM)",
      "D": "Only present during depolarisation",
      "E": "More in the ER than cytosol"
    },
    "answer": "C",
    "explanation": "K\u207a concentration is higher inside cells (~140 mM) compared to extracellular fluid (~5 mM), which helps maintain membrane potential.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 49,
    "question": "What distinguishes active transport from passive transport?",
    "options": {
      "A": "It occurs down the concentration gradient",
      "B": "It does not require any proteins",
      "C": "It moves solutes against their gradient using energy",
      "D": "It is faster than facilitated diffusion",
      "E": "It only occurs with gases"
    },
    "answer": "C",
    "explanation": "Active transport requires energy to move substances against their concentration gradient, unlike passive transport.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 50,
    "question": "Which is a characteristic difference between channels and transporters?",
    "options": {
      "A": "Channels can perform active transport",
      "B": "Transporters are faster than channels",
      "C": "Channels allow faster passive transport and can be gated",
      "D": "Both operate exclusively in the ER",
      "E": "Transporters move ions via osmosis"
    },
    "answer": "C",
    "explanation": "Channels are faster than transporters and can be ligand- or voltage-gated, while transporters may allow active or passive transport.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 51,
    "question": "Which statement about simple diffusion across membranes is TRUE?",
    "options": {
      "A": "It requires ATP hydrolysis to occur",
      "B": "It allows movement of molecules like O2 and CO2 down their gradient",
      "C": "It occurs only via GLUT transporters",
      "D": "It is used for hydrophilic molecules",
      "E": "It requires ion channels"
    },
    "answer": "B",
    "explanation": "Simple diffusion allows small nonpolar molecules like O2 and CO2 to move directly across the membrane down their concentration gradient.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 52,
    "question": "Which GLUT transporter is most specific to neurons and has the highest glucose affinity?",
    "options": {
      "A": "GLUT1",
      "B": "GLUT2",
      "C": "GLUT3",
      "D": "GLUT4",
      "E": "GLUT7"
    },
    "answer": "C",
    "explanation": "GLUT3, primarily in the brain, has a high affinity (low Km ~1.4 mM) for glucose, suitable for constant energy supply.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 53,
    "question": "What is the role of Na\u207a/K\u207a-ATPase in primary active transport?",
    "options": {
      "A": "To passively balance osmotic pressure",
      "B": "To convert glucose into ATP",
      "C": "To pump 3 Na\u207a out and 2 K\u207a in per ATP hydrolyzed",
      "D": "To move Cl\u207b and Ca\u00b2\u207a in opposite directions",
      "E": "To generate cAMP for signalling"
    },
    "answer": "C",
    "explanation": "Na\u207a/K\u207a-ATPase uses ATP to pump 3 Na\u207a out and 2 K\u207a in, maintaining the resting membrane potential and ion gradients.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 54,
    "question": "What is the source of energy for secondary active transport?",
    "options": {
      "A": "Direct ATP hydrolysis at the transporter site",
      "B": "The concentration gradient established by another active pump",
      "C": "Passive movement of oxygen",
      "D": "Thermal vibrations of membrane lipids",
      "E": "Hydrolysis of glucose"
    },
    "answer": "B",
    "explanation": "Secondary active transport uses the gradient set by a primary active transporter (e.g. Na\u207a gradient from Na\u207a/K\u207a-ATPase).",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 55,
    "question": "Which transporter mediates glucose uptake in the intestine via symport with Na\u207a?",
    "options": {
      "A": "GLUT1",
      "B": "GLUT3",
      "C": "SGLT1",
      "D": "Na\u207a/K\u207a-ATPase",
      "E": "CFTR"
    },
    "answer": "C",
    "explanation": "SGLT1 is a sodium-glucose symporter that uses Na\u207a gradient to transport glucose into gut epithelial cells.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 56,
    "question": "Which correctly pairs a receptor type with its mechanism?",
    "options": {
      "A": "GPCR \u2013 opens ion channels directly",
      "B": "Ligand-gated receptor \u2013 catalyses phosphorylation",
      "C": "RTK \u2013 dimerises and phosphorylates tyrosine residues",
      "D": "Intracellular receptor \u2013 triggers cAMP production",
      "E": "GPCR \u2013 transports ligands into the cell"
    },
    "answer": "C",
    "explanation": "Receptor tyrosine kinases (RTKs) dimerise and autophosphorylate upon ligand binding, activating intracellular pathways.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 57,
    "question": "Which of the following best describes a GPCR signalling pathway?",
    "options": {
      "A": "Ligand binds GPCR \u2192 G protein binds GDP \u2192 channels close",
      "B": "Ligand binds \u2192 G protein binds GTP \u2192 enzyme activation \u2192 second messenger production",
      "C": "GPCRs phosphorylate ligands directly",
      "D": "GPCRs allow glucose to enter the cell",
      "E": "G proteins synthesize insulin in \u03b2 cells"
    },
    "answer": "B",
    "explanation": "GPCR activation leads to G protein activation (GTP binding), stimulating enzymes to generate second messengers like cAMP.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 58,
    "question": "What is the role of cyclic AMP (cAMP) in GPCR signalling?",
    "options": {
      "A": "Acts as a ligand for membrane receptors",
      "B": "Acts as a second messenger to activate protein kinases",
      "C": "Directly opens voltage-gated Ca\u00b2\u207a channels",
      "D": "Inhibits all gene expression",
      "E": "Degrades excess ATP"
    },
    "answer": "B",
    "explanation": "cAMP is a second messenger produced in response to GPCR activation that stimulates protein kinases to modify cellular activity.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 59,
    "question": "Which type of receptor does cortisol primarily bind to?",
    "options": {
      "A": "GPCR",
      "B": "Ionotropic receptor",
      "C": "Enzyme-coupled receptor",
      "D": "Intracellular receptor",
      "E": "Membrane glycoprotein"
    },
    "answer": "D",
    "explanation": "Cortisol is a hydrophobic steroid hormone that crosses membranes to bind intracellular receptors and regulate gene expression.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 60,
    "question": "Which of these statements about ligand-gated ion channels is CORRECT?",
    "options": {
      "A": "They are activated by ATP hydrolysis",
      "B": "They bind hydrophobic ligands like cortisol",
      "C": "They allow ion flow in response to specific ligand binding",
      "D": "They always transport glucose",
      "E": "They use G proteins to function"
    },
    "answer": "C",
    "explanation": "Ligand-gated ion channels (e.g. nicotinic ACh receptor) open in response to ligand binding, allowing specific ion flow.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 61,
    "question": "Which of the following best describes a catabolic pathway?",
    "options": {
      "A": "Using energy to build complex biomolecules",
      "B": "Breaking down fuel molecules to generate energy",
      "C": "Synthesis of lipids in the smooth endoplasmic reticulum",
      "D": "Replication of DNA during cell division",
      "E": "Protein folding in the endoplasmic reticulum"
    },
    "answer": "B",
    "explanation": "Catabolic pathways break down fuel molecules (like carbohydrates and fats) to release energy. Anabolic pathways, by contrast, use energy to build complex biomolecules.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 62,
    "question": "A chemical reaction will proceed spontaneously if which condition is met?",
    "options": {
      "A": "\u0394G > 0",
      "B": "\u0394G = 0",
      "C": "\u0394G < 0",
      "D": "\u0394G > 1",
      "E": "\u0394G < 1"
    },
    "answer": "C",
    "explanation": "A reaction is spontaneous when the change in free energy (\u0394G) is negative, indicating it releases energy overall.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 63,
    "question": "What is the standard free energy change (\u0394G\u00b0) for ATP hydrolysis to ADP + Pi?",
    "options": {
      "A": "+30.5 kJ\u00b7mol\u207b\u00b9",
      "B": "\u221230.5 kJ\u00b7mol\u207b\u00b9",
      "C": "\u22122879 kJ\u00b7mol\u207b\u00b9",
      "D": "+2879 kJ\u00b7mol\u207b\u00b9",
      "E": "0 kJ\u00b7mol\u207b\u00b9"
    },
    "answer": "B",
    "explanation": "Under standard conditions, ATP hydrolysis to ADP and inorganic phosphate has \u0394G\u00b0 = \u221230.5 kJ\u00b7mol\u207b\u00b9, making it energetically favourable.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 64,
    "question": "How does the cell use ATP to drive energetically unfavourable reactions?",
    "options": {
      "A": "By storing electrons in ATP\u2019s phosphate bonds",
      "B": "By coupling unfavourable reactions to the hydrolysis of ATP",
      "C": "By increasing the concentration of substrates",
      "D": "By changing the pH of the reaction environment",
      "E": "By direct oxidation of ATP to water"
    },
    "answer": "B",
    "explanation": "Cells couple unfavourable reactions (positive \u0394G) to the hydrolysis of ATP (negative \u0394G) so that the overall process becomes energetically favourable.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 65,
    "question": "Oxidation of a chemical species is defined as:",
    "options": {
      "A": "Gain of electrons",
      "B": "Loss of protons",
      "C": "Loss of electrons",
      "D": "Formation of hydrogen bonds",
      "E": "Release of heat"
    },
    "answer": "C",
    "explanation": "Oxidation refers to the loss of electrons by a molecule, atom, or ion.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 66,
    "question": "In aerobic respiration, the electrons from oxidized food molecules are ultimately passed to:",
    "options": {
      "A": "NAD+ directly",
      "B": "Coenzyme A",
      "C": "O\u2082, forming H\u2082O",
      "D": "Glucose",
      "E": "ATP"
    },
    "answer": "C",
    "explanation": "In aerobic respiration, electrons removed from food molecules are eventually transferred to molecular oxygen (O\u2082), producing water.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 67,
    "question": "Which of the following is NOT an activated carrier used in metabolism?",
    "options": {
      "A": "NADH",
      "B": "FADH\u2082",
      "C": "Coenzyme A",
      "D": "RNA polymerase",
      "E": "NADPH"
    },
    "answer": "D",
    "explanation": "RNA polymerase is an enzyme involved in transcription, not an activated carrier. NADH, FADH\u2082, CoA, and NADPH all serve as carriers of electrons or chemical groups.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 68,
    "question": "NADPH differs from NADH primarily because it:",
    "options": {
      "A": "Carries electrons only in catabolic pathways",
      "B": "Has an extra phosphate and is mainly used in anabolic reactions",
      "C": "Cannot accept protons",
      "D": "Is covalently bound to enzymes",
      "E": "Releases more energy when oxidized"
    },
    "answer": "B",
    "explanation": "NADPH has an additional phosphate group compared to NADH and functions mainly as a reducing agent in anabolic (biosynthetic) pathways.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 69,
    "question": "Which statement about FAD is correct?",
    "options": {
      "A": "It accepts only electrons, not protons",
      "B": "It is not bound to any enzymes",
      "C": "It accepts two electrons and two protons to form FADH\u2082",
      "D": "It donates phosphate groups to substrates",
      "E": "It operates exclusively in the cytosol"
    },
    "answer": "C",
    "explanation": "FAD accepts two electrons and two protons to become FADH\u2082, and is often covalently bound to its specific dehydrogenase enzymes.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 70,
    "question": "Coenzyme A (CoA) functions primarily as a carrier of:",
    "options": {
      "A": "Phosphate groups",
      "B": "Acyl groups via thioester bonds",
      "C": "Electrons in the electron transport chain",
      "D": "Amino groups in transamination",
      "E": "Nucleotides in DNA synthesis"
    },
    "answer": "B",
    "explanation": "CoA carries acyl groups (such as acetyl) by forming high-energy thioester bonds, making acetyl-CoA a key metabolic intermediate.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 71,
    "question": "During one turn of the citric acid cycle (per acetyl-CoA), how many NADH, FADH\u2082, and ATP (or GTP) molecules are produced?",
    "options": {
      "A": "2 NADH, 2 FADH\u2082, 2 ATP",
      "B": "3 NADH, 1 FADH\u2082, 1 ATP",
      "C": "1 NADH, 3 FADH\u2082, 1 ATP",
      "D": "3 NADH, 3 FADH\u2082, 2 ATP",
      "E": "4 NADH, 1 FADH\u2082, 1 ATP"
    },
    "answer": "B",
    "explanation": "Each acetyl-CoA yields 3 NADH, 1 FADH\u2082, and 1 ATP (or GTP) during the citric acid (Krebs) cycle.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 72,
    "question": "Rate-determining enzymes in metabolic pathways are often located at steps where \u0394G is:",
    "options": {
      "A": "Close to zero",
      "B": "Highly positive",
      "C": "Highly negative",
      "D": "Unchanged",
      "E": "Variable, depending on the enzyme"
    },
    "answer": "C",
    "explanation": "Rate-determining (control) steps are typically those with large negative \u0394G, making them effectively irreversible and key points for regulation.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 73,
    "question": "Which of the following is an example of a short-term control mechanism of metabolism?",
    "options": {
      "A": "Changes in gene expression",
      "B": "Proteolysis of enzymes",
      "C": "Allosteric inhibition or activation",
      "D": "Altered transcription rate",
      "E": "Protein synthesis regulation"
    },
    "answer": "C",
    "explanation": "Allosteric regulation (inhibitors or activators binding to enzymes) occurs within seconds to minutes and constitutes short-term control.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 74,
    "question": "Adrenaline primarily affects metabolism by:",
    "options": {
      "A": "Inhibiting glycolysis and promoting lipid synthesis",
      "B": "Activating glycogen breakdown and increasing blood glucose",
      "C": "Stimulating protein synthesis in muscle",
      "D": "Reducing fatty acid mobilization",
      "E": "Enhancing DNA replication in liver cells"
    },
    "answer": "B",
    "explanation": "Adrenaline (epinephrine) activates glycogen phosphorylase, promoting glycogen breakdown and raising blood glucose for \u2018fight-or-flight\u2019 responses.",
    "category": "FOM-BIOCHEMISTRY"
  },
  {
    "id": 75,
    "question": "Which of the following is an anabolic process?",
    "options": {
      "A": "Glycolysis",
      "B": "Citric acid cycle",
      "C": "Protein synthesis",
      "D": "Oxidative phosphorylation",
      "E": "Electron transport"
    },
    "answer": "C",
    "explanation": "Protein synthesis builds complex biomolecules from amino acids, consuming ATP and thus represents an anabolic process.",
    "category": "FOM-BIOCHEMISTRY"
  },
    {
    "id": 76,
    "question": "Which of the following is a measure of spread used for numerical variables?",
    "options": {
      "A": "Risk ratio",
      "B": "Prevalence",
      "C": "Standard deviation",
      "D": "Binary proportion",
      "E": "Chi-square test"
    },
    "answer": "C",
    "explanation": "Standard deviation measures the spread of numerical data around the mean. Risk ratio and prevalence are measures of effect and frequency respectively, not spread.",
    "category": "FOM-EBM"
  },
  {
    "id": 77,
    "question": "Which graph is most appropriate for representing continuous data such as height?",
    "options": {
      "A": "Pie chart",
      "B": "Bar chart",
      "C": "Histogram",
      "D": "Venn diagram",
      "E": "Box plot"
    },
    "answer": "C",
    "explanation": "Histograms are used for visualizing continuous data. Bar and pie charts are more suited for categorical data.",
    "category": "FOM-EBM"
  },
  {
    "id": 78,
    "question": "How is incidence rate best defined?",
    "options": {
      "A": "Number of existing cases at one time",
      "B": "Risk in the exposed group",
      "C": "New cases divided by disease-free population and time",
      "D": "Prevalence multiplied by risk ratio",
      "E": "Total deaths per year"
    },
    "answer": "C",
    "explanation": "Incidence rate = new cases / (number initially disease-free × time interval). It reflects how quickly new cases arise.",
    "category": "FOM-EBM"
  },
  {
    "id": 79,
    "question": "Which of the following variables is considered unordered categorical?",
    "options": {
      "A": "Social class",
      "B": "Ethnicity",
      "C": "BMI",
      "D": "Post-treatment mortality",
      "E": "Educational level"
    },
    "answer": "B",
    "explanation": "Ethnicity is a nominal (unordered categorical) variable. Social class and educational level are ordered, BMI is continuous, and mortality is binary.",
    "category": "FOM-EBM"
  },
  {
    "id": 80,
    "question": "What does a risk ratio of 1.75 indicate?",
    "options": {
      "A": "75% reduction in risk",
      "B": "Risk is 1.75% of baseline",
      "C": "Risk is 75% higher in exposed group",
      "D": "No difference between groups",
      "E": "75 cases per 1000"
    },
    "answer": "C",
    "explanation": "A risk ratio >1 indicates increased risk in the exposed group. A ratio of 1.75 suggests a 75% higher risk than controls.",
    "category": "FOM-EBM"
  },
  {
    "id": 81,
    "question": "What is the main limitation of cross-sectional studies?",
    "options": {
      "A": "They are expensive and time-consuming",
      "B": "They cannot assess the burden of disease",
      "C": "They do not allow assessment of causality",
      "D": "They are only used for animal studies",
      "E": "They require experimental intervention"
    },
    "answer": "C",
    "explanation": "Cross-sectional studies can estimate disease burden but do not establish temporal relationships, making causal inference unreliable.",
    "category": "FOM-EBM"
  },
  {
    "id": 82,
    "question": "Which of the following is true about prevalence?",
    "options": {
      "A": "It equals incidence multiplied by average disease duration",
      "B": "It reflects only new cases",
      "C": "It is used to assess death rates",
      "D": "It increases as cure rates improve",
      "E": "It cannot be used in chronic conditions"
    },
    "answer": "A",
    "explanation": "Prevalence = Incidence × Average duration of disease. It includes all existing cases, not just new ones.",
    "category": "FOM-EBM"
  },
  {
    "id": 83,
    "question": "Which is an example of an ordered categorical variable?",
    "options": {
      "A": "Ethnicity",
      "B": "Blood type",
      "C": "Social class",
      "D": "Platelet count",
      "E": "Sex"
    },
    "answer": "C",
    "explanation": "Social class is ordered (e.g., I, II, III). Ethnicity and blood type are unordered, platelet count is continuous, and sex is binary.",
    "category": "FOM-EBM"
  },
  {
    "id": 84,
    "question": "Which of the following enhances representativeness in study sampling?",
    "options": {
      "A": "Random sampling",
      "B": "Convenience sampling",
      "C": "Case-control sampling",
      "D": "Snowball sampling",
      "E": "Self-selection"
    },
    "answer": "A",
    "explanation": "Random sampling helps ensure that the study sample reflects the target population, minimizing selection bias.",
    "category": "FOM-EBM"
  },
  {
    "id": 85,
    "question": "Which of the following best defines a descriptive study?",
    "options": {
      "A": "A study that evaluates a new treatment",
      "B": "A study that tests causality between variables",
      "C": "A study that maps disease patterns over time",
      "D": "A study with random allocation of exposures",
      "E": "A study measuring recall bias"
    },
    "answer": "C",
    "explanation": "Descriptive studies describe disease by time, place, and person without evaluating causality or interventions.",
    "category": "FOM-EBM"
  },
    {
    "id": 86,
    "question": "What does a risk ratio of 2.0 indicate?",
    "options": {
      "A": "A 2% increase in disease risk",
      "B": "The treatment halves the disease risk",
      "C": "There is no difference in risk",
      "D": "The exposed group is twice as likely to get the disease",
      "E": "The study is invalid"
    },
    "answer": "D",
    "explanation": "A risk ratio (relative risk) of 2.0 means the exposed group has double the risk of disease compared to the unexposed group. This is a relative measure of effect.",
    "category": "FOM-EBM"
  },
  {
    "id": 87,
    "question": "Which of the following best defines prevalence?",
    "options": {
      "A": "New cases per person-year",
      "B": "Number of deaths over time",
      "C": "Total cases at a specific time point",
      "D": "Proportion of population who are smokers",
      "E": "Average risk of disease in 5 years"
    },
    "answer": "C",
    "explanation": "Prevalence is the proportion of individuals with a disease at a specific point in time. It includes both new and existing cases.",
    "category": "FOM-EBM"
  },
  {
    "id": 88,
    "question": "Which distribution type is described by mode < median < mean?",
    "options": {
      "A": "Normal",
      "B": "Symmetrical",
      "C": "Negatively skewed",
      "D": "Uniform",
      "E": "Positively skewed"
    },
    "answer": "E",
    "explanation": "In a positively skewed distribution, the long right tail causes the mean to be greater than the median, which is greater than the mode.",
    "category": "FOM-EBM"
  },
  {
    "id": 89,
    "question": "Which statement about cross-sectional studies is TRUE?",
    "options": {
      "A": "They can establish causation",
      "B": "They measure disease incidence",
      "C": "They are experimental studies",
      "D": "They are used to assess disease burden",
      "E": "They measure risk over time"
    },
    "answer": "D",
    "explanation": "Cross-sectional studies are observational designs used to estimate prevalence (burden) of disease in a population at a single time point.",
    "category": "FOM-EBM"
  },
  {
    "id": 90,
    "question": "What is the purpose of using random sampling in epidemiological studies?",
    "options": {
      "A": "To ensure fast data collection",
      "B": "To exclude unhealthy individuals",
      "C": "To minimise volunteer bias",
      "D": "To ensure every population member has equal chance of selection",
      "E": "To manipulate exposures for analysis"
    },
    "answer": "D",
    "explanation": "Random sampling ensures representativeness by giving each individual an equal probability of being selected, reducing selection bias.",
    "category": "FOM-EBM"
  },
  {
    "id": 91,
    "question": "In a normal distribution, approximately 95% of values fall within which interval?",
    "options": {
      "A": "Mean ± 1 SD",
      "B": "Mean ± 1.5 SD",
      "C": "Mean ± 1.96 SD",
      "D": "Mean ± 2.5 SD",
      "E": "Mean ± 3 SD"
    },
    "answer": "C",
    "explanation": "The 95% reference range in a normal distribution is mean ± 1.96 SD. This is used clinically to determine what counts as 'normal' results.",
    "category": "FOM-EBM"
  },
  {
    "id": 92,
    "question": "Which scenario is an example of reverse causality in a cross-sectional study?",
    "options": {
      "A": "Smoking leads to lung cancer",
      "B": "High BMI measured after hypertension diagnosis",
      "C": "Lower income linked to increased obesity",
      "D": "Genetic factors linked to diabetes",
      "E": "Cancer leading to early mortality"
    },
    "answer": "B",
    "explanation": "Reverse causality occurs when the outcome might actually influence the exposure. For example, people may gain weight due to their hypertension treatment.",
    "category": "FOM-EBM"
  },
  {
    "id": 93,
    "question": "Which factor does NOT explain apparent changes in disease trends over time?",
    "options": {
      "A": "Improved diagnostic techniques",
      "B": "Random fluctuation (chance)",
      "C": "Changes in population age structure",
      "D": "Environmental risk factors",
      "E": "Consistency in ICD coding"
    },
    "answer": "E",
    "explanation": "Inconsistent ICD coding can create artificial changes in trends, not consistency. The other factors explain real or artefactual changes.",
    "category": "FOM-EBM"
  },
  {
    "id": 94,
    "question": "What best explains selection bias in a study?",
    "options": {
      "A": "Study is too small",
      "B": "Sample is not representative of target population",
      "C": "Data are not normally distributed",
      "D": "Too many variables are measured",
      "E": "Statistical test was inappropriate"
    },
    "answer": "B",
    "explanation": "Selection bias occurs when the study sample differs systematically from the target population, reducing internal validity.",
    "category": "FOM-EBM"
  },
  {
    "id": 95,
    "question": "Which method best estimates how fast new cases of disease are occurring?",
    "options": {
      "A": "Prevalence",
      "B": "Incidence rate",
      "C": "Standard deviation",
      "D": "Confidence interval",
      "E": "Risk difference"
    },
    "answer": "B",
    "explanation": "Incidence rate = new cases / (population at risk × time). It reflects the speed of new case occurrence over time.",
    "category": "FOM-EBM"
  },
    {
    "id": 96,
    "question": "What does the standard error (SE) represent in statistics?",
    "options": {
      "A": "The standard deviation of a population",
      "B": "The variability between different populations",
      "C": "The precision of a sample statistic as an estimate of a population value",
      "D": "The difference between control and treatment groups",
      "E": "The average bias in the study"
    },
    "answer": "C",
    "explanation": "The standard error measures how precisely a sample statistic (e.g. mean) estimates the population parameter. A smaller SE indicates greater precision.",
    "category": "FOM-EBM"
  },
  {
    "id": 97,
    "question": "Which of the following correctly describes a 95% confidence interval?",
    "options": {
      "A": "There is a 95% chance the sample mean is correct",
      "B": "95% of the population falls within the interval",
      "C": "95% of sample statistics fall within 1.96 SD of the mean",
      "D": "There is a 95% chance the population value lies within the interval",
      "E": "It guarantees the true value is inside the range"
    },
    "answer": "D",
    "explanation": "A 95% CI means that if the study were repeated many times, 95% of the calculated intervals would contain the true population value.",
    "category": "FOM-EBM"
  },
  {
    "id": 98,
    "question": "Which factor will reduce the standard error of the mean?",
    "options": {
      "A": "Smaller population",
      "B": "Larger sample size",
      "C": "Higher variability in data",
      "D": "Lower standard deviation",
      "E": "Wider confidence interval"
    },
    "answer": "B",
    "explanation": "Larger sample sizes reduce the standard error, increasing precision of the estimate. SE = SD/√n.",
    "category": "FOM-EBM"
  },
  {
    "id": 99,
    "question": "Which interpretation of a P value is most accurate?",
    "options": {
      "A": "The probability that the null hypothesis is true",
      "B": "The probability that the alternative hypothesis is true",
      "C": "The probability of observing the data assuming the null hypothesis is true",
      "D": "The chance the observed result occurred by bias",
      "E": "The probability of clinical significance"
    },
    "answer": "C",
    "explanation": "A P value represents the probability of obtaining results as extreme as the observed ones if the null hypothesis were true.",
    "category": "FOM-EBM"
  },
  {
    "id": 100,
    "question": "Which situation demonstrates the difference between statistical and clinical significance?",
    "options": {
      "A": "A large trial shows P = 0.07 with wide CI",
      "B": "A small study finds a 20% difference with P = 0.2",
      "C": "A large trial finds a 2% mortality reduction with P < 0.001",
      "D": "A study with few participants shows RR = 2.0",
      "E": "An underpowered trial shows no difference"
    },
    "answer": "C",
    "explanation": "Statistical significance (low P value) does not imply clinical importance. A 2% mortality reduction may not justify using an expensive drug.",
    "category": "FOM-EBM"
  },
  {
    "id": 101,
    "question": "Why can a small clinical trial show no statistical significance despite a large effect?",
    "options": {
      "A": "The null hypothesis is incorrect",
      "B": "The sample was non-random",
      "C": "It is underpowered due to high variability or low n",
      "D": "Standard deviation is always too high",
      "E": "The confidence interval is automatically invalid"
    },
    "answer": "C",
    "explanation": "Small trials have lower power. Even if a real effect exists, the small sample may not detect it due to wide confidence intervals and large standard errors.",
    "category": "FOM-EBM"
  },
  {
    "id": 102,
    "question": "Which of the following best describes 'absence of evidence is not evidence of absence'?",
    "options": {
      "A": "A P value < 0.05 proves the null hypothesis",
      "B": "Wide confidence intervals mean treatment is effective",
      "C": "A non-significant result in a small study cannot rule out an effect",
      "D": "If the confidence interval includes zero, the effect is clinically important",
      "E": "Small trials produce narrow confidence intervals"
    },
    "answer": "C",
    "explanation": "A lack of statistical significance in a small study may simply reflect low power, not the absence of a real effect.",
    "category": "FOM-EBM"
  },
  {
    "id": 103,
    "question": "What is the correct formula to calculate a 95% confidence interval for a population proportion?",
    "options": {
      "A": "mean ± (2 × SD)",
      "B": "p ± (1.96 × SE(p))",
      "C": "proportion × SD",
      "D": "p × (SE × 2)",
      "E": "mean ± (1.64 × SE)"
    },
    "answer": "B",
    "explanation": "The 95% CI for a proportion is calculated as p ± 1.96 × SE(p), where SE(p) = sqrt[p(1-p)/n].",
    "category": "FOM-EBM"
  },
  {
    "id": 104,
    "question": "What does a narrow confidence interval indicate about a study estimate?",
    "options": {
      "A": "The study has high bias",
      "B": "The point estimate is incorrect",
      "C": "The estimate is highly precise",
      "D": "The result is statistically insignificant",
      "E": "The effect is clinically important"
    },
    "answer": "C",
    "explanation": "A narrow CI means less variability in the estimate, i.e. higher precision. This typically results from a large sample size or low standard deviation.",
    "category": "FOM-EBM"
  },
  {
    "id": 105,
    "question": "What can be inferred if a study's P value is < 0.05?",
    "options": {
      "A": "The result is clinically meaningful",
      "B": "There is strong evidence against the null hypothesis",
      "C": "The effect is large",
      "D": "The study is free from bias",
      "E": "The sample was representative"
    },
    "answer": "B",
    "explanation": "A P value < 0.05 indicates strong evidence against the null hypothesis, but it does not comment on clinical importance or study validity.",
    "category": "FOM-EBM"
  },
    {
    "id": 106,
    "question": "Which study design provides the strongest evidence of causality?",
    "options": {
      "A": "Cross-sectional study",
      "B": "Case-control study",
      "C": "Ecological study",
      "D": "Randomised controlled trial",
      "E": "Retrospective cohort study"
    },
    "answer": "D",
    "explanation": "RCTs are interventional studies where participants are randomly assigned to treatment or control groups, minimising confounding and providing the strongest evidence of causality.",
    "category": "FOM-EBM"
  },
  {
    "id": 107,
    "question": "What does the number needed to treat to benefit (NNTB) represent?",
    "options": {
      "A": "The number of patients harmed by treatment",
      "B": "The number of patients who develop side effects",
      "C": "The number of patients needed to treat to prevent one bad outcome",
      "D": "The cost per life saved",
      "E": "The population incidence of disease"
    },
    "answer": "C",
    "explanation": "NNTB is the inverse of the risk difference and indicates how many patients need to receive treatment to prevent one adverse outcome.",
    "category": "FOM-EBM"
  },
  {
    "id": 108,
    "question": "In a cohort study, what is the main advantage compared to case-control studies?",
    "options": {
      "A": "Faster results for rare diseases",
      "B": "No need for follow-up",
      "C": "Measurement of exposure occurs before disease onset",
      "D": "Cheaper and easier to conduct",
      "E": "Allows for randomisation"
    },
    "answer": "C",
    "explanation": "Cohort studies are prospective and measure exposures before outcomes, clarifying the temporal relationship.",
    "category": "FOM-EBM"
  },
  {
    "id": 109,
    "question": "Which value is the null hypothesis for a risk ratio?",
    "options": {
      "A": "0",
      "B": "1",
      "C": "100",
      "D": "-1",
      "E": "0.5"
    },
    "answer": "B",
    "explanation": "A risk ratio (or odds ratio) of 1 means no difference in risk between groups. It's the null value when testing for association.",
    "category": "FOM-EBM"
  },
  {
    "id": 110,
    "question": "In a case-control study, which measure of association is most appropriate?",
    "options": {
      "A": "Risk difference",
      "B": "Risk ratio",
      "C": "Incidence rate",
      "D": "Odds ratio",
      "E": "Prevalence ratio"
    },
    "answer": "D",
    "explanation": "Risk cannot be calculated in case-control studies due to unknown population sizes. Odds ratios are used instead.",
    "category": "FOM-EBM"
  },
  {
    "id": 111,
    "question": "What does a confidence interval for a risk ratio that includes 1.0 indicate?",
    "options": {
      "A": "There is a strong protective effect",
      "B": "The result is statistically significant",
      "C": "The true value may indicate no effect",
      "D": "The risk ratio is invalid",
      "E": "Exposure is definitely harmful"
    },
    "answer": "C",
    "explanation": "If the CI includes 1, there may be no true difference between groups. The result is not statistically significant.",
    "category": "FOM-EBM"
  },
  {
    "id": 112,
    "question": "Why are odds ratios approximately equal to risk ratios when disease is rare?",
    "options": {
      "A": "The odds become negligible",
      "B": "Prevalence approximates incidence",
      "C": "Odds and risk converge as disease probability approaches zero",
      "D": "Case-control studies use true risk",
      "E": "Control group size increases"
    },
    "answer": "C",
    "explanation": "When disease is rare, d/n ≈ d/h, making odds ≈ risk, and OR ≈ RR.",
    "category": "FOM-EBM"
  },
  {
    "id": 113,
    "question": "Which feature is essential in a well-conducted randomised controlled trial?",
    "options": {
      "A": "Case matching by age",
      "B": "Non-random group allocation",
      "C": "Blinding of participants and assessors",
      "D": "Use of historical data",
      "E": "Measuring outcomes before exposures"
    },
    "answer": "C",
    "explanation": "Blinding reduces bias. Randomisation and blinding together improve validity of RCTs.",
    "category": "FOM-EBM"
  },
  {
    "id": 114,
    "question": "What does it mean if a study’s risk difference confidence interval contains zero?",
    "options": {
      "A": "Statistically significant effect is present",
      "B": "Strong evidence of benefit",
      "C": "Result may be due to chance; no significant effect detected",
      "D": "The treatment is harmful",
      "E": "It supports the use of the intervention"
    },
    "answer": "C",
    "explanation": "A confidence interval including 0 suggests the result may not be statistically significant (null value for RD = 0).",
    "category": "FOM-EBM"
  },
  {
    "id": 115,
    "question": "Why might a case-control study be preferred over a cohort study?",
    "options": {
      "A": "It provides stronger causal inference",
      "B": "It uses prospective data",
      "C": "It is more cost-effective for rare diseases",
      "D": "It avoids recall bias",
      "E": "It allows measurement of incidence"
    },
    "answer": "C",
    "explanation": "Case-control studies are cheaper and more efficient for rare diseases, avoiding the need for large sample sizes.",
    "category": "FOM-EBM"
  },
    {
    "id": 116,
    "question": "Which of the following best defines a confounder?",
    "options": {
      "A": "A variable on the causal pathway between exposure and outcome",
      "B": "A variable associated with both the exposure and the outcome",
      "C": "An unrelated variable used as a control",
      "D": "An outcome that causes the exposure",
      "E": "A random variable that explains statistical noise"
    },
    "answer": "B",
    "explanation": "A confounder is associated with both the exposure and the outcome and can distort their apparent relationship. It is not part of the causal pathway.",
    "category": "FOM-EBM"
  },
  {
    "id": 117,
    "question": "Which of the following is NOT one of Bradford Hill’s criteria for causality?",
    "options": {
      "A": "Temporality",
      "B": "Biological gradient",
      "C": "Plausibility",
      "D": "Statistical significance",
      "E": "Consistency"
    },
    "answer": "D",
    "explanation": "Bradford Hill's criteria include temporality, consistency, strength, specificity, plausibility, coherence, biological gradient, experiment, and analogy — but not statistical significance.",
    "category": "FOM-EBM"
  },
  {
    "id": 118,
    "question": "Why is temporality essential in causal inference?",
    "options": {
      "A": "It measures how common the exposure is",
      "B": "It ensures the exposure occurs after the outcome",
      "C": "It confirms that the exposure precedes the outcome",
      "D": "It adjusts for all known confounders",
      "E": "It increases study power"
    },
    "answer": "C",
    "explanation": "Temporality — the cause precedes the effect — is the only necessary criterion for causality and is essential for interpreting a causal relationship.",
    "category": "FOM-EBM"
  },
  {
    "id": 119,
    "question": "Which of the following scenarios best illustrates selection bias?",
    "options": {
      "A": "Participants drop out due to side effects",
      "B": "The sample only includes patients attending a private clinic",
      "C": "Recall of exposure is inaccurate",
      "D": "Exposure is measured with poor precision",
      "E": "Only outcomes that are statistically significant are published"
    },
    "answer": "B",
    "explanation": "Selection bias occurs when the study sample is not representative of the target population, such as when only certain subgroups are included.",
    "category": "FOM-EBM"
  },
  {
    "id": 120,
    "question": "Which type of bias occurs when cases are more likely than controls to remember exposures?",
    "options": {
      "A": "Observer bias",
      "B": "Selection bias",
      "C": "Information bias",
      "D": "Recall bias",
      "E": "Channeling bias"
    },
    "answer": "D",
    "explanation": "Recall bias is a type of information bias common in retrospective studies when cases remember past exposures differently than controls.",
    "category": "FOM-EBM"
  },
  {
    "id": 121,
    "question": "Which of the following reduces confounding in a randomized trial?",
    "options": {
      "A": "Matching",
      "B": "Blinding",
      "C": "Loss to follow-up",
      "D": "Random allocation",
      "E": "Large sample size"
    },
    "answer": "D",
    "explanation": "Random allocation distributes known and unknown confounders equally across groups, reducing confounding by design.",
    "category": "FOM-EBM"
  },
  {
    "id": 122,
    "question": "Which Bradford Hill criterion refers to a dose-response relationship?",
    "options": {
      "A": "Coherence",
      "B": "Biological gradient",
      "C": "Temporality",
      "D": "Analogy",
      "E": "Strength"
    },
    "answer": "B",
    "explanation": "Biological gradient refers to a dose-response relationship, where increasing levels of exposure lead to a greater effect.",
    "category": "FOM-EBM"
  },
  {
    "id": 123,
    "question": "Which bias occurs when loss to follow-up is related to both exposure and outcome?",
    "options": {
      "A": "Information bias",
      "B": "Non-differential misclassification",
      "C": "Attrition bias",
      "D": "Surveillance bias",
      "E": "Interviewer bias"
    },
    "answer": "C",
    "explanation": "Attrition bias occurs when dropout is not random and is related to both exposure and outcome, potentially skewing results.",
    "category": "FOM-EBM"
  },
  {
    "id": 124,
    "question": "Which of the following is an example of information bias?",
    "options": {
      "A": "Using different diagnostic tools for exposed and unexposed groups",
      "B": "Only including healthy participants",
      "C": "Failing to blind the outcome assessor",
      "D": "Loss to follow-up in a cohort study",
      "E": "Matching by sex in a case-control study"
    },
    "answer": "A",
    "explanation": "Information bias arises from systematic errors in measurement of exposure or outcome. Using different tools introduces differential misclassification.",
    "category": "FOM-EBM"
  },
  {
    "id": 125,
    "question": "Which approach can be used at the analysis stage to control for confounding?",
    "options": {
      "A": "Blinding",
      "B": "Stratification",
      "C": "Randomisation",
      "D": "Matching",
      "E": "Allocation concealment"
    },
    "answer": "B",
    "explanation": "Stratification involves analysing subgroups to control for confounding. Other methods like matching and randomisation are done at the design stage.",
    "category": "FOM-EBM"
  },
    {
    "id": 126,
    "question": "Which of the following best defines public health?",
    "options": {
      "A": "Treating diseases using evidence-based medicine",
      "B": "The science and art of preventing disease and promoting health through organised efforts of society",
      "C": "The assessment and diagnosis of individual patients",
      "D": "Medical interventions aimed at curing chronic diseases",
      "E": "The use of antibiotics to treat communicable disease"
    },
    "answer": "B",
    "explanation": "Public health is defined as the science and art of preventing disease, prolonging life, and promoting health through organised efforts of society.",
    "category": "FOM-EBM"
  },
  {
    "id": 127,
    "question": "Which of the following best describes tertiary prevention?",
    "options": {
      "A": "Preventing disease onset",
      "B": "Screening asymptomatic individuals",
      "C": "Treating and rehabilitating people with established disease",
      "D": "Reducing exposure to risk factors",
      "E": "Educating the public about disease symptoms"
    },
    "answer": "C",
    "explanation": "Tertiary prevention focuses on reducing complications and disability from established disease, such as stroke rehabilitation.",
    "category": "FOM-EBM"
  },
  {
    "id": 128,
    "question": "What is the key feature of the 'Prevention Paradox'?",
    "options": {
      "A": "Prevention only works in high-risk individuals",
      "B": "Most people benefit greatly from preventive measures",
      "C": "Prevention has greater population benefit than individual benefit",
      "D": "Prevention is always cost-effective",
      "E": "Prevention can only be applied in clinical settings"
    },
    "answer": "C",
    "explanation": "The Prevention Paradox describes how a measure that brings substantial benefit to the population may offer little to each individual participant.",
    "category": "FOM-EBM"
  },
  {
    "id": 129,
    "question": "Which of the following is a limitation of the high-risk strategy?",
    "options": {
      "A": "It cannot identify individuals at risk",
      "B": "It benefits the entire population equally",
      "C": "It often misses the majority of disease burden in the population",
      "D": "It eliminates the need for public health",
      "E": "It focuses too much on environmental factors"
    },
    "answer": "C",
    "explanation": "The high-risk strategy targets individuals, but many cases occur in the general population with moderate risk, limiting its overall impact.",
    "category": "FOM-EBM"
  },
  {
    "id": 130,
    "question": "Which of the following best defines DALYs (Disability Adjusted Life Years)?",
    "options": {
      "A": "Years lost due to ageing",
      "B": "Years lived in perfect health",
      "C": "Sum of years lost due to premature death and years lived with disability",
      "D": "The number of people who die from a disease",
      "E": "Years of treatment needed for chronic illness"
    },
    "answer": "C",
    "explanation": "DALYs are calculated by adding years of life lost due to early death and years lived with disability, providing a measure of disease burden.",
    "category": "FOM-EBM"
  },
  {
    "id": 131,
    "question": "What is a key global health challenge currently faced by low and middle-income countries?",
    "options": {
      "A": "Decline in non-communicable diseases",
      "B": "Double burden of communicable and non-communicable diseases",
      "C": "Overfunding of public health infrastructure",
      "D": "Lack of exposure to urbanisation",
      "E": "Excessive maternal mortality in Europe"
    },
    "answer": "B",
    "explanation": "These countries face a dual burden: persisting communicable diseases and rising non-communicable diseases due to rapid urbanisation and globalisation.",
    "category": "FOM-EBM"
  },
  {
    "id": 132,
    "question": "Which of the following Sustainable Development Goals (SDGs) directly targets health?",
    "options": {
      "A": "Zero Hunger",
      "B": "Good Health and Well-being",
      "C": "Industry, Innovation and Infrastructure",
      "D": "Peace, Justice and Strong Institutions",
      "E": "Climate Action"
    },
    "answer": "B",
    "explanation": "SDG 3 aims to ensure healthy lives and promote well-being for all at all ages.",
    "category": "FOM-EBM"
  },
  {
    "id": 133,
    "question": "Which of the following is considered a negative health impact of urbanisation?",
    "options": {
      "A": "Increased access to healthcare",
      "B": "Improved education opportunities",
      "C": "Air pollution and overcrowding",
      "D": "Higher income levels",
      "E": "Reduced chronic disease rates"
    },
    "answer": "C",
    "explanation": "Urbanisation can worsen health through environmental issues like overcrowding, pollution, and limited sanitation in rapidly growing areas.",
    "category": "FOM-EBM"
  },
  {
    "id": 134,
    "question": "Which public health domain focuses on managing infectious diseases, chemicals, and radiation?",
    "options": {
      "A": "Health improvement",
      "B": "Healthcare public health",
      "C": "Health protection",
      "D": "Clinical governance",
      "E": "Health promotion"
    },
    "answer": "C",
    "explanation": "Health protection is the public health domain that manages threats like infectious diseases and environmental hazards.",
    "category": "FOM-EBM"
  },
  {
    "id": 135,
    "question": "Which global organisation was instrumental in launching the Millennium Development Goals (MDGs)?",
    "options": {
      "A": "World Trade Organization",
      "B": "UNESCO",
      "C": "World Health Organization",
      "D": "United Nations",
      "E": "World Bank"
    },
    "answer": "D",
    "explanation": "The MDGs were launched at the Millennium Summit in 2000 by the United Nations, with support from WHO and other agencies.",
    "category": "FOM-EBM"
  },
    {
    "id": 136,
    "question": "What is the approximate percentage of total body weight that is water in an average adult human?",
    "options": {
      "A": "30%",
      "B": "50%",
      "C": "60%",
      "D": "80%",
      "E": "5%"
    },
    "answer": "C",
    "explanation": "Approximately 60% of total body weight is water, distributed between the intracellular and extracellular fluid compartments.",
    "category": "FOM-PPN"
  },
  {
    "id": 137,
    "question": "Which ion has a significantly higher concentration in the intracellular fluid (ICF) compared to the extracellular fluid (ECF)?",
    "options": {
      "A": "Sodium",
      "B": "Potassium",
      "C": "Calcium",
      "D": "Chloride",
      "E": "Iron"
    },
    "answer": "B",
    "explanation": "Potassium is much more concentrated in the ICF (~120 mmol/L) than the ECF (~4 mmol/L), which is essential for maintaining the resting membrane potential.",
    "category": "FOM-PPN"
  },
  {
    "id": 138,
    "question": "What best defines homeostasis?",
    "options": {
      "A": "Complete absence of change in the body",
      "B": "An unstable internal environment",
      "C": "The maintenance of a constant internal environment",
      "D": "Rapid cellular proliferation",
      "E": "Hormone secretion regulation only"
    },
    "answer": "C",
    "explanation": "Homeostasis refers to the body's ability to maintain a stable internal environment, a concept first proposed by Claude Bernard and later expanded by Walter Cannon.",
    "category": "FOM-PPN"
  },
  {
    "id": 139,
    "question": "In a negative feedback loop, what component compares actual values to the set point?",
    "options": {
      "A": "Receptor",
      "B": "Effector",
      "C": "Processor (Integrating centre)",
      "D": "Response",
      "E": "Muscle"
    },
    "answer": "C",
    "explanation": "The processor or integrating centre compares current values to the target set point and activates effectors if deviation is detected.",
    "category": "FOM-PPN"
  },
  {
    "id": 140,
    "question": "Which of the following would increase effective osmotic pressure in the ECF?",
    "options": {
      "A": "Adding water",
      "B": "Increasing Na+ concentration",
      "C": "Decreasing glucose",
      "D": "Lowering K+ concentration",
      "E": "Introducing more aquaporins"
    },
    "answer": "B",
    "explanation": "Effective osmotic pressure depends on the concentration of non-permeable solutes such as Na+; increasing it raises osmotic pressure and draws water toward that compartment.",
    "category": "FOM-PPN"
  },
  {
    "id": 141,
    "question": "What is the concentration of calcium in the extracellular fluid (ECF)?",
    "options": {
      "A": "0.0001 mmol/L",
      "B": "1.25 mmol/L",
      "C": "140 mmol/L",
      "D": "4 mmol/L",
      "E": "0.25 mmol/L"
    },
    "answer": "B",
    "explanation": "ECF calcium concentration is approximately 1.25 mmol/L, much higher than the ICF level of 0.0001 mmol/L.",
    "category": "FOM-PPN"
  },
  {
    "id": 142,
    "question": "What best describes osmosis?",
    "options": {
      "A": "Movement of water from low to high solute concentration across a semi-permeable membrane",
      "B": "Movement of ions down their electrochemical gradient",
      "C": "Bulk flow of water due to hydrostatic pressure",
      "D": "Protein-mediated active transport of glucose",
      "E": "Efflux of potassium from cells"
    },
    "answer": "A",
    "explanation": "Osmosis is the passive movement of water from an area of lower solute concentration to higher solute concentration across a semi-permeable membrane.",
    "category": "FOM-PPN"
  },
  {
    "id": 143,
    "question": "Which of the following best describes the ECF:ICF ratio of calcium concentration?",
    "options": {
      "A": "0.0001:1.25",
      "B": "1.25:0.0001",
      "C": "140:4",
      "D": "10:140",
      "E": "Equal in both compartments"
    },
    "answer": "B",
    "explanation": "Calcium is ~1.25 mmol/L in ECF and ~0.0001 mmol/L in ICF, making the ratio ECF:ICF = 1.25:0.0001.",
    "category": "FOM-PPN"
  },
  {
    "id": 144,
    "question": "Who introduced the concept of 'milieu intérieur' as a foundation of physiology?",
    "options": {
      "A": "Walter Cannon",
      "B": "Sydney Ringer",
      "C": "Claude Bernard",
      "D": "Alexander Fleming",
      "E": "Louis Pasteur"
    },
    "answer": "C",
    "explanation": "Claude Bernard coined the term 'milieu intérieur' to describe the internal environment essential for organism stability.",
    "category": "FOM-PPN"
  },
  {
    "id": 145,
    "question": "What mainly determines the volume of the extracellular fluid compartment?",
    "options": {
      "A": "Oxygen concentration",
      "B": "Potassium content",
      "C": "Total body protein",
      "D": "Sodium content",
      "E": "Hydrostatic pressure"
    },
    "answer": "D",
    "explanation": "Sodium is the primary osmotically active solute in the ECF and thus governs ECF volume.",
    "category": "FOM-PPN"
  },
    {
    "id": 146,
    "question": "What is the defining feature of a hypertonic solution when red blood cells are placed in it?",
    "options": {
      "A": "Cells remain unchanged",
      "B": "Cells swell and burst",
      "C": "Cells shrink and become crenated",
      "D": "Cells divide rapidly",
      "E": "Cells change color"
    },
    "answer": "C",
    "explanation": "Hypertonic solutions have higher effective osmotic pressure than ICF, drawing water out of cells and causing them to shrink (crenation).",
    "category": "FOM-PPN"
  },
  {
    "id": 147,
    "question": "What happens to red blood cells placed in distilled water?",
    "options": {
      "A": "They shrink and crenate",
      "B": "No change occurs",
      "C": "They swell and haemolyse",
      "D": "They divide",
      "E": "They secrete water"
    },
    "answer": "C",
    "explanation": "Distilled water is hypotonic, so water moves into cells by osmosis, causing them to swell and potentially burst (haemolysis).",
    "category": "FOM-PPN"
  },
  {
    "id": 148,
    "question": "Which of the following best describes an isotonic solution?",
    "options": {
      "A": "Causes haemolysis of red blood cells",
      "B": "Causes crenation of red blood cells",
      "C": "No net water movement across membranes",
      "D": "Dissolves proteins in plasma",
      "E": "Decreases osmotic pressure"
    },
    "answer": "C",
    "explanation": "An isotonic solution has the same effective osmotic pressure as the ICF, resulting in no net water movement.",
    "category": "FOM-PPN"
  },
  {
    "id": 149,
    "question": "What clinical use does 2.7% NaCl solution have?",
    "options": {
      "A": "Daily hydration",
      "B": "Curing anaemia",
      "C": "Treating cerebral oedema",
      "D": "Supplementing potassium",
      "E": "Increasing haemoglobin levels"
    },
    "answer": "C",
    "explanation": "2.7% NaCl is hypertonic and used cautiously in intensive care, e.g., to draw fluid out of the brain during cerebral oedema.",
    "category": "FOM-PPN"
  },
  {
    "id": 150,
    "question": "Which process requires ATP expenditure in the body?",
    "options": {
      "A": "Simple diffusion",
      "B": "Osmosis",
      "C": "Flux",
      "D": "Bulk flow",
      "E": "Facilitated diffusion"
    },
    "answer": "D",
    "explanation": "Bulk flow involves moving fluid via pressure gradients, which are generated by pumps (e.g., cardiac, respiratory) that use ATP.",
    "category": "FOM-PPN"
  },
  {
    "id": 151,
    "question": "According to Fick’s Law, the rate of diffusion increases with:",
    "options": {
      "A": "Decreased surface area",
      "B": "Lower partial pressure gradient",
      "C": "Increased membrane thickness",
      "D": "Greater surface area",
      "E": "Increased distance"
    },
    "answer": "D",
    "explanation": "Fick’s Law states diffusion is directly proportional to membrane surface area and partial pressure gradient, and inversely proportional to thickness.",
    "category": "FOM-PPN"
  },
  {
    "id": 152,
    "question": "Why is bulk flow necessary in the body?",
    "options": {
      "A": "Flux alone can move oxygen over large distances",
      "B": "Diffusion is too slow over large distances",
      "C": "Osmosis stops at capillaries",
      "D": "Blood is too viscous",
      "E": "Diffusion damages cell membranes"
    },
    "answer": "B",
    "explanation": "Diffusion is rapid only over micrometres. Over centimetres, it would take hours—bulk flow solves this limitation for systemic circulation.",
    "category": "FOM-PPN"
  },
  {
    "id": 153,
    "question": "Which formula correctly represents fluid flow (Q)?",
    "options": {
      "A": "Q = Resistance / ΔP",
      "B": "Q = Surface Area x Pressure",
      "C": "Q = ΔP / Resistance",
      "D": "Q = Diffusion Rate x Osmolarity",
      "E": "Q = Volume x Concentration"
    },
    "answer": "C",
    "explanation": "Flow (Q) is directly proportional to the pressure gradient (ΔP) and inversely proportional to resistance (R): Q = ΔP / R.",
    "category": "FOM-PPN"
  },
  {
    "id": 154,
    "question": "Which of the following statements about diffusion (flux) is true?",
    "options": {
      "A": "It requires ATP",
      "B": "It moves substances against a gradient",
      "C": "It relies on partial pressure or concentration gradients",
      "D": "It only occurs in veins",
      "E": "It is slower than active transport"
    },
    "answer": "C",
    "explanation": "Flux refers to passive movement of solutes/gases down concentration or partial pressure gradients, requiring no energy input.",
    "category": "FOM-PPN"
  },
  {
    "id": 155,
    "question": "Which is NOT a method of gas transport in the blood?",
    "options": {
      "A": "Dissolved in plasma",
      "B": "Bound to proteins like haemoglobin",
      "C": "Chemically altered forms like HCO3−",
      "D": "Encapsulated in vesicles",
      "E": "Freely floating as molecules"
    },
    "answer": "D",
    "explanation": "Gases are carried dissolved, bound to proteins, or chemically converted (e.g., CO2 to bicarbonate), not in vesicles.",
    "category": "FOM-PPN"
  },
    {
    "id": 156,
    "question": "Which of the following best describes partial pressure (P)?",
    "options": {
      "A": "The amount of fluid pressure in arteries",
      "B": "The individual pressure a gas exerts in a mixture",
      "C": "The atmospheric pressure at sea level",
      "D": "The difference in osmolality between compartments",
      "E": "The total pressure in the alveoli only"
    },
    "answer": "B",
    "explanation": "Partial pressure refers to the pressure a single gas would exert if it occupied the entire volume alone. It contributes to the total pressure in a gas mixture.",
    "category": "FOM-PPN"
  },
  {
    "id": 157,
    "question": "What determines the pressure in the kinetic theory of gases?",
    "options": {
      "A": "Total solute concentration",
      "B": "Rate of osmosis",
      "C": "Collision of gas molecules with container walls",
      "D": "Enzymatic reactions",
      "E": "Chemical bonding of gases"
    },
    "answer": "C",
    "explanation": "According to the kinetic theory, gas pressure results from molecules colliding with the walls of their container. More collisions = more pressure.",
    "category": "FOM-PPN"
  },
  {
    "id": 158,
    "question": "In cardiovascular physiology, arterioles are referred to as:",
    "options": {
      "A": "Exchange vessels",
      "B": "Volume regulators",
      "C": "Resistance vessels",
      "D": "Oxygen reservoirs",
      "E": "Pressure dampers"
    },
    "answer": "C",
    "explanation": "Arterioles regulate blood flow and pressure by altering resistance—hence the name 'resistance vessels'.",
    "category": "FOM-PPN"
  },
  {
    "id": 159,
    "question": "Why is distilled water dangerous as an IV infusion?",
    "options": {
      "A": "It causes vasoconstriction",
      "B": "It depletes sodium rapidly",
      "C": "It leads to haemolysis due to water influx",
      "D": "It increases effective osmotic pressure",
      "E": "It has low potassium"
    },
    "answer": "C",
    "explanation": "Distilled water is hypotonic and causes water to rush into red blood cells, leading to swelling and lysis (haemolysis).",
    "category": "FOM-PPN"
  },
  {
    "id": 160,
    "question": "What causes oedema in conditions like heart failure?",
    "options": {
      "A": "Increased diffusion",
      "B": "Impaired venous return increasing hydrostatic pressure",
      "C": "Hypoventilation",
      "D": "Dehydration",
      "E": "Increased metabolic rate"
    },
    "answer": "B",
    "explanation": "In heart failure, elevated venous pressures increase hydrostatic pressure in capillaries, pushing fluid into the interstitial space (oedema).",
    "category": "FOM-PPN"
  },
  {
    "id": 161,
    "question": "Which statement about osmosis is TRUE?",
    "options": {
      "A": "It moves water toward areas of low solute concentration",
      "B": "It requires metabolic energy",
      "C": "It’s driven by random gas molecule motion",
      "D": "It moves water toward higher osmolarity",
      "E": "It increases with lower water activity in ICF"
    },
    "answer": "D",
    "explanation": "Water moves by osmosis from low to high solute concentration—toward areas of higher osmolarity or lower water activity.",
    "category": "FOM-PPN"
  },
  {
    "id": 162,
    "question": "Which of the following contributes to basal metabolic rate (BMR) due to energy demand?",
    "options": {
      "A": "Facilitated diffusion",
      "B": "Flux across capillaries",
      "C": "Simple diffusion of CO2",
      "D": "Cardiac and respiratory muscle activity",
      "E": "Cell membrane repolarisation"
    },
    "answer": "D",
    "explanation": "The generation of pressure gradients by respiratory and cardiac muscles requires ATP and contributes significantly to resting energy expenditure.",
    "category": "FOM-PPN"
  },
  {
    "id": 163,
    "question": "What happens when a red blood cell is placed in a hypotonic solution?",
    "options": {
      "A": "It remains unchanged",
      "B": "It loses water and shrinks",
      "C": "It takes up water and swells",
      "D": "It initiates active transport",
      "E": "It dissolves"
    },
    "answer": "C",
    "explanation": "A hypotonic solution has lower solute concentration than the ICF, causing water to enter the cell via osmosis, leading to swelling.",
    "category": "FOM-PPN"
  },
  {
    "id": 164,
    "question": "Why does increasing the thickness of a membrane decrease the rate of diffusion?",
    "options": {
      "A": "It increases temperature",
      "B": "It lowers osmotic pressure",
      "C": "It raises hydrostatic resistance",
      "D": "It increases diffusion distance",
      "E": "It raises the solute concentration"
    },
    "answer": "D",
    "explanation": "Fick’s Law shows that diffusion rate is inversely proportional to membrane thickness; more thickness = more distance to cross.",
    "category": "FOM-PPN"
  },
  {
    "id": 165,
    "question": "Which scenario most clearly requires bulk flow rather than diffusion?",
    "options": {
      "A": "Oxygen movement across alveoli",
      "B": "CO2 leaving a muscle cell",
      "C": "Plasma entering the glomerulus",
      "D": "Glucose entering erythrocytes",
      "E": "Water entering mitochondria"
    },
    "answer": "C",
    "explanation": "Bulk flow is needed to move large volumes of fluid like plasma into the glomerulus; diffusion alone would be too slow and inefficient.",
    "category": "FOM-PPN"
  },
    {
    "id": 166,
    "question": "Which of the following is the defining feature of paracrine signalling?",
    "options": {
      "A": "Signal travels through the bloodstream",
      "B": "Cell releases hormone into circulation",
      "C": "Signal diffuses in interstitial fluid to nearby cells",
      "D": "Cell activates its own receptors",
      "E": "Neurotransmitter is released at synapse"
    },
    "answer": "C",
    "explanation": "Paracrine signalling involves local diffusion of chemical messengers through interstitial fluid to nearby target cells.",
    "category": "FOM-PPN"
  },
  {
    "id": 167,
    "question": "Which type of receptor is involved when acetylcholine triggers depolarisation in skeletal muscle?",
    "options": {
      "A": "Enzyme-linked receptor",
      "B": "G-protein-coupled receptor",
      "C": "Ligand-gated ion channel",
      "D": "Steroid hormone receptor",
      "E": "Tyrosine kinase receptor"
    },
    "answer": "C",
    "explanation": "The nicotinic acetylcholine receptor is a ligand-gated ion channel that allows Na⁺ influx, causing depolarisation of the skeletal muscle membrane.",
    "category": "FOM-PPN"
  },
  {
    "id": 168,
    "question": "What is the main mechanism by which intracellular receptors alter cell function?",
    "options": {
      "A": "Activation of G-proteins",
      "B": "Regulation of membrane potential",
      "C": "Phosphorylation cascades",
      "D": "Gene expression changes",
      "E": "Opening of calcium channels"
    },
    "answer": "D",
    "explanation": "Intracellular receptors (e.g. steroid or thyroid hormone receptors) bind ligands, enter the nucleus, and alter gene transcription.",
    "category": "FOM-PPN"
  },
  {
    "id": 169,
    "question": "Which of the following best describes a G-protein-coupled receptor (GPCR)?",
    "options": {
      "A": "Completely intracellular receptor",
      "B": "Receptor that binds directly to DNA",
      "C": "Receptor with 7 transmembrane domains coupled to G-proteins",
      "D": "Ion channel activated by ligand binding",
      "E": "Enzyme that cross-phosphorylates"
    },
    "answer": "C",
    "explanation": "GPCRs span the membrane 7 times and activate heterotrimeric G-proteins upon ligand binding, triggering second messenger cascades.",
    "category": "FOM-PPN"
  },
  {
    "id": 170,
    "question": "Which second messenger is produced via adenylyl cyclase activation by GPCRs?",
    "options": {
      "A": "GTP",
      "B": "ATP",
      "C": "cAMP",
      "D": "Na⁺",
      "E": "Calmodulin"
    },
    "answer": "C",
    "explanation": "Activated adenylyl cyclase converts ATP into cyclic AMP (cAMP), a key second messenger that regulates many cellular processes.",
    "category": "FOM-PPN"
  },
  {
    "id": 171,
    "question": "What is the mechanism of cholera toxin's effect on intestinal cells?",
    "options": {
      "A": "Blocks calcium channels",
      "B": "Stimulates Gs α-subunit to inhibit GTP hydrolysis",
      "C": "Prevents acetylcholine breakdown",
      "D": "Inhibits adenylyl cyclase",
      "E": "Activates sodium pumps"
    },
    "answer": "B",
    "explanation": "Cholera toxin prevents GTP hydrolysis on Gsα, keeping it active. This overstimulates cAMP production, disrupting water/electrolyte balance.",
    "category": "FOM-PPN"
  },
  {
    "id": 172,
    "question": "Which of the following is a key function of second messengers like cAMP or Ca²⁺?",
    "options": {
      "A": "Directly open ion channels without proteins",
      "B": "Bind DNA to alter transcription",
      "C": "Amplify the signal from receptor activation",
      "D": "Cause receptor desensitisation",
      "E": "Exit the cell to signal neighbours"
    },
    "answer": "C",
    "explanation": "Second messengers amplify signals by activating multiple downstream targets inside the cell, increasing the efficiency of signalling.",
    "category": "FOM-PPN"
  },
  {
    "id": 173,
    "question": "Which receptor mechanism is directly involved in insulin signalling?",
    "options": {
      "A": "Ligand-gated ion channel",
      "B": "GPCR",
      "C": "Receptor tyrosine kinase (RTK)",
      "D": "Intracellular steroid receptor",
      "E": "Gap junction receptor"
    },
    "answer": "C",
    "explanation": "Insulin binds to a receptor tyrosine kinase which undergoes cross-phosphorylation and activates intracellular signalling cascades.",
    "category": "FOM-PPN"
  },
  {
    "id": 174,
    "question": "Which receptor type would be responsible for detecting oestrogen inside a target cell?",
    "options": {
      "A": "Ligand-gated ion channel",
      "B": "G-protein-coupled receptor",
      "C": "Receptor tyrosine kinase",
      "D": "Intracellular nuclear receptor",
      "E": "Enzyme-linked receptor"
    },
    "answer": "D",
    "explanation": "Oestrogen is lipid-soluble and binds intracellular nuclear receptors that regulate gene expression.",
    "category": "FOM-PPN"
  },
  {
    "id": 175,
    "question": "Why are G-protein-coupled receptors (GPCRs) considered major drug targets?",
    "options": {
      "A": "They act only in the cytosol",
      "B": "They undergo rapid gene editing",
      "C": "They regulate non-signalling processes only",
      "D": "They are involved in diverse physiological pathways",
      "E": "They don't amplify signals"
    },
    "answer": "D",
    "explanation": "GPCRs regulate a wide array of functions including neurotransmission, metabolism, and hormone signalling, making them excellent drug targets.",
    "category": "FOM-PPN"
  },
    {
    "id": 176,
    "question": "What is the primary ion responsible for generating the resting membrane potential (RMP) in neurons?",
    "options": {
      "A": "Sodium (Na⁺)",
      "B": "Calcium (Ca²⁺)",
      "C": "Chloride (Cl⁻)",
      "D": "Potassium (K⁺)",
      "E": "Magnesium (Mg²⁺)"
    },
    "answer": "D",
    "explanation": "The RMP is largely due to K⁺ leaking out of the cell through open potassium channels, moving the membrane potential toward EK (~ -95 mV).",
    "category": "FOM-PPN"
  },
  {
    "id": 177,
    "question": "Which equation is used to calculate the reversal (equilibrium) potential for an ion?",
    "options": {
      "A": "Goldman-Hodgkin-Katz equation",
      "B": "Ohm’s Law",
      "C": "Michaelis-Menten equation",
      "D": "Nernst equation",
      "E": "Bernoulli’s principle"
    },
    "answer": "D",
    "explanation": "The Nernst equation calculates the equilibrium potential for an ion based on intra- and extracellular concentrations and the ion's charge.",
    "category": "FOM-PPN"
  },
  {
    "id": 178,
    "question": "What does it mean when a membrane reaches the equilibrium potential for a specific ion?",
    "options": {
      "A": "No net movement of that ion occurs",
      "B": "The membrane becomes impermeable to all ions",
      "C": "The ion concentration becomes equal inside and outside",
      "D": "ATP is no longer required",
      "E": "The ion is at maximum influx"
    },
    "answer": "A",
    "explanation": "At the equilibrium potential, electrical and chemical forces acting on that ion are balanced, so there is no net flux.",
    "category": "FOM-PPN"
  },
  {
    "id": 179,
    "question": "Why is the resting membrane potential more positive than the potassium equilibrium potential?",
    "options": {
      "A": "K⁺ channels are fully open",
      "B": "Cl⁻ influx dominates",
      "C": "Na⁺ and Ca²⁺ leak into the cell",
      "D": "Na⁺/K⁺ ATPase shuts down",
      "E": "Membrane is impermeable to ions"
    },
    "answer": "C",
    "explanation": "Although K⁺ dominates, small Na⁺ and Ca²⁺ inward leaks depolarize the membrane slightly, making RMP more positive than EK.",
    "category": "FOM-PPN"
  },
  {
    "id": 180,
    "question": "What role does the Na⁺/K⁺ ATPase play in neuronal membranes?",
    "options": {
      "A": "Generates action potentials directly",
      "B": "Blocks all ion movement",
      "C": "Maintains Na⁺ and K⁺ gradients using ATP",
      "D": "Releases neurotransmitters",
      "E": "Opens ligand-gated ion channels"
    },
    "answer": "C",
    "explanation": "The Na⁺/K⁺ ATPase actively pumps 3 Na⁺ out and 2 K⁺ in, preserving their gradients and supporting the RMP.",
    "category": "FOM-PPN"
  },
  {
    "id": 181,
    "question": "What would happen to the membrane potential if ATP production ceased?",
    "options": {
      "A": "Membrane potential becomes more negative",
      "B": "Na⁺/K⁺ gradients slowly collapse",
      "C": "Ion channels are blocked immediately",
      "D": "Neuron depolarizes instantly",
      "E": "Action potentials are enhanced"
    },
    "answer": "B",
    "explanation": "Without ATP, Na⁺/K⁺ ATPase stops working. Over time, ion gradients collapse, and membrane potential dissipates.",
    "category": "FOM-PPN"
  },
  {
    "id": 182,
    "question": "Which of the following is true about inward rectifier K⁺ channels (Kir)?",
    "options": {
      "A": "They allow only sodium to pass",
      "B": "They transport ions against the gradient",
      "C": "They are more efficient at letting K⁺ in than out",
      "D": "They directly generate action potentials",
      "E": "They are always closed at rest"
    },
    "answer": "C",
    "explanation": "Inward rectifiers allow K⁺ into the cell more easily than out, but in physiological conditions they mainly pass K⁺ outward.",
    "category": "FOM-PPN"
  },
  {
    "id": 183,
    "question": "Which of the following concentrations is typical for K⁺ in a mammalian neuron?",
    "options": {
      "A": "K⁺ extracellular = 140 mM, intracellular = 4 mM",
      "B": "K⁺ extracellular = 4 mM, intracellular = 140 mM",
      "C": "K⁺ extracellular = 1.25 mM, intracellular = 0.0001 mM",
      "D": "K⁺ extracellular = 120 mM, intracellular = 4 mM",
      "E": "K⁺ is equally distributed inside and outside"
    },
    "answer": "B",
    "explanation": "Typical K⁺ distribution is ~4 mM outside and ~140 mM inside, creating a strong gradient favoring efflux.",
    "category": "FOM-PPN"
  },
  {
    "id": 184,
    "question": "Which of the following explains why ion channels can exhibit selectivity?",
    "options": {
      "A": "They block all molecules smaller than ions",
      "B": "Their pores are too narrow for any ion",
      "C": "They contain specific amino acid sequences that filter ions",
      "D": "They require ATP to open",
      "E": "They only work at pH < 4.0"
    },
    "answer": "C",
    "explanation": "Ion channels have selectivity filters formed by specific amino acids that allow only certain ions (e.g., K⁺ vs Na⁺) to pass.",
    "category": "FOM-PPN"
  },
  {
    "id": 185,
    "question": "What does an IV (current-voltage) plot illustrate in relation to membrane potential?",
    "options": {
      "A": "ATP consumption over time",
      "B": "How fast action potentials are generated",
      "C": "Relationship between membrane voltage and ionic current",
      "D": "Change in ion concentrations",
      "E": "Blood flow across capillaries"
    },
    "answer": "C",
    "explanation": "An IV plot shows how ionic current varies with changes in membrane voltage, providing insight into channel function and reversal potentials.",
    "category": "FOM-PPN"
  },
    {
    "id": 186,
    "question": "Which ion is primarily responsible for the depolarisation phase of the neuronal action potential?",
    "options": {
      "A": "K⁺",
      "B": "Na⁺",
      "C": "Ca²⁺",
      "D": "Cl⁻",
      "E": "Mg²⁺"
    },
    "answer": "B",
    "explanation": "Depolarisation is caused by a rapid influx of Na⁺ through voltage-gated sodium channels.",
    "category": "FOM-PPN"
  },
  {
    "id": 187,
    "question": "What causes repolarisation of the membrane after an action potential?",
    "options": {
      "A": "Closure of Na⁺ channels only",
      "B": "Influx of K⁺ ions",
      "C": "Efflux of K⁺ ions",
      "D": "Opening of Ca²⁺ channels",
      "E": "Deactivation of Cl⁻ pumps"
    },
    "answer": "C",
    "explanation": "Repolarisation occurs due to the delayed opening of voltage-gated K⁺ channels allowing K⁺ to leave the cell.",
    "category": "FOM-PPN"
  },
  {
    "id": 188,
    "question": "What feature of the action potential ensures it does not decay as it travels along the axon?",
    "options": {
      "A": "Low resistance of axonal membranes",
      "B": "Large intracellular volume",
      "C": "Regeneration by voltage-gated ion channels",
      "D": "Salt diffusion",
      "E": "Continuous neurotransmitter release"
    },
    "answer": "C",
    "explanation": "The action potential is regenerated at each point along the membrane by activation of voltage-gated channels.",
    "category": "FOM-PPN"
  },
  {
    "id": 189,
    "question": "What terminates the positive feedback loop of Na⁺ influx during an action potential?",
    "options": {
      "A": "Inactivation of K⁺ channels",
      "B": "Blockage by ATPase",
      "C": "Inactivation of Na⁺ channels",
      "D": "Opening of chloride channels",
      "E": "Increased membrane capacitance"
    },
    "answer": "C",
    "explanation": "Voltage-gated Na⁺ channels inactivate shortly after opening, which halts further Na⁺ influx.",
    "category": "FOM-PPN"
  },
  {
    "id": 190,
    "question": "Which channel type opens later and helps restore the resting potential?",
    "options": {
      "A": "Ligand-gated Na⁺ channel",
      "B": "Delayed rectifier K⁺ channel",
      "C": "Voltage-gated Ca²⁺ channel",
      "D": "Chloride antiporter",
      "E": "Sodium leak channel"
    },
    "answer": "B",
    "explanation": "Delayed rectifier K⁺ channels open after Na⁺ channels to help repolarise the membrane.",
    "category": "FOM-PPN"
  },
  {
    "id": 191,
    "question": "Which of the following best describes the 'all-or-none' nature of an action potential?",
    "options": {
      "A": "Its amplitude varies with stimulus strength",
      "B": "It initiates only in myelinated neurons",
      "C": "It occurs fully once threshold is reached",
      "D": "It increases with each stimulus",
      "E": "It requires neurotransmitter input"
    },
    "answer": "C",
    "explanation": "Once membrane potential reaches threshold, an AP is triggered and propagates with full amplitude regardless of stimulus strength.",
    "category": "FOM-PPN"
  },
  {
    "id": 192,
    "question": "What is the primary function of the absolute refractory period?",
    "options": {
      "A": "Prevent ion leakage",
      "B": "Allow oscillatory firing",
      "C": "Block retrograde conduction",
      "D": "Increase firing frequency",
      "E": "Open chloride channels"
    },
    "answer": "C",
    "explanation": "The absolute refractory period ensures unidirectional propagation by preventing reactivation of recently depolarised membrane.",
    "category": "FOM-PPN"
  },
  {
    "id": 193,
    "question": "How does myelination increase conduction velocity?",
    "options": {
      "A": "More voltage-gated channels",
      "B": "Prevents repolarisation",
      "C": "Reduces membrane resistance",
      "D": "Facilitates saltatory conduction",
      "E": "Delays refractory periods"
    },
    "answer": "D",
    "explanation": "Myelination allows APs to 'jump' between nodes of Ranvier, increasing speed and reducing energy consumption.",
    "category": "FOM-PPN"
  },
  {
    "id": 194,
    "question": "What cells form the myelin sheath in the central nervous system?",
    "options": {
      "A": "Schwann cells",
      "B": "Astrocytes",
      "C": "Oligodendrocytes",
      "D": "Ependymal cells",
      "E": "Microglia"
    },
    "answer": "C",
    "explanation": "Oligodendrocytes myelinate multiple axons in the CNS, unlike Schwann cells which myelinate one axon in the PNS.",
    "category": "FOM-PPN"
  },
  {
    "id": 195,
    "question": "What effect would tetrodotoxin (TTX) have on neurons?",
    "options": {
      "A": "Enhances K⁺ efflux",
      "B": "Blocks Na⁺ channels, preventing AP generation",
      "C": "Activates Ca²⁺ influx",
      "D": "Opens Cl⁻ channels excessively",
      "E": "Stimulates neurotransmitter release"
    },
    "answer": "B",
    "explanation": "TTX blocks voltage-gated Na⁺ channels, preventing depolarisation and propagation of action potentials.",
    "category": "FOM-PPN"
  },
    {
    "id": 196,
    "question": "What ion is directly responsible for triggering acetylcholine (ACh) release at the neuromuscular junction?",
    "options": {
      "A": "Na⁺",
      "B": "K⁺",
      "C": "Cl⁻",
      "D": "Ca²⁺",
      "E": "Mg²⁺"
    },
    "answer": "D",
    "explanation": "Depolarisation opens voltage-gated Ca²⁺ channels, and Ca²⁺ influx triggers vesicle fusion and ACh release.",
    "category": "FOM-PPN"
  },
  {
    "id": 197,
    "question": "What type of receptor is the nicotinic acetylcholine receptor (nAChR) on skeletal muscle?",
    "options": {
      "A": "G-protein coupled receptor",
      "B": "Receptor tyrosine kinase",
      "C": "Ligand-gated ion channel",
      "D": "Voltage-gated ion channel",
      "E": "Enzyme-linked receptor"
    },
    "answer": "C",
    "explanation": "nAChR is a ligand-gated ion channel that opens in response to ACh and is permeable to Na⁺ and K⁺.",
    "category": "FOM-PPN"
  },
  {
    "id": 198,
    "question": "Which enzyme rapidly terminates the action of acetylcholine at the NMJ?",
    "options": {
      "A": "Monoamine oxidase",
      "B": "Choline acetyltransferase",
      "C": "Na⁺/K⁺ ATPase",
      "D": "Acetylcholinesterase",
      "E": "COMT"
    },
    "answer": "D",
    "explanation": "Acetylcholinesterase (AChE) hydrolyses ACh in the synaptic cleft, stopping the signal at the NMJ.",
    "category": "FOM-PPN"
  },
  {
    "id": 199,
    "question": "What is the role of SNARE proteins at the neuromuscular junction?",
    "options": {
      "A": "Degrade acetylcholine",
      "B": "Form ion channels",
      "C": "Facilitate vesicle fusion for neurotransmitter release",
      "D": "Reuptake choline",
      "E": "Block Ca²⁺ channels"
    },
    "answer": "C",
    "explanation": "SNARE proteins mediate Ca²⁺-dependent fusion of ACh-containing vesicles with the presynaptic membrane.",
    "category": "FOM-PPN"
  },
  {
    "id": 200,
    "question": "What is the endplate potential (EPP)?",
    "options": {
      "A": "A voltage spike at the axon hillock",
      "B": "Membrane potential in a dendrite",
      "C": "Postsynaptic depolarisation caused by ACh",
      "D": "Membrane repolarisation due to K⁺ efflux",
      "E": "Voltage required to open Ca²⁺ channels"
    },
    "answer": "C",
    "explanation": "The endplate potential is a graded depolarisation in the muscle fibre caused by ACh-activated Na⁺ influx.",
    "category": "FOM-PPN"
  },
  {
    "id": 201,
    "question": "Which condition involves autoantibodies against acetylcholine receptors at the NMJ?",
    "options": {
      "A": "Parkinson’s disease",
      "B": "Multiple sclerosis",
      "C": "Myasthenia gravis",
      "D": "Botulism",
      "E": "ALS"
    },
    "answer": "C",
    "explanation": "Myasthenia gravis is an autoimmune disorder in which antibodies block or destroy nAChRs at the NMJ.",
    "category": "FOM-PPN"
  },
  {
    "id": 202,
    "question": "Which of the following blocks voltage-gated Ca²⁺ channels at motor nerve terminals in Lambert-Eaton syndrome?",
    "options": {
      "A": "Autoantibodies",
      "B": "Acetylcholinesterase",
      "C": "Botulinum toxin",
      "D": "Curare",
      "E": "Choline kinase"
    },
    "answer": "A",
    "explanation": "Lambert-Eaton syndrome involves autoantibodies that impair presynaptic Ca²⁺ channels, reducing ACh release.",
    "category": "FOM-PPN"
  },
  {
    "id": 203,
    "question": "What is the role of choline acetyltransferase (ChAT)?",
    "options": {
      "A": "Breaks down ACh in the synaptic cleft",
      "B": "Transports ACh into vesicles",
      "C": "Synthesises ACh from choline and acetyl-CoA",
      "D": "Blocks ACh receptors",
      "E": "Inhibits vesicle fusion"
    },
    "answer": "C",
    "explanation": "Choline acetyltransferase catalyses the formation of ACh from choline and acetyl-CoA in the presynaptic terminal.",
    "category": "FOM-PPN"
  },
  {
    "id": 204,
    "question": "Which substance inhibits acetylcholine release at the NMJ by cleaving SNARE proteins?",
    "options": {
      "A": "Curare",
      "B": "Latrotoxin",
      "C": "Botulinum toxin",
      "D": "Acetylcholinesterase",
      "E": "War gases"
    },
    "answer": "C",
    "explanation": "Botulinum toxin cleaves SNARE proteins, preventing vesicle fusion and ACh release.",
    "category": "FOM-PPN"
  },
  {
    "id": 205,
    "question": "What is the clinical effect of curare at the neuromuscular junction?",
    "options": {
      "A": "Enhances ACh release",
      "B": "Blocks ACh degradation",
      "C": "Stimulates Ca²⁺ influx",
      "D": "Blocks nAChRs, causing flaccid paralysis",
      "E": "Increases ACh reuptake"
    },
    "answer": "D",
    "explanation": "Curare blocks nicotinic ACh receptors on muscle fibres, preventing depolarisation and causing paralysis.",
    "category": "FOM-PPN"
  },
    {
    "id": 206,
    "question": "What is the primary function of the autonomic nervous system (ANS)?",
    "options": {
      "A": "Conscious control of skeletal muscles",
      "B": "Regulation of external sensory input",
      "C": "Control of internal organ function and homeostasis",
      "D": "Initiation of voluntary movement",
      "E": "Processing auditory information"
    },
    "answer": "C",
    "explanation": "The ANS controls involuntary functions of internal organs and maintains the biochemical and metabolic state of the body.",
    "category": "FOM-PPN"
  },
  {
    "id": 207,
    "question": "Which of the following is a hallmark of sympathetic nervous system activation?",
    "options": {
      "A": "Increased intestinal motility",
      "B": "Bronchial constriction",
      "C": "Pupil constriction",
      "D": "Increased heart rate and force of contraction",
      "E": "Urinary bladder contraction"
    },
    "answer": "D",
    "explanation": "Sympathetic activity increases heart rate and contraction force to enhance oxygen delivery in fight-or-flight situations.",
    "category": "FOM-PPN"
  },
  {
    "id": 208,
    "question": "Which neurotransmitter is released by preganglionic neurons in both sympathetic and parasympathetic systems?",
    "options": {
      "A": "Dopamine",
      "B": "Acetylcholine",
      "C": "Noradrenaline",
      "D": "Serotonin",
      "E": "GABA"
    },
    "answer": "B",
    "explanation": "All preganglionic fibres in the ANS release acetylcholine (ACh) onto nicotinic receptors in ganglia.",
    "category": "FOM-PPN"
  },
  {
    "id": 209,
    "question": "What is the primary neurotransmitter at sympathetic postganglionic terminals (except sweat glands)?",
    "options": {
      "A": "Acetylcholine",
      "B": "Serotonin",
      "C": "Noradrenaline",
      "D": "Adrenaline",
      "E": "Dopamine"
    },
    "answer": "C",
    "explanation": "Noradrenaline (NA) is released by most sympathetic postganglionic neurons, except those innervating sweat glands, which use ACh.",
    "category": "FOM-PPN"
  },
  {
    "id": 210,
    "question": "What is the function of the adrenal medulla in sympathetic activation?",
    "options": {
      "A": "Secretes dopamine",
      "B": "Stores calcium",
      "C": "Releases adrenaline into the bloodstream",
      "D": "Absorbs noradrenaline",
      "E": "Inhibits sympathetic preganglionic fibres"
    },
    "answer": "C",
    "explanation": "The adrenal medulla is stimulated by sympathetic preganglionic fibres to secrete adrenaline (epinephrine), prolonging sympathetic effects.",
    "category": "FOM-PPN"
  },
  {
    "id": 211,
    "question": "Which of the following best describes parasympathetic influence on the eye?",
    "options": {
      "A": "Pupil dilation and lens flattening",
      "B": "Pupil constriction and lens curvature increase",
      "C": "Visual cortex activation",
      "D": "Adrenaline release from retina",
      "E": "Optic nerve depolarisation"
    },
    "answer": "B",
    "explanation": "Parasympathetic activation causes miosis (pupil constriction) and accommodation for near vision by increasing lens curvature.",
    "category": "FOM-PPN"
  },
  {
    "id": 212,
    "question": "What happens to the GI tract under parasympathetic stimulation?",
    "options": {
      "A": "Inhibition of motility and secretion",
      "B": "Increased motility and secretion",
      "C": "Vasoconstriction of GI blood supply",
      "D": "Stimulation of glucose release",
      "E": "Suppression of smooth muscle activity"
    },
    "answer": "B",
    "explanation": "Parasympathetic stimulation enhances 'rest and digest' functions, including salivation, gastric motility, and enzyme secretion.",
    "category": "FOM-PPN"
  },
  {
    "id": 213,
    "question": "Which organ receives direct sympathetic innervation without a postganglionic neuron?",
    "options": {
      "A": "Liver",
      "B": "Adrenal medulla",
      "C": "Heart",
      "D": "Stomach",
      "E": "Lung"
    },
    "answer": "B",
    "explanation": "The adrenal medulla is directly innervated by sympathetic preganglionic neurons and acts like a modified ganglion.",
    "category": "FOM-PPN"
  },
  {
    "id": 214,
    "question": "What is the sympathetic effect on arterioles supplying the skin and abdominal viscera?",
    "options": {
      "A": "Strong dilation",
      "B": "No effect",
      "C": "Strong constriction",
      "D": "Increased permeability",
      "E": "Complete shutdown"
    },
    "answer": "C",
    "explanation": "Sympathetic activation causes vasoconstriction in skin and abdominal viscera to redirect blood to critical organs like muscles and brain.",
    "category": "FOM-PPN"
  },
  {
    "id": 215,
    "question": "Which statement best reflects the functional relationship between sympathetic and parasympathetic systems?",
    "options": {
      "A": "Only one system is ever active",
      "B": "They always act antagonistically",
      "C": "They are activated simultaneously to the same organs",
      "D": "Both systems are active at baseline and can act independently or synergistically",
      "E": "They both use noradrenaline as their final transmitter"
    },
    "answer": "D",
    "explanation": "In reality, both systems are tonically active and may act antagonistically or synergistically depending on the target organ.",
    "category": "FOM-PPN"
  },
    {
    "id": 216,
    "question": "What is the basic functional unit of skeletal muscle?",
    "options": {
      "A": "Sarcomere",
      "B": "Myofibril",
      "C": "Motor unit",
      "D": "Neuromuscular junction",
      "E": "Muscle spindle"
    },
    "answer": "C",
    "explanation": "The motor unit, comprising a motor neuron and all the muscle fibers it innervates, is the functional unit for force generation.",
    "category": "FOM-PPN"
  },
  {
    "id": 217,
    "question": "Which type of muscle is innervated exclusively by the somatic nervous system?",
    "options": {
      "A": "Smooth muscle",
      "B": "Cardiac muscle",
      "C": "Skeletal muscle",
      "D": "Diaphragm",
      "E": "Iris sphincter"
    },
    "answer": "C",
    "explanation": "Skeletal muscle is voluntarily controlled by the somatic nervous system and only contracts when directly stimulated by a motor neuron.",
    "category": "FOM-PPN"
  },
  {
    "id": 218,
    "question": "Why does smooth muscle appear non-striated under the microscope?",
    "options": {
      "A": "It lacks myosin",
      "B": "It has no nucleus",
      "C": "It lacks orderly sarcomeres",
      "D": "It is myelinated",
      "E": "It contains actin only"
    },
    "answer": "C",
    "explanation": "Smooth muscle lacks the ordered sarcomere structure seen in skeletal and cardiac muscle, so it does not show striations.",
    "category": "FOM-PPN"
  },
  {
    "id": 219,
    "question": "Which muscle type has gap junctions and is not typically innervated?",
    "options": {
      "A": "Skeletal muscle",
      "B": "Smooth muscle",
      "C": "Cardiac muscle",
      "D": "Diaphragmatic muscle",
      "E": "Extraocular muscle"
    },
    "answer": "C",
    "explanation": "Cardiac muscle cells are electrically connected via gap junctions and are not typically directly innervated — action potentials propagate cell-to-cell.",
    "category": "FOM-PPN"
  },
  {
    "id": 220,
    "question": "In skeletal muscle, where is calcium stored before contraction?",
    "options": {
      "A": "Golgi apparatus",
      "B": "Sarcoplasmic reticulum",
      "C": "T tubules",
      "D": "Nucleus",
      "E": "Cytoplasm"
    },
    "answer": "B",
    "explanation": "The sarcoplasmic reticulum (SR) is a specialized organelle that stores calcium, releasing it upon stimulation to initiate contraction.",
    "category": "FOM-PPN"
  },
  {
    "id": 221,
    "question": "Which of the following is involved in rapid conduction of action potentials into the interior of muscle fibres?",
    "options": {
      "A": "Tropomyosin",
      "B": "Troponin",
      "C": "T tubules",
      "D": "Z lines",
      "E": "Intercalated discs"
    },
    "answer": "C",
    "explanation": "T tubules are extensions of the plasma membrane that carry depolarisation signals deep into the muscle fibre, triggering calcium release from the SR.",
    "category": "FOM-PPN"
  },
  {
    "id": 222,
    "question": "What happens during the absence of ATP in the muscle cross-bridge cycle?",
    "options": {
      "A": "Calcium is pumped into the cytosol",
      "B": "Myosin detaches from actin",
      "C": "Actin and myosin remain tightly bound",
      "D": "Troponin becomes inactive",
      "E": "Muscle contraction weakens"
    },
    "answer": "C",
    "explanation": "Without ATP, myosin heads cannot detach from actin, causing a sustained contraction — seen in rigor mortis.",
    "category": "FOM-PPN"
  },
  {
    "id": 223,
    "question": "Which factor limits force generation in skeletal muscle?",
    "options": {
      "A": "Blood supply",
      "B": "Recruitment of motor units",
      "C": "Resting membrane potential",
      "D": "Oxygen content",
      "E": "Sympathetic nervous system input"
    },
    "answer": "B",
    "explanation": "Skeletal muscle force depends on how many motor units are recruited; more units = greater force.",
    "category": "FOM-PPN"
  },
  {
    "id": 224,
    "question": "Which of the following best describes Henneman’s Size Principle?",
    "options": {
      "A": "All motor units fire simultaneously",
      "B": "Larger motor units are always recruited first",
      "C": "Smaller motor units are recruited before larger ones",
      "D": "Motor units fire at random",
      "E": "Only large muscles follow recruitment order"
    },
    "answer": "C",
    "explanation": "Smaller motor units, which generate less force, are recruited first during increasing muscle activation — a principle that ensures fine control.",
    "category": "FOM-PPN"
  },
  {
    "id": 225,
    "question": "How does the sympathetic nervous system increase cardiac muscle contraction force?",
    "options": {
      "A": "By recruiting more muscle fibres",
      "B": "By increasing calcium release in each cell",
      "C": "By activating parasympathetic fibres",
      "D": "By hyperpolarising cardiac cells",
      "E": "By reducing ATP consumption"
    },
    "answer": "B",
    "explanation": "SNS stimulation via β1-adrenoceptors increases intracellular calcium in cardiac muscle, enhancing force of contraction in each fibre.",
    "category": "FOM-PPN"
  },
  {
    "id": 226,
    "question": "Which statement about smooth muscle is correct?",
    "options": {
      "A": "It cannot be stimulated by hormones",
      "B": "It contracts only when voluntarily activated",
      "C": "It lacks actin and myosin filaments",
      "D": "Its contraction is regulated by both nerves and hormones",
      "E": "It always contracts rhythmically"
    },
    "answer": "D",
    "explanation": "Smooth muscle contraction is influenced by autonomic innervation and circulating factors such as adrenaline or acetylcholine.",
    "category": "FOM-PPN"
  },
  {
    "id": 227,
    "question": "What is the primary trigger for contraction in all muscle types?",
    "options": {
      "A": "Sodium influx",
      "B": "ATP synthesis",
      "C": "Glucose uptake",
      "D": "Calcium influx or release",
      "E": "Chloride efflux"
    },
    "answer": "D",
    "explanation": "In all muscle types, an increase in intracellular calcium initiates contraction by interacting with regulatory proteins.",
    "category": "FOM-PPN"
  },
  {
    "id": 228,
    "question": "Which structure in muscle fibre directly interacts with the sarcoplasmic reticulum to release calcium?",
    "options": {
      "A": "Myofibril",
      "B": "Mitochondria",
      "C": "Nucleus",
      "D": "T tubules",
      "E": "Z-discs"
    },
    "answer": "D",
    "explanation": "T tubules carry the depolarisation signal to the SR, triggering calcium release for contraction.",
    "category": "FOM-PPN"
  },
  {
    "id": 229,
    "question": "Which muscle type uses 'recruitment' of motor units to vary contraction force?",
    "options": {
      "A": "Cardiac",
      "B": "Smooth",
      "C": "Skeletal",
      "D": "All of the above",
      "E": "None of the above"
    },
    "answer": "C",
    "explanation": "Only skeletal muscle varies total force via recruitment of additional motor units; cardiac and smooth muscle regulate force per fibre/cell.",
    "category": "FOM-PPN"
  },
  {
    "id": 230,
    "question": "Which hormone increases the number of beta-adrenergic receptors in cardiac muscle, enhancing force of contraction?",
    "options": {
      "A": "Adrenaline",
      "B": "Insulin",
      "C": "Cortisol",
      "D": "Thyroxine",
      "E": "Noradrenaline"
    },
    "answer": "D",
    "explanation": "Thyroxine (T4) increases beta-receptor density in cardiac tissue, sensitising the heart to sympathetic stimulation and enhancing contraction.",
    "category": "FOM-PPN"
  },
    {
    "id": 231,
    "question": "Why is basic knowledge of medical genetics essential for medical students?",
    "options": {
      "A": "It is required for media interviews",
      "B": "It helps interpret radiological scans",
      "C": "It is assessed and critical for medical decision-making",
      "D": "It improves surgical technique",
      "E": "It helps calculate heart rate"
    },
    "answer": "C",
    "explanation": "Understanding medical genetics is essential for interpreting patient risk, understanding disease mechanisms, and it is a core assessed component.",
    "category": "FOM-Genetics"
  },
  {
    "id": 232,
    "question": "Which of the following is NOT a valid use of genetics in modern medicine?",
    "options": {
      "A": "Forensic identification",
      "B": "Designing pacemakers",
      "C": "Pharmacogenomics",
      "D": "Prenatal screening",
      "E": "Genetic counselling"
    },
    "answer": "B",
    "explanation": "Pacemaker design is an engineering issue, not directly related to genetics. All other listed uses are valid medical applications of genetics.",
    "category": "FOM-Genetics"
  },
  {
    "id": 233,
    "question": "Which term refers to the likelihood that a gene will result in a clinical phenotype?",
    "options": {
      "A": "Penetrance",
      "B": "Heritability",
      "C": "Allele frequency",
      "D": "Monogenic",
      "E": "Dominance"
    },
    "answer": "A",
    "explanation": "Penetrance describes the proportion of individuals with a genetic mutation who exhibit clinical symptoms.",
    "category": "FOM-Genetics"
  },
  {
    "id": 234,
    "question": "What does the 'nature vs nurture' debate primarily concern in genetics?",
    "options": {
      "A": "Mutation repair rate",
      "B": "Gene-environment interactions",
      "C": "Dominant inheritance",
      "D": "CRISPR safety",
      "E": "Mitochondrial disease"
    },
    "answer": "B",
    "explanation": "The 'nature vs nurture' debate focuses on how much of a trait or disease is determined by genetics vs environmental factors.",
    "category": "FOM-Genetics"
  },
  {
    "id": 235,
    "question": "Which of the following technologies enables precise editing of DNA?",
    "options": {
      "A": "GWAS",
      "B": "Next-generation sequencing",
      "C": "CRISPR",
      "D": "PCR",
      "E": "FISH"
    },
    "answer": "C",
    "explanation": "CRISPR allows targeted modification of DNA sequences and is a tool for gene editing.",
    "category": "FOM-Genetics"
  },
  {
    "id": 236,
    "question": "Which genetic study method identifies associations between SNPs and disease traits across the genome?",
    "options": {
      "A": "CRISPR",
      "B": "Sanger sequencing",
      "C": "Western blotting",
      "D": "GWAS",
      "E": "Gene therapy"
    },
    "answer": "D",
    "explanation": "Genome-Wide Association Studies (GWAS) detect statistical links between specific SNPs and traits across populations.",
    "category": "FOM-Genetics"
  },
  {
    "id": 237,
    "question": "Which concept explains the variation in traits caused by a combination of genetic and environmental factors?",
    "options": {
      "A": "Monogenic inheritance",
      "B": "Codominance",
      "C": "Multifactorial inheritance",
      "D": "Mosaicism",
      "E": "Pleiotropy"
    },
    "answer": "C",
    "explanation": "Multifactorial inheritance refers to traits or conditions influenced by multiple genes and environmental inputs.",
    "category": "FOM-Genetics"
  },
  {
    "id": 238,
    "question": "Which is a common ethical concern in medical genetics?",
    "options": {
      "A": "Underuse of radiotherapy",
      "B": "Consent for genetic testing",
      "C": "Lack of antibiotics",
      "D": "Liver transplant shortages",
      "E": "EEG accuracy"
    },
    "answer": "B",
    "explanation": "Consent, privacy, and informed decision-making are major ethical concerns in the application of genetic testing and data sharing.",
    "category": "FOM-Genetics"
  },
  {
    "id": 239,
    "question": "Which of the following is a feature of stratified medicine?",
    "options": {
      "A": "Same treatment for all patients",
      "B": "Treatments based only on age",
      "C": "Tailoring interventions to subgroups based on genetic or risk profiles",
      "D": "Trial-and-error medication prescribing",
      "E": "Avoiding treatment for high-risk patients"
    },
    "answer": "C",
    "explanation": "Stratified medicine uses group-level risk or response data (e.g., genetic markers) to guide interventions.",
    "category": "FOM-Genetics"
  },
  {
    "id": 240,
    "question": "What is the key difference between personalised and stratified medicine?",
    "options": {
      "A": "Stratified medicine is used only in surgery",
      "B": "Personalised medicine is based on individual-specific data",
      "C": "Personalised medicine is less accurate",
      "D": "Stratified medicine is cheaper and always better",
      "E": "Personalised medicine uses radiology instead of genetics"
    },
    "answer": "B",
    "explanation": "While stratified medicine targets subgroups, personalised medicine aims for individual-level customisation based on specific data, including genetics.",
    "category": "FOM-Genetics"
  },
  {
    "id": 241,
    "question": "What is heritability?",
    "options": {
      "A": "Likelihood a gene is inherited from the father only",
      "B": "Rate of mutation in offspring",
      "C": "Proportion of variation in a trait due to genetic factors",
      "D": "Percentage of genetic recombination",
      "E": "Dominance of alleles in a population"
    },
    "answer": "C",
    "explanation": "Heritability estimates the fraction of phenotypic variance in a population that is attributable to genetic differences.",
    "category": "FOM-Genetics"
  },
  {
    "id": 242,
    "question": "Which of the following is a major limitation of genetic testing?",
    "options": {
      "A": "Cannot detect any mutations",
      "B": "Always gives definitive results",
      "C": "May reveal uncertain or incidental findings",
      "D": "Only works in children",
      "E": "Cannot be done prenatally"
    },
    "answer": "C",
    "explanation": "Genetic testing may uncover variants of uncertain significance or incidental findings unrelated to the test indication.",
    "category": "FOM-Genetics"
  },
  {
    "id": 243,
    "question": "Which early medical application of genetics involved a dietary recommendation by Pythagoras?",
    "options": {
      "A": "Avoiding meat for cancer prevention",
      "B": "Restricting dairy in lactose intolerance",
      "C": "Avoiding fava beans due to G6PD deficiency",
      "D": "Eating raw garlic for heart health",
      "E": "Increasing salt intake for dehydration"
    },
    "answer": "C",
    "explanation": "Pythagoras warned against fava beans — a practice consistent with G6PD deficiency, where such foods can cause haemolysis.",
    "category": "FOM-Genetics"
  },
  {
    "id": 244,
    "question": "Which term best describes using DNA data to match crime scene evidence?",
    "options": {
      "A": "Pharmacogenomics",
      "B": "Gene therapy",
      "C": "Forensic genetics",
      "D": "Epigenetics",
      "E": "Transgenics"
    },
    "answer": "C",
    "explanation": "Forensic genetics applies DNA analysis to legal investigations, such as identifying suspects from biological evidence.",
    "category": "FOM-Genetics"
  },
  {
    "id": 245,
    "question": "What does CRISPR primarily allow researchers to do?",
    "options": {
      "A": "Measure hormone levels",
      "B": "Edit genes at specific locations",
      "C": "Block neurotransmitters",
      "D": "Scan for cancer via imaging",
      "E": "Measure BMI from blood"
    },
    "answer": "B",
    "explanation": "CRISPR enables targeted editing of specific DNA sequences, offering potential treatments for genetic diseases.",
    "category": "FOM-Genetics"
  },
    {
    "id": 246,
    "question": "Which term refers to the complete set of genetic material in an organism?",
    "options": {
      "A": "Chromosome",
      "B": "Allele",
      "C": "Genome",
      "D": "Transcriptome",
      "E": "Proteome"
    },
    "answer": "C",
    "explanation": "The genome encompasses all the DNA in an organism, including coding and non-coding regions.",
    "category": "FOM-Genetics"
  },
  {
    "id": 247,
    "question": "How many chromosomes are found in a normal human somatic cell?",
    "options": {
      "A": "44",
      "B": "23",
      "C": "48",
      "D": "46",
      "E": "92"
    },
    "answer": "D",
    "explanation": "Human somatic cells have 46 chromosomes: 22 pairs of autosomes and 1 pair of sex chromosomes.",
    "category": "FOM-Genetics"
  },
  {
    "id": 248,
    "question": "Which of the following disorders is commonly X-linked and affects males more frequently?",
    "options": {
      "A": "Sickle cell anaemia",
      "B": "Haemophilia",
      "C": "Cystic fibrosis",
      "D": "Huntington’s disease",
      "E": "Phenylketonuria"
    },
    "answer": "B",
    "explanation": "Haemophilia is X-linked recessive, so males with one defective X are affected, whereas females need two copies.",
    "category": "FOM-Genetics"
  },
  {
    "id": 249,
    "question": "What is the backbone of DNA composed of?",
    "options": {
      "A": "Amino acids",
      "B": "Phospholipids and proteins",
      "C": "Nitrogen bases only",
      "D": "Phosphate and deoxyribose sugar",
      "E": "RNA polymers"
    },
    "answer": "D",
    "explanation": "DNA’s backbone is a sugar-phosphate chain made of deoxyribose and phosphate groups linked by phosphodiester bonds.",
    "category": "FOM-Genetics"
  },
  {
    "id": 250,
    "question": "In which direction is DNA synthesised?",
    "options": {
      "A": "5' to 5'",
      "B": "3' to 5'",
      "C": "5' to 3'",
      "D": "Random",
      "E": "3' to 3'"
    },
    "answer": "C",
    "explanation": "DNA is synthesised in the 5' to 3' direction by DNA polymerase, which adds nucleotides to the free 3’ OH group.",
    "category": "FOM-Genetics"
  },
  {
    "id": 251,
    "question": "Which sugar is found in RNA but not DNA?",
    "options": {
      "A": "Glucose",
      "B": "Deoxyribose",
      "C": "Sucrose",
      "D": "Fructose",
      "E": "Ribose"
    },
    "answer": "E",
    "explanation": "RNA contains ribose, which has a hydroxyl group at the 2' position; DNA contains deoxyribose, lacking that OH.",
    "category": "FOM-Genetics"
  },
  {
    "id": 252,
    "question": "Which nitrogenous base is found in RNA but not DNA?",
    "options": {
      "A": "Cytosine",
      "B": "Guanine",
      "C": "Adenine",
      "D": "Thymine",
      "E": "Uracil"
    },
    "answer": "E",
    "explanation": "Uracil replaces thymine in RNA and pairs with adenine.",
    "category": "FOM-Genetics"
  },
  {
    "id": 253,
    "question": "What does the term 'antiparallel' mean in DNA structure?",
    "options": {
      "A": "Two strands are identical in sequence",
      "B": "Strands wind in opposite helical directions",
      "C": "One strand is RNA and one is DNA",
      "D": "Strands run in opposite 5’ to 3’ directions",
      "E": "Strands replicate independently"
    },
    "answer": "D",
    "explanation": "In DNA, one strand runs 5’ to 3’, and the other 3’ to 5’, making them antiparallel for proper base pairing and replication.",
    "category": "FOM-Genetics"
  },
  {
    "id": 254,
    "question": "Which statement correctly describes a phosphodiester bond?",
    "options": {
      "A": "Connects nitrogenous bases",
      "B": "Links adjacent amino acids",
      "C": "Connects sugars to phosphates in DNA/RNA",
      "D": "Found only in tRNA",
      "E": "Formed by hydrogen bonding"
    },
    "answer": "C",
    "explanation": "Phosphodiester bonds link the 3’ OH of one sugar to the 5’ phosphate of the next, forming the backbone of nucleic acids.",
    "category": "FOM-Genetics"
  },
  {
    "id": 255,
    "question": "Which base pairs are correctly matched in DNA?",
    "options": {
      "A": "A–C and G–T",
      "B": "A–T and G–C",
      "C": "A–G and T–C",
      "D": "A–U and G–C",
      "E": "A–G and C–T"
    },
    "answer": "B",
    "explanation": "In DNA, adenine pairs with thymine (A–T) via two hydrogen bonds, and guanine with cytosine (G–C) via three.",
    "category": "FOM-Genetics"
  },
  {
    "id": 256,
    "question": "Which of the following correctly describes RNA structure?",
    "options": {
      "A": "Double stranded with thymine",
      "B": "Single stranded with uracil",
      "C": "Double helix with ribose",
      "D": "Only composed of purines",
      "E": "Triple-stranded in eukaryotes"
    },
    "answer": "B",
    "explanation": "RNA is typically single-stranded, contains ribose sugar, and uses uracil instead of thymine.",
    "category": "FOM-Genetics"
  },
  {
    "id": 257,
    "question": "Which process copies DNA into RNA?",
    "options": {
      "A": "Replication",
      "B": "Transcription",
      "C": "Translation",
      "D": "Transduction",
      "E": "Transformation"
    },
    "answer": "B",
    "explanation": "Transcription is the synthesis of RNA from a DNA template.",
    "category": "FOM-Genetics"
  },
  {
    "id": 258,
    "question": "Which base pairing is found in RNA?",
    "options": {
      "A": "A–T",
      "B": "C–T",
      "C": "A–U",
      "D": "G–U",
      "E": "T–T"
    },
    "answer": "C",
    "explanation": "In RNA, adenine pairs with uracil (A–U).",
    "category": "FOM-Genetics"
  },
  {
    "id": 259,
    "question": "What does the '3’ OH group' refer to in DNA?",
    "options": {
      "A": "The end of the DNA strand containing a phosphate group",
      "B": "The location where ribose is found",
      "C": "The hydroxyl group on the 3’ carbon of the sugar",
      "D": "The part of the base that forms hydrogen bonds",
      "E": "A signal for DNA transcription"
    },
    "answer": "C",
    "explanation": "The 3’ OH on the sugar is the site where DNA polymerase adds new nucleotides during replication.",
    "category": "FOM-Genetics"
  },
  {
    "id": 260,
    "question": "What is the correct complementary strand to 5’-ATCGGA-3’?",
    "options": {
      "A": "5’-TAGCCT-3’",
      "B": "3’-TAGCCT-5’",
      "C": "3’-TACGGT-5’",
      "D": "5’-TCCGAT-3’",
      "E": "3’-TCCGAT-5’"
    },
    "answer": "B",
    "explanation": "The complementary strand must be antiparallel and complementary: A with T, T with A, C with G, etc.",
    "category": "FOM-Genetics"
  },
    {
    "id": 261,
    "question": "Approximately how many base pairs make up the human genome?",
    "options": {
      "A": "3.2 billion",
      "B": "1.5 billion",
      "C": "46 million",
      "D": "20,000",
      "E": "140,000"
    },
    "answer": "A",
    "explanation": "The human genome contains roughly 3.2 billion (3,200Mb) base pairs of DNA.",
    "category": "FOM-Genetics"
  },
  {
    "id": 262,
    "question": "Which part of the human genome accounts for the largest proportion of DNA?",
    "options": {
      "A": "Protein-coding exons",
      "B": "Regulatory DNA",
      "C": "Repetitive DNA",
      "D": "tRNA genes",
      "E": "Telomeres"
    },
    "answer": "C",
    "explanation": "Repetitive DNA makes up ~47% of the genome, mostly consisting of transposable elements and tandem repeats.",
    "category": "FOM-Genetics"
  },
  {
    "id": 263,
    "question": "What are pseudogenes?",
    "options": {
      "A": "Genes that code for new proteins",
      "B": "Mutated copies of functional genes that no longer work",
      "C": "Segments of viral DNA that attack ribosomes",
      "D": "Regulatory sequences in enhancers",
      "E": "Functional ribosomal genes"
    },
    "answer": "B",
    "explanation": "Pseudogenes are defunct versions of genes that have lost their protein-coding ability due to mutations.",
    "category": "FOM-Genetics"
  },
  {
    "id": 264,
    "question": "What is a key difference between processed and conventional pseudogenes?",
    "options": {
      "A": "Only processed pseudogenes contain exons",
      "B": "Processed pseudogenes are generated by reverse transcription",
      "C": "Conventional pseudogenes are made by CRISPR",
      "D": "Processed pseudogenes contain tRNA",
      "E": "Conventional pseudogenes are only found in bacteria"
    },
    "answer": "B",
    "explanation": "Processed pseudogenes arise from reverse-transcribed mRNA inserted back into the genome.",
    "category": "FOM-Genetics"
  },
  {
    "id": 265,
    "question": "Which enzyme is responsible for generating processed pseudogenes?",
    "options": {
      "A": "DNA polymerase",
      "B": "Telomerase",
      "C": "Ligase",
      "D": "Reverse transcriptase",
      "E": "RNA polymerase"
    },
    "answer": "D",
    "explanation": "Reverse transcriptase copies mRNA into DNA, enabling formation of processed pseudogenes.",
    "category": "FOM-Genetics"
  },
  {
    "id": 266,
    "question": "What is the function of telomerase?",
    "options": {
      "A": "Adds introns to mRNA",
      "B": "Synthesises telomere repeats at chromosome ends",
      "C": "Forms centromeres",
      "D": "Transcribes ribosomal RNA",
      "E": "Regulates exons"
    },
    "answer": "B",
    "explanation": "Telomerase maintains chromosome ends by adding TTAGGG repeats to prevent loss of genetic material during replication.",
    "category": "FOM-Genetics"
  },
  {
    "id": 267,
    "question": "Which term describes DNA sequences that can move within the genome?",
    "options": {
      "A": "Exons",
      "B": "Telomeres",
      "C": "Transposons",
      "D": "Enhancers",
      "E": "Spliceosomes"
    },
    "answer": "C",
    "explanation": "Transposons are mobile genetic elements, often making up a significant portion of the human genome as repetitive sequences.",
    "category": "FOM-Genetics"
  },
  {
    "id": 268,
    "question": "Which of the following is a possible role of transposons in evolution?",
    "options": {
      "A": "Acting as telomerase substrates",
      "B": "Degrading protein products",
      "C": "Creating new gene regulatory regions",
      "D": "Repairing introns",
      "E": "Producing ribosomes"
    },
    "answer": "C",
    "explanation": "Transposons can insert into regulatory DNA and affect gene expression, contributing to evolution.",
    "category": "FOM-Genetics"
  },
  {
    "id": 269,
    "question": "Why might humans retain so much repetitive and parasitic DNA?",
    "options": {
      "A": "It encodes all enzymes",
      "B": "It helps detoxify drugs",
      "C": "It may play roles in gene regulation and evolution",
      "D": "It prevents DNA replication",
      "E": "It eliminates pseudogenes"
    },
    "answer": "C",
    "explanation": "Although once thought 'junk', repetitive DNA may offer regulatory advantages and contribute to genomic evolution.",
    "category": "FOM-Genetics"
  },
  {
    "id": 270,
    "question": "What mechanism allows one gene to produce multiple proteins?",
    "options": {
      "A": "Reverse transcription",
      "B": "Alternative splicing",
      "C": "Mutation",
      "D": "Base excision repair",
      "E": "Gene duplication"
    },
    "answer": "B",
    "explanation": "Alternative splicing allows different combinations of exons to be joined, resulting in multiple proteins from one gene.",
    "category": "FOM-Genetics"
  },
  {
    "id": 271,
    "question": "Which term best describes DNA that does not code for protein but regulates transcription?",
    "options": {
      "A": "Exon",
      "B": "Enhancer",
      "C": "Spliceosome",
      "D": "Intronic RNA",
      "E": "Ribozyme"
    },
    "answer": "B",
    "explanation": "Enhancers are non-coding DNA regions that increase transcription levels of target genes.",
    "category": "FOM-Genetics"
  },
  {
    "id": 272,
    "question": "Which is a potential consequence of trinucleotide repeat expansion?",
    "options": {
      "A": "Protein stability",
      "B": "Reduced mRNA export",
      "C": "Disease due to abnormal proteins",
      "D": "Spliceosome degradation",
      "E": "RNA polymerase inhibition"
    },
    "answer": "C",
    "explanation": "Excessive trinucleotide repeats (e.g., CAG) can lead to disorders like Huntington’s disease by producing toxic proteins.",
    "category": "FOM-Genetics"
  },
  {
    "id": 273,
    "question": "How are tandem repeats propagated in the genome?",
    "options": {
      "A": "Ribosomal shunting",
      "B": "DNA methylation",
      "C": "DNA replication slippage",
      "D": "Transcription reversal",
      "E": "Histone replacement"
    },
    "answer": "C",
    "explanation": "DNA polymerase can slip during replication, causing trinucleotide expansions (e.g., CAG-CAG-CAG repeats).",
    "category": "FOM-Genetics"
  },
  {
    "id": 274,
    "question": "Which region of the chromosome is involved in proper segregation during mitosis?",
    "options": {
      "A": "Telomere",
      "B": "Exon",
      "C": "Centromere",
      "D": "Intron",
      "E": "Origin of replication"
    },
    "answer": "C",
    "explanation": "The centromere is the region where spindle fibers attach to ensure accurate chromosome segregation during cell division.",
    "category": "FOM-Genetics"
  },
  {
    "id": 275,
    "question": "Which is a post-translational modification that can alter protein function?",
    "options": {
      "A": "Glycosylation",
      "B": "Replication",
      "C": "Transcription",
      "D": "Methylation of DNA",
      "E": "Translation initiation"
    },
    "answer": "A",
    "explanation": "Glycosylation modifies proteins after translation and can affect protein folding, activity, or cell targeting.",
    "category": "FOM-Genetics"
  },
    {
    "id": 276,
    "question": "In which direction is new DNA synthesised?",
    "options": {
      "A": "3' to 3'",
      "B": "5' to 3'",
      "C": "3' to 5'",
      "D": "5' to 5'",
      "E": "Random"
    },
    "answer": "B",
    "explanation": "DNA polymerases synthesize DNA in the 5' to 3' direction by adding nucleotides to the free 3' OH group.",
    "category": "FOM-Genetics"
  },
  {
    "id": 277,
    "question": "Which of the following is a required feature for DNA polymerase activity?",
    "options": {
      "A": "High temperature",
      "B": "Pre-existing primer with a 3' OH group",
      "C": "ATP as the only nucleotide",
      "D": "Helicase inhibition",
      "E": "Ribosomes"
    },
    "answer": "B",
    "explanation": "DNA polymerase requires a primer with a free 3’ hydroxyl group to begin elongation.",
    "category": "FOM-Genetics"
  },
  {
    "id": 278,
    "question": "Which enzyme is responsible for laying down the primer during DNA replication?",
    "options": {
      "A": "DNA polymerase I",
      "B": "Primase",
      "C": "Ligase",
      "D": "Helicase",
      "E": "Topoisomerase"
    },
    "answer": "B",
    "explanation": "Primase synthesizes a short RNA primer to provide a starting point for DNA polymerase.",
    "category": "FOM-Genetics"
  },
  {
    "id": 279,
    "question": "What is the role of DNA polymerase I in prokaryotic DNA replication?",
    "options": {
      "A": "Lays down primers",
      "B": "Unwinds the helix",
      "C": "Replaces RNA primers with DNA",
      "D": "Adds telomeres",
      "E": "Inserts transposons"
    },
    "answer": "C",
    "explanation": "DNA polymerase I removes RNA primers using 5’→3’ exonuclease activity and replaces them with DNA.",
    "category": "FOM-Genetics"
  },
  {
    "id": 280,
    "question": "Which enzyme has 3’→5’ exonuclease activity for proofreading?",
    "options": {
      "A": "Ligase",
      "B": "Helicase",
      "C": "DNA polymerase",
      "D": "Primase",
      "E": "Topoisomerase"
    },
    "answer": "C",
    "explanation": "Many DNA polymerases possess 3'→5' exonuclease activity to remove mispaired bases for proofreading.",
    "category": "FOM-Genetics"
  },
  {
    "id": 281,
    "question": "Which enzyme relieves torsional stress ahead of the replication fork?",
    "options": {
      "A": "Helicase",
      "B": "Primase",
      "C": "Ligase",
      "D": "Topoisomerase (Gyrase)",
      "E": "Polymerase δ"
    },
    "answer": "D",
    "explanation": "Topoisomerase (type II, or gyrase in prokaryotes) prevents supercoiling during DNA unwinding.",
    "category": "FOM-Genetics"
  },
  {
    "id": 282,
    "question": "What is the function of DNA ligase during replication?",
    "options": {
      "A": "Synthesizes RNA primers",
      "B": "Unwinds the DNA helix",
      "C": "Joins Okazaki fragments on the lagging strand",
      "D": "Adds dNTPs",
      "E": "Performs base excision repair"
    },
    "answer": "C",
    "explanation": "DNA ligase seals nicks between Okazaki fragments by forming phosphodiester bonds.",
    "category": "FOM-Genetics"
  },
  {
    "id": 283,
    "question": "Which enzyme is targeted by fluoroquinolone antibiotics?",
    "options": {
      "A": "Helicase",
      "B": "Human topoisomerase I",
      "C": "Prokaryotic topoisomerase (gyrase)",
      "D": "RNA polymerase",
      "E": "DNA ligase"
    },
    "answer": "C",
    "explanation": "Fluoroquinolones inhibit bacterial gyrase, disrupting replication and killing the cell.",
    "category": "FOM-Genetics"
  },
  {
    "id": 284,
    "question": "What is a key difference in replication between prokaryotes and eukaryotes?",
    "options": {
      "A": "Eukaryotes use RNA polymerase for replication",
      "B": "Prokaryotes don’t use DNA ligase",
      "C": "Eukaryotes have multiple origins of replication",
      "D": "Prokaryotes replicate in mitochondria",
      "E": "Prokaryotes require telomerase"
    },
    "answer": "C",
    "explanation": "Eukaryotic chromosomes are linear and large, so multiple replication origins ensure timely DNA duplication.",
    "category": "FOM-Genetics"
  },
  {
    "id": 285,
    "question": "Which enzyme removes RNA primers in eukaryotic DNA replication?",
    "options": {
      "A": "DNA polymerase α",
      "B": "FEN1 and RNase H",
      "C": "Helicase",
      "D": "Ligase",
      "E": "Gyrase"
    },
    "answer": "B",
    "explanation": "FEN1 and RNase H remove RNA primers in eukaryotes, allowing DNA polymerase δ to fill in the gaps.",
    "category": "FOM-Genetics"
  },
  {
    "id": 286,
    "question": "What is the role of DNA polymerase δ in eukaryotic replication?",
    "options": {
      "A": "Lays down RNA primers",
      "B": "Synthesizes the lagging strand",
      "C": "Cuts Okazaki fragments",
      "D": "Removes introns",
      "E": "Maintains telomeres"
    },
    "answer": "B",
    "explanation": "DNA polymerase δ extends the lagging strand in eukaryotic cells following primer removal.",
    "category": "FOM-Genetics"
  },
  {
    "id": 287,
    "question": "Which activity is unique to DNA polymerase I in prokaryotes?",
    "options": {
      "A": "Synthesising new RNA primers",
      "B": "Adding dNTPs only",
      "C": "Removing RNA primers with 5’→3’ exonuclease activity",
      "D": "Proofreading via 3’→5’ exonuclease activity only",
      "E": "Repairing base mismatches"
    },
    "answer": "C",
    "explanation": "DNA polymerase I removes RNA primers and replaces them with DNA using 5’→3’ exonuclease activity, a function unique from DNA pol III.",
    "category": "FOM-Genetics"
  },
  {
    "id": 288,
    "question": "Which topoisomerase is used as a chemotherapy target in humans?",
    "options": {
      "A": "DNA polymerase δ",
      "B": "Topoisomerase I or II",
      "C": "RNA polymerase",
      "D": "DNA ligase",
      "E": "Helicase"
    },
    "answer": "B",
    "explanation": "Human topoisomerases I and II are targeted by chemotherapy drugs to block DNA replication in cancer cells.",
    "category": "FOM-Genetics"
  },
  {
    "id": 289,
    "question": "Which feature is shared by all DNA polymerases?",
    "options": {
      "A": "5’→3’ exonuclease activity",
      "B": "Ability to initiate synthesis de novo",
      "C": "5’→3’ synthesis direction",
      "D": "RNA removal",
      "E": "Ligase function"
    },
    "answer": "C",
    "explanation": "All DNA polymerases synthesise DNA in the 5’→3’ direction.",
    "category": "FOM-Genetics"
  },
  {
    "id": 290,
    "question": "What is the function of the helicase enzyme in replication?",
    "options": {
      "A": "Lays primers",
      "B": "Unwinds DNA double helix",
      "C": "Joins Okazaki fragments",
      "D": "Inserts ribonucleotides",
      "E": "Checks for base mismatches"
    },
    "answer": "B",
    "explanation": "Helicase separates the two strands of DNA to allow replication machinery to access templates.",
    "category": "FOM-Genetics"
  },
    {
    "id": 291,
    "question": "What is the definition of a DNA mutation?",
    "options": {
      "A": "Temporary DNA unwinding",
      "B": "Change in ribosome binding",
      "C": "Change in nucleotide sequence of a genome region",
      "D": "Methylation of CpG islands",
      "E": "Loss of a chromosome"
    },
    "answer": "C",
    "explanation": "A mutation is defined as a change in the nucleotide sequence of a short region of the genome.",
    "category": "FOM-Genetics"
  },
  {
    "id": 292,
    "question": "Which of the following is a type of point mutation?",
    "options": {
      "A": "Inversion",
      "B": "Duplication",
      "C": "Single base substitution",
      "D": "Large deletion",
      "E": "Translocation"
    },
    "answer": "C",
    "explanation": "Point mutations involve a single base change, such as substitutions.",
    "category": "FOM-Genetics"
  },
  {
    "id": 293,
    "question": "What type of DNA mutation results from the incorporation of a chemical mimic of a nucleotide?",
    "options": {
      "A": "Insertion",
      "B": "Deletion",
      "C": "Point mutation",
      "D": "Frameshift",
      "E": "Duplication"
    },
    "answer": "C",
    "explanation": "Chemical mimics of nucleotides can lead to incorrect base pairing and point mutations.",
    "category": "FOM-Genetics"
  },
  {
    "id": 294,
    "question": "Which repair mechanism fixes small, non-bulky base lesions?",
    "options": {
      "A": "Nucleotide excision repair",
      "B": "Mismatch repair",
      "C": "Base excision repair",
      "D": "Direct repair",
      "E": "Recombinational repair"
    },
    "answer": "C",
    "explanation": "Base excision repair corrects small base modifications or single base mismatches by removing the damaged base.",
    "category": "FOM-Genetics"
  },
  {
    "id": 295,
    "question": "Which DNA repair pathway specifically removes bulky lesions like thymine dimers caused by UV light?",
    "options": {
      "A": "Mismatch repair",
      "B": "Direct repair",
      "C": "Base excision repair",
      "D": "Nucleotide excision repair",
      "E": "Fanconi repair"
    },
    "answer": "D",
    "explanation": "Nucleotide excision repair is the main mechanism to remove bulky lesions, such as UV-induced thymine dimers.",
    "category": "FOM-Genetics"
  },
  {
    "id": 296,
    "question": "What are the three main steps common to excision repair mechanisms?",
    "options": {
      "A": "Replication, transcription, translation",
      "B": "Recognition, excision, replacement",
      "C": "Ligation, unwinding, helicase binding",
      "D": "Condensation, deamination, rehydration",
      "E": "Export, import, replication"
    },
    "answer": "B",
    "explanation": "All excision-based repairs involve: recognising damage, removing the faulty region, and filling the gap with correct bases.",
    "category": "FOM-Genetics"
  },
  {
    "id": 297,
    "question": "A defect in mismatch repair leads to which inherited condition?",
    "options": {
      "A": "Xeroderma pigmentosum",
      "B": "Lynch syndrome",
      "C": "Fanconi anaemia",
      "D": "Cockayne syndrome",
      "E": "Werner’s syndrome"
    },
    "answer": "B",
    "explanation": "Hereditary nonpolyposis colorectal cancer (Lynch syndrome) results from mismatch repair defects.",
    "category": "FOM-Genetics"
  },
  {
    "id": 298,
    "question": "Which condition is caused by defective repair of UV-induced DNA damage?",
    "options": {
      "A": "Bloom syndrome",
      "B": "Ataxia telangiectasia",
      "C": "Xeroderma pigmentosum",
      "D": "Werner’s syndrome",
      "E": "BRCA1 mutation"
    },
    "answer": "C",
    "explanation": "Xeroderma pigmentosum is characterised by hypersensitivity to UV light due to impaired nucleotide excision repair.",
    "category": "FOM-Genetics"
  },
  {
    "id": 299,
    "question": "BRCA1 and BRCA2 mutations are associated with defective repair of what?",
    "options": {
      "A": "Point mutations",
      "B": "UV-induced dimers",
      "C": "Double strand breaks",
      "D": "Oxidative damage",
      "E": "Transposon excision"
    },
    "answer": "C",
    "explanation": "BRCA1 and BRCA2 are involved in homologous recombination repair of double strand breaks.",
    "category": "FOM-Genetics"
  },
  {
    "id": 300,
    "question": "Which genetic disorder is associated with mutation in the ATM gene, leading to defective DNA break recognition?",
    "options": {
      "A": "Fanconi anaemia",
      "B": "Cockayne syndrome",
      "C": "Bloom syndrome",
      "D": "Ataxia telangiectasia",
      "E": "Lynch syndrome"
    },
    "answer": "D",
    "explanation": "Ataxia telangiectasia is due to mutations in ATM, affecting DNA damage response to double-strand breaks.",
    "category": "FOM-Genetics"
  },
  {
    "id": 301,
    "question": "A child presents with brittle hair, photosensitivity, and mental retardation. Which condition is most likely?",
    "options": {
      "A": "Xeroderma pigmentosum",
      "B": "Trichothiodystrophy",
      "C": "Werner’s syndrome",
      "D": "Cockayne syndrome",
      "E": "Fanconi anaemia"
    },
    "answer": "B",
    "explanation": "Trichothiodystrophy involves defective nucleotide excision repair leading to brittle hair, UV sensitivity, and intellectual disability.",
    "category": "FOM-Genetics"
  },
  {
    "id": 302,
    "question": "Which repair mechanism uses direct reversal of DNA damage without excising the base?",
    "options": {
      "A": "Mismatch repair",
      "B": "Nucleotide excision repair",
      "C": "Base excision repair",
      "D": "Direct repair",
      "E": "Double strand break repair"
    },
    "answer": "D",
    "explanation": "Direct repair corrects base modifications directly (e.g. methylation), without removing the base or nucleotide.",
    "category": "FOM-Genetics"
  },
  {
    "id": 303,
    "question": "What enzyme is most commonly associated with repair of methylated guanine?",
    "options": {
      "A": "DNA polymerase δ",
      "B": "MGMT (O6-methylguanine DNA methyltransferase)",
      "C": "FEN1",
      "D": "Topoisomerase I",
      "E": "Exonuclease III"
    },
    "answer": "B",
    "explanation": "MGMT removes methyl groups from O6-methylguanine directly via a suicide mechanism, preventing mismatches.",
    "category": "FOM-Genetics"
  },
  {
    "id": 304,
    "question": "Cockayne syndrome affects which type of DNA repair?",
    "options": {
      "A": "Mismatch repair",
      "B": "Transcription-coupled nucleotide excision repair",
      "C": "Base excision repair",
      "D": "Homologous recombination",
      "E": "Non-homologous end joining"
    },
    "answer": "B",
    "explanation": "Cockayne syndrome involves defects in transcription-coupled NER, affecting actively transcribed regions.",
    "category": "FOM-Genetics"
  },
  {
    "id": 305,
    "question": "Which syndrome results from mutations in WRN, a RecQ helicase involved in homologous recombination?",
    "options": {
      "A": "Werner’s syndrome",
      "B": "Bloom’s syndrome",
      "C": "Xeroderma pigmentosum",
      "D": "Trichothiodystrophy",
      "E": "Fanconi anaemia"
    },
    "answer": "A",
    "explanation": "Werner’s syndrome results from WRN mutations and is associated with premature aging and impaired DNA repair.",
    "category": "FOM-Genetics"
  },
    {
    "id": 306,
    "question": "Which RNA polymerase is responsible for synthesizing mRNA in eukaryotic cells?",
    "options": {
      "A": "RNA polymerase I",
      "B": "RNA polymerase II",
      "C": "RNA polymerase III",
      "D": "DNA polymerase",
      "E": "Reverse transcriptase"
    },
    "answer": "B",
    "explanation": "RNA polymerase II synthesises mRNA, which is the template for protein translation.",
    "category": "FOM-Genetics"
  },
  {
    "id": 307,
    "question": "What is the role of the TATA box in eukaryotic transcription?",
    "options": {
      "A": "Enhancer binding site",
      "B": "Initiation of replication",
      "C": "Site for transcription factor and RNA polymerase II binding",
      "D": "Termination signal for transcription",
      "E": "Splice site for mRNA"
    },
    "answer": "C",
    "explanation": "The TATA box is a core promoter element that helps position RNA polymerase II via transcription factors.",
    "category": "FOM-Genetics"
  },
  {
    "id": 308,
    "question": "Which RNA molecule is a ribozyme involved in peptide bond formation?",
    "options": {
      "A": "tRNA",
      "B": "28S rRNA",
      "C": "mRNA",
      "D": "siRNA",
      "E": "snRNA"
    },
    "answer": "B",
    "explanation": "28S rRNA catalyzes peptide bond formation during translation and functions as a ribozyme.",
    "category": "FOM-Genetics"
  },
  {
    "id": 309,
    "question": "Which of the following RNA types is involved in RNA splicing?",
    "options": {
      "A": "tRNA",
      "B": "siRNA",
      "C": "snRNA",
      "D": "miRNA",
      "E": "rRNA"
    },
    "answer": "C",
    "explanation": "Small nuclear RNAs (snRNAs) are components of the spliceosome involved in intron removal.",
    "category": "FOM-Genetics"
  },
  {
    "id": 310,
    "question": "Alternative splicing allows:",
    "options": {
      "A": "The conversion of RNA into DNA",
      "B": "Multiple protein isoforms from one gene",
      "C": "Repair of DNA damage",
      "D": "Blocking of transcription",
      "E": "Direct translation of DNA"
    },
    "answer": "B",
    "explanation": "Alternative splicing generates different mature mRNAs from the same pre-mRNA, producing protein diversity.",
    "category": "FOM-Genetics"
  },
  {
    "id": 311,
    "question": "Which modification typically occurs at the 5’ end of eukaryotic pre-mRNA?",
    "options": {
      "A": "Polyadenylation",
      "B": "Methylation of introns",
      "C": "5’ cap addition",
      "D": "Splicing",
      "E": "Exon skipping"
    },
    "answer": "C",
    "explanation": "A 7-methylguanosine cap is added to the 5’ end of mRNA to protect it and aid in translation initiation.",
    "category": "FOM-Genetics"
  },
  {
    "id": 312,
    "question": "What is the function of transcription factors in gene regulation?",
    "options": {
      "A": "Splice introns",
      "B": "Block ribosome binding",
      "C": "Recruit RNA polymerase to the promoter",
      "D": "Transport mRNA out of the nucleus",
      "E": "Degrade mRNA"
    },
    "answer": "C",
    "explanation": "Transcription factors bind promoter/enhancer regions to help recruit RNA polymerase II to initiate transcription.",
    "category": "FOM-Genetics"
  },
  {
    "id": 313,
    "question": "What is the role of enhancer sequences in transcription?",
    "options": {
      "A": "Initiate replication",
      "B": "Signal mRNA degradation",
      "C": "Increase transcription rate via transcription factor binding",
      "D": "Block promoter access",
      "E": "Mark introns for removal"
    },
    "answer": "C",
    "explanation": "Enhancers are DNA elements that bind transcription factors to increase the transcription rate of a gene.",
    "category": "FOM-Genetics"
  },
  {
    "id": 314,
    "question": "What effect does histone acetylation have on gene expression?",
    "options": {
      "A": "Represses transcription by condensing chromatin",
      "B": "Inhibits DNA replication",
      "C": "Facilitates transcription by loosening chromatin",
      "D": "Blocks RNA polymerase binding",
      "E": "Triggers methylation"
    },
    "answer": "C",
    "explanation": "Acetylation of histone tails opens chromatin structure (euchromatin), making DNA accessible for transcription.",
    "category": "FOM-Genetics"
  },
  {
    "id": 315,
    "question": "Which of the following statements about DNA methylation is correct?",
    "options": {
      "A": "Increases gene transcription",
      "B": "Only occurs in prokaryotes",
      "C": "Associated with gene silencing",
      "D": "Marks RNA for export",
      "E": "Occurs on ribosomal RNA"
    },
    "answer": "C",
    "explanation": "DNA methylation, particularly at CpG islands, is associated with transcriptional repression.",
    "category": "FOM-Genetics"
  },
  {
    "id": 316,
    "question": "Which component is part of the pre-initiation complex for RNA polymerase II?",
    "options": {
      "A": "Ribosome",
      "B": "DNA ligase",
      "C": "Mediator complex",
      "D": "DNA polymerase III",
      "E": "Topoisomerase I"
    },
    "answer": "C",
    "explanation": "The mediator complex bridges transcription factors and RNA polymerase II during pre-initiation complex assembly.",
    "category": "FOM-Genetics"
  },
  {
    "id": 317,
    "question": "What is euchromatin?",
    "options": {
      "A": "Methylated, tightly packed chromatin",
      "B": "Inactive form of mRNA",
      "C": "Loosely packed chromatin, transcriptionally active",
      "D": "DNA only found in gametes",
      "E": "Cytoplasmic DNA"
    },
    "answer": "C",
    "explanation": "Euchromatin is loosely packed, allowing transcriptional machinery to access DNA for gene expression.",
    "category": "FOM-Genetics"
  },
  {
    "id": 318,
    "question": "Which factor enables cell-type specific transcription of the same gene?",
    "options": {
      "A": "Ribosomal RNA",
      "B": "Universal DNA sequence",
      "C": "Cell-specific transcription factors",
      "D": "Promoter mutation",
      "E": "Histone dephosphorylation"
    },
    "answer": "C",
    "explanation": "The same DNA sequence can be transcribed differently in different cells due to specific transcription factors.",
    "category": "FOM-Genetics"
  },
  {
    "id": 319,
    "question": "What property is shared by all RNA polymerases?",
    "options": {
      "A": "Ability to proofread",
      "B": "Primer requirement",
      "C": "Synthesis in 5’ to 3’ direction",
      "D": "Reverse transcription ability",
      "E": "Template-free synthesis"
    },
    "answer": "C",
    "explanation": "All RNA polymerases synthesise RNA in the 5' to 3' direction using a DNA template.",
    "category": "FOM-Genetics"
  },
  {
    "id": 320,
    "question": "Which post-transcriptional modification helps prevent degradation of eukaryotic mRNA?",
    "options": {
      "A": "Exon skipping",
      "B": "5’ capping",
      "C": "DNA methylation",
      "D": "Translocation",
      "E": "RNA editing"
    },
    "answer": "B",
    "explanation": "The 5’ methyl cap protects mRNA from degradation and aids in ribosome recognition for translation.",
    "category": "FOM-Genetics"
  },
    {
    "id": 321,
    "question": "Which statement about the genetic code is correct?",
    "options": {
      "A": "It is overlapping",
      "B": "Each codon consists of four nucleotides",
      "C": "It is (almost) universal across organisms",
      "D": "Each amino acid is coded by only one codon",
      "E": "It includes codons for DNA polymerase"
    },
    "answer": "C",
    "explanation": "The genetic code is (almost) universal and consists of non-overlapping triplets (codons).",
    "category": "FOM-Genetics"
  },
  {
    "id": 322,
    "question": "What does a tRNA molecule carry during translation?",
    "options": {
      "A": "Transcription factors",
      "B": "DNA polymerase",
      "C": "A specific amino acid matching its anticodon",
      "D": "Stop codons",
      "E": "Ribosomal subunits"
    },
    "answer": "C",
    "explanation": "Each tRNA has an anticodon that pairs with the mRNA codon and carries the corresponding amino acid.",
    "category": "FOM-Genetics"
  },
  {
    "id": 323,
    "question": "Which ribosomal subunits form the 80S ribosome in eukaryotes?",
    "options": {
      "A": "30S and 50S",
      "B": "20S and 60S",
      "C": "40S and 60S",
      "D": "28S and 18S",
      "E": "70S and 10S"
    },
    "answer": "C",
    "explanation": "The eukaryotic ribosome is 80S, formed by 40S (small) and 60S (large) subunits.",
    "category": "FOM-Genetics"
  },
  {
    "id": 324,
    "question": "What is the first codon to be translated in nearly all eukaryotic mRNAs?",
    "options": {
      "A": "UAG",
      "B": "UGA",
      "C": "AUG",
      "D": "CUU",
      "E": "UAA"
    },
    "answer": "C",
    "explanation": "AUG is the start codon in eukaryotes, coding for methionine (Met).",
    "category": "FOM-Genetics"
  },
  {
    "id": 325,
    "question": "Which ribosomal site receives the incoming aminoacyl-tRNA during elongation?",
    "options": {
      "A": "P site",
      "B": "E site",
      "C": "A site",
      "D": "Z site",
      "E": "D site"
    },
    "answer": "C",
    "explanation": "During elongation, the A (aminoacyl) site accepts the new aminoacyl-tRNA.",
    "category": "FOM-Genetics"
  },
  {
    "id": 326,
    "question": "Which enzymatic activity forms the peptide bond during translation?",
    "options": {
      "A": "Ligase",
      "B": "Peptidyl transferase",
      "C": "Aminoacyl synthase",
      "D": "Topoisomerase",
      "E": "Helicase"
    },
    "answer": "B",
    "explanation": "Peptidyl transferase, part of the ribosome’s large subunit (28S rRNA), catalyzes peptide bond formation.",
    "category": "FOM-Genetics"
  },
  {
    "id": 327,
    "question": "Which event terminates translation?",
    "options": {
      "A": "Binding of DNA polymerase",
      "B": "tRNA release",
      "C": "Stop codon recognition by a release factor",
      "D": "mRNA degradation",
      "E": "Intronic splicing"
    },
    "answer": "C",
    "explanation": "Translation ends when a stop codon (UAA, UAG, or UGA) is recognised by release factors, not tRNA.",
    "category": "FOM-Genetics"
  },
  {
    "id": 328,
    "question": "Which post-translational modification commonly regulates protein activity?",
    "options": {
      "A": "DNA replication",
      "B": "RNA splicing",
      "C": "Phosphorylation",
      "D": "Peptide bond formation",
      "E": "Glycolysis"
    },
    "answer": "C",
    "explanation": "Phosphorylation (by kinases) is a common reversible modification that regulates protein function.",
    "category": "FOM-Genetics"
  },
  {
    "id": 329,
    "question": "Which antibiotic inhibits the binding of aminoacyl-tRNA to the A site in prokaryotes?",
    "options": {
      "A": "Erythromycin",
      "B": "Tetracycline",
      "C": "Chloramphenicol",
      "D": "Cycloheximide",
      "E": "Streptomycin"
    },
    "answer": "B",
    "explanation": "Tetracycline binds the 30S ribosomal subunit and blocks aminoacyl-tRNA from entering the A site.",
    "category": "FOM-Genetics"
  },
  {
    "id": 330,
    "question": "Which ribosomal RNA is damaged by ricin, leading to inhibition of protein synthesis?",
    "options": {
      "A": "5S",
      "B": "18S",
      "C": "28S",
      "D": "23S",
      "E": "16S"
    },
    "answer": "C",
    "explanation": "Ricin depurinates 28S rRNA in the large (60S) ribosomal subunit, halting protein synthesis.",
    "category": "FOM-Genetics"
  },
  {
    "id": 331,
    "question": "Which site does the initiator Met-tRNA bind during eukaryotic initiation?",
    "options": {
      "A": "E site",
      "B": "D site",
      "C": "P site",
      "D": "A site",
      "E": "R site"
    },
    "answer": "C",
    "explanation": "Met-tRNAi binds directly to the P site on the small ribosomal subunit during initiation.",
    "category": "FOM-Genetics"
  },
  {
    "id": 332,
    "question": "Which protein factor assists in ribosome translocation during elongation?",
    "options": {
      "A": "EF-Tu",
      "B": "EF1",
      "C": "EF2",
      "D": "IF2",
      "E": "RF1"
    },
    "answer": "C",
    "explanation": "EF2 (eukaryotes) mediates the translocation of the ribosome along the mRNA during elongation.",
    "category": "FOM-Genetics"
  },
  {
    "id": 333,
    "question": "Which of the following is NOT a common post-translational modification?",
    "options": {
      "A": "Phosphorylation",
      "B": "Glycosylation",
      "C": "Proteolytic cleavage",
      "D": "DNA methylation",
      "E": "Hydroxylation"
    },
    "answer": "D",
    "explanation": "DNA methylation is an epigenetic change, not a post-translational protein modification.",
    "category": "FOM-Genetics"
  },
  {
    "id": 334,
    "question": "Which protein synthesis inhibitor acts on eukaryotic ribosomes only?",
    "options": {
      "A": "Tetracycline",
      "B": "Streptomycin",
      "C": "Erythromycin",
      "D": "Cycloheximide",
      "E": "Chloramphenicol"
    },
    "answer": "D",
    "explanation": "Cycloheximide inhibits translocation in eukaryotic ribosomes but has no effect on prokaryotic translation.",
    "category": "FOM-Genetics"
  },
  {
    "id": 335,
    "question": "What does peptidyl transferase activity reside in?",
    "options": {
      "A": "tRNA",
      "B": "40S ribosomal subunit",
      "C": "Protein elongation factors",
      "D": "28S ribosomal RNA",
      "E": "DNA polymerase"
    },
    "answer": "D",
    "explanation": "The 28S rRNA in the 60S subunit of eukaryotes acts as a ribozyme catalyzing peptide bond formation.",
    "category": "FOM-Genetics"
  },
    {
    "id": 336,
    "question": "What percentage of the human genome is variable between individuals?",
    "options": {
      "A": "1%",
      "B": "0.5%",
      "C": "0.1%",
      "D": "10%",
      "E": "99.9%"
    },
    "answer": "C",
    "explanation": "Human genomes are 99.9% identical, meaning 0.1% (~3 million base pairs) differ between individuals.",
    "category": "FOM-Genetics"
  },
  {
    "id": 337,
    "question": "Which of the following describes a point mutation?",
    "options": {
      "A": "Duplication of a whole gene",
      "B": "Insertion of a large DNA fragment",
      "C": "Single nucleotide substitution",
      "D": "Triplet expansion",
      "E": "Splicing error"
    },
    "answer": "C",
    "explanation": "A point mutation is a single base substitution, often due to incorrect or modified nucleotides.",
    "category": "FOM-Genetics"
  },
  {
    "id": 338,
    "question": "Which base is produced when cytosine undergoes deamination?",
    "options": {
      "A": "Thymine",
      "B": "Adenine",
      "C": "Uracil",
      "D": "Guanine",
      "E": "Cytosine"
    },
    "answer": "C",
    "explanation": "Deamination of cytosine converts it into uracil, potentially leading to a C→T transition if unrepaired.",
    "category": "FOM-Genetics"
  },
  {
    "id": 339,
    "question": "A mutation that introduces a premature stop codon is called:",
    "options": {
      "A": "Missense mutation",
      "B": "Silent mutation",
      "C": "Nonsense mutation",
      "D": "Splice mutation",
      "E": "Insertion mutation"
    },
    "answer": "C",
    "explanation": "A nonsense mutation creates a premature stop codon, truncating the protein.",
    "category": "FOM-Genetics"
  },
  {
    "id": 340,
    "question": "Which mutation leads to a frameshift?",
    "options": {
      "A": "Substitution of a single base",
      "B": "Insertion of three bases",
      "C": "Deletion of one base",
      "D": "Silent mutation",
      "E": "Promoter mutation"
    },
    "answer": "C",
    "explanation": "Insertion or deletion of bases not in multiples of three causes a frameshift, altering downstream codons.",
    "category": "FOM-Genetics"
  },
  {
    "id": 341,
    "question": "The mutation in sickle cell disease results in substitution of which amino acid?",
    "options": {
      "A": "Valine for glutamate",
      "B": "Lysine for arginine",
      "C": "Glycine for alanine",
      "D": "Methionine for leucine",
      "E": "Aspartate for serine"
    },
    "answer": "A",
    "explanation": "Sickle cell disease involves a GAG → GTG mutation, replacing glutamate with valine in β-globin.",
    "category": "FOM-Genetics"
  },
  {
    "id": 342,
    "question": "Which of the following best describes a compound heterozygote?",
    "options": {
      "A": "Two wild-type alleles",
      "B": "One mutated and one wild-type allele",
      "C": "Two identical mutated alleles",
      "D": "Two different mutations in the same gene",
      "E": "Mutation in non-coding DNA"
    },
    "answer": "D",
    "explanation": "Compound heterozygotes have two different mutant alleles at a particular gene locus.",
    "category": "FOM-Genetics"
  },
  {
    "id": 343,
    "question": "Which of the following mutations can cause β-thalassaemia?",
    "options": {
      "A": "Promoter mutation",
      "B": "Splice site mutation",
      "C": "Poly-A signal mutation",
      "D": "Coding region insertion or deletion",
      "E": "All of the above"
    },
    "answer": "E",
    "explanation": "All listed mutations can reduce β-globin expression or lead to abnormal mRNA/protein in β-thalassaemia.",
    "category": "FOM-Genetics"
  },
  {
    "id": 344,
    "question": "A frameshift mutation caused by an insertion is less severe if:",
    "options": {
      "A": "It occurs in a coding exon",
      "B": "It is near the promoter",
      "C": "It is divisible by 3",
      "D": "It occurs in an intron",
      "E": "It is followed by a stop codon"
    },
    "answer": "C",
    "explanation": "Insertions or deletions divisible by 3 preserve the reading frame and are less disruptive.",
    "category": "FOM-Genetics"
  },
  {
    "id": 345,
    "question": "Mutations that disrupt splicing can result in:",
    "options": {
      "A": "Increased mRNA stability",
      "B": "Intron retention or exon skipping",
      "C": "Enhanced translation",
      "D": "DNA methylation",
      "E": "Longer poly-A tails"
    },
    "answer": "B",
    "explanation": "Splicing mutations may cause faulty splicing patterns such as exon skipping or intron inclusion.",
    "category": "FOM-Genetics"
  },
  {
    "id": 346,
    "question": "Which of the following is a disease commonly caused by splicing mutations?",
    "options": {
      "A": "Cystic fibrosis",
      "B": "β-thalassaemia",
      "C": "Duchenne muscular dystrophy",
      "D": "Huntington’s disease",
      "E": "Phenylketonuria"
    },
    "answer": "B",
    "explanation": "Up to 60% of mutations that cause β-thalassaemia affect mRNA splicing.",
    "category": "FOM-Genetics"
  },
  {
    "id": 347,
    "question": "Which of the following is true about silent mutations?",
    "options": {
      "A": "They always affect protein function",
      "B": "They change the amino acid sequence",
      "C": "They can alter splicing or mRNA structure",
      "D": "They create stop codons",
      "E": "They delete exons"
    },
    "answer": "C",
    "explanation": "Although they don’t change the amino acid, silent mutations may still affect mRNA stability or splicing.",
    "category": "FOM-Genetics"
  },
  {
    "id": 348,
    "question": "Which type of mutation leads to loss of β-globin in β0-thalassaemia?",
    "options": {
      "A": "Nonsense mutation in exon 1",
      "B": "Insertion in an intron",
      "C": "Promoter upregulation",
      "D": "GU→AU splice site mutation",
      "E": "Poly-A tail extension"
    },
    "answer": "D",
    "explanation": "A GU→AU splice site mutation disrupts correct mRNA splicing, abolishing β-globin synthesis (β0).",
    "category": "FOM-Genetics"
  },
  {
    "id": 349,
    "question": "A dominant mutation typically results in:",
    "options": {
      "A": "No change in phenotype",
      "B": "Altered phenotype with one mutant allele",
      "C": "Phenotype only when homozygous",
      "D": "Mutation of both alleles",
      "E": "No protein expression"
    },
    "answer": "B",
    "explanation": "Dominant mutations manifest with just one copy of a mutant gene.",
    "category": "FOM-Genetics"
  },
  {
    "id": 350,
    "question": "What is a heterozygous individual?",
    "options": {
      "A": "Carries two identical alleles",
      "B": "Has no mutations",
      "C": "Carries two different alleles at a locus",
      "D": "Only one X chromosome",
      "E": "Lacks β-globin"
    },
    "answer": "C",
    "explanation": "A heterozygote has two different alleles for a gene at a given locus.",
    "category": "FOM-Genetics"
  },
    {
    "id": 351,
    "question": "During which phase of the cell cycle is DNA replicated?",
    "options": {
      "A": "G1 phase",
      "B": "S phase",
      "C": "G2 phase",
      "D": "M phase",
      "E": "Cytokinesis"
    },
    "answer": "B",
    "explanation": "DNA synthesis (replication) occurs during the S phase of interphase.",
    "category": "FOM-Genetics"
  },
  {
    "id": 352,
    "question": "Which protein type regulates progression through the cell cycle?",
    "options": {
      "A": "Transaminases",
      "B": "Cyclins",
      "C": "Proteases",
      "D": "Kinesins",
      "E": "Topoisomerases"
    },
    "answer": "B",
    "explanation": "Cyclins bind to and activate cyclin-dependent kinases (CDKs) to drive cell cycle transitions.",
    "category": "FOM-Genetics"
  },
  {
    "id": 353,
    "question": "What is the function of cyclin-dependent kinases (CDKs)?",
    "options": {
      "A": "Degrade cyclins",
      "B": "Direct mitotic spindle formation",
      "C": "Phosphorylate target proteins to regulate the cell cycle",
      "D": "Condense chromosomes",
      "E": "Initiate DNA repair"
    },
    "answer": "C",
    "explanation": "CDKs phosphorylate specific substrates to regulate transitions between cell cycle stages.",
    "category": "FOM-Genetics"
  },
  {
    "id": 354,
    "question": "What occurs during metaphase of mitosis?",
    "options": {
      "A": "Chromosomes condense and spindle forms",
      "B": "Nuclear envelope reforms",
      "C": "Chromosomes align at the equator",
      "D": "Sister chromatids are pulled to opposite poles",
      "E": "Cytoplasm divides"
    },
    "answer": "C",
    "explanation": "In metaphase, chromosomes are aligned at the metaphase plate by spindle fibres.",
    "category": "FOM-Genetics"
  },
  {
    "id": 355,
    "question": "What best defines the G0 phase?",
    "options": {
      "A": "Cell division",
      "B": "Cell death",
      "C": "Active DNA replication",
      "D": "A quiescent, non-dividing state",
      "E": "Cytokinesis"
    },
    "answer": "D",
    "explanation": "G0 is a resting phase where cells exit the cycle and do not prepare for division.",
    "category": "FOM-Genetics"
  },
  {
    "id": 356,
    "question": "What occurs during anaphase of mitosis?",
    "options": {
      "A": "Sister chromatids separate and move to opposite poles",
      "B": "DNA replication",
      "C": "Spindle fibres begin to form",
      "D": "Chromosomes align at equator",
      "E": "Cytokinesis begins"
    },
    "answer": "A",
    "explanation": "Anaphase involves the separation of sister chromatids to opposite ends of the cell.",
    "category": "FOM-Genetics"
  },
  {
    "id": 357,
    "question": "What is the result of meiosis?",
    "options": {
      "A": "Two diploid daughter cells",
      "B": "Two haploid cells",
      "C": "Four diploid cells",
      "D": "Four haploid cells",
      "E": "Eight polyploid cells"
    },
    "answer": "D",
    "explanation": "Meiosis produces four genetically distinct haploid cells from a diploid parent cell.",
    "category": "FOM-Genetics"
  },
  {
    "id": 358,
    "question": "What feature of meiosis increases genetic variation?",
    "options": {
      "A": "DNA replication",
      "B": "Sister chromatid separation",
      "C": "Crossing over and independent assortment",
      "D": "Cytokinesis",
      "E": "Chromatin condensation"
    },
    "answer": "C",
    "explanation": "Crossing over and independent assortment during meiosis I increase genetic diversity.",
    "category": "FOM-Genetics"
  },
  {
    "id": 359,
    "question": "Which phase of meiosis is associated with homologous chromosomes separating?",
    "options": {
      "A": "Prophase I",
      "B": "Metaphase II",
      "C": "Anaphase I",
      "D": "Telophase II",
      "E": "Interphase"
    },
    "answer": "C",
    "explanation": "In Anaphase I of meiosis, homologous chromosomes (not chromatids) are separated.",
    "category": "FOM-Genetics"
  },
  {
    "id": 360,
    "question": "What occurs during telophase of mitosis?",
    "options": {
      "A": "Chromosomes condense",
      "B": "Chromatids align at equator",
      "C": "Nuclear membranes reform",
      "D": "DNA replication begins",
      "E": "Microtubules attach to centromeres"
    },
    "answer": "C",
    "explanation": "During telophase, chromosomes decondense and nuclear membranes are reassembled.",
    "category": "FOM-Genetics"
  },
  {
    "id": 361,
    "question": "Which structure forms the spindle apparatus?",
    "options": {
      "A": "Centrosome",
      "B": "Nucleolus",
      "C": "Lysosome",
      "D": "Mitochondria",
      "E": "Kinetochore"
    },
    "answer": "A",
    "explanation": "The centrosome organizes microtubules and forms the mitotic spindle.",
    "category": "FOM-Genetics"
  },
  {
    "id": 362,
    "question": "What is the role of the kinetochore during mitosis?",
    "options": {
      "A": "Produces spindle fibres",
      "B": "Condenses chromatin",
      "C": "Attaches chromosomes to spindle microtubules",
      "D": "Initiates transcription",
      "E": "Binds CDKs"
    },
    "answer": "C",
    "explanation": "Kinetochores are protein complexes that link spindle fibres to centromeres on chromosomes.",
    "category": "FOM-Genetics"
  },
  {
    "id": 363,
    "question": "Which phase of meiosis resembles mitosis?",
    "options": {
      "A": "Meiosis I",
      "B": "G0",
      "C": "Anaphase I",
      "D": "Meiosis II",
      "E": "S phase"
    },
    "answer": "D",
    "explanation": "Meiosis II is similar to mitosis, where sister chromatids separate.",
    "category": "FOM-Genetics"
  },
  {
    "id": 364,
    "question": "How many chromosomes are present in human haploid cells?",
    "options": {
      "A": "23",
      "B": "46",
      "C": "69",
      "D": "92",
      "E": "12"
    },
    "answer": "A",
    "explanation": "Human gametes (haploid) contain 23 chromosomes; diploid cells have 46.",
    "category": "FOM-Genetics"
  },
  {
    "id": 365,
    "question": "Which checkpoint ensures DNA is undamaged before entering mitosis?",
    "options": {
      "A": "G1/S",
      "B": "S phase",
      "C": "M/G1",
      "D": "G2/M",
      "E": "Anaphase"
    },
    "answer": "D",
    "explanation": "The G2/M checkpoint ensures all DNA is replicated and undamaged before mitosis begins.",
    "category": "FOM-Genetics"
  },
    {
    "id": 366,
    "question": "Which chromosomal condition is compatible with life?",
    "options": {
      "A": "Monosomy 21",
      "B": "Trisomy 21",
      "C": "Monosomy 1",
      "D": "Trisomy 2",
      "E": "Trisomy 7"
    },
    "answer": "B",
    "explanation": "Only trisomies of chromosomes 21, 18, and 13 are compatible with life, with trisomy 21 causing Down syndrome.",
    "category": "FOM-Genetics"
  },
  {
    "id": 367,
    "question": "What is the most common cause of early human pregnancy loss?",
    "options": {
      "A": "Rh incompatibility",
      "B": "Aneuploidy",
      "C": "Ectopic implantation",
      "D": "Hormonal imbalance",
      "E": "Uterine abnormalities"
    },
    "answer": "B",
    "explanation": "Aneuploidy, or abnormal numbers of chromosomes, is the leading cause of miscarriage.",
    "category": "FOM-Genetics"
  },
  {
    "id": 368,
    "question": "Which process increases genetic diversity during meiosis?",
    "options": {
      "A": "Spindle formation",
      "B": "Cytokinesis",
      "C": "Homologous recombination",
      "D": "DNA replication",
      "E": "Chromosome condensation"
    },
    "answer": "C",
    "explanation": "Recombination between homologous chromosomes in prophase I leads to genetic diversity.",
    "category": "FOM-Genetics"
  },
  {
    "id": 369,
    "question": "What is a balanced translocation?",
    "options": {
      "A": "Equal division of sister chromatids",
      "B": "Loss of genetic material",
      "C": "Exchange of DNA with no net loss",
      "D": "Trisomy of chromosome 15",
      "E": "Non-disjunction event"
    },
    "answer": "C",
    "explanation": "Balanced translocations involve reciprocal exchange of DNA between nonhomologous chromosomes without net gain or loss of genetic material.",
    "category": "FOM-Genetics"
  },
  {
    "id": 370,
    "question": "What is Lyonisation?",
    "options": {
      "A": "A type of gene amplification",
      "B": "Selective X chromosome inactivation in females",
      "C": "A form of non-Mendelian inheritance",
      "D": "A type of chromosomal translocation",
      "E": "Random mitotic recombination"
    },
    "answer": "B",
    "explanation": "Lyonisation refers to the random inactivation of one X chromosome in female cells to achieve dosage compensation.",
    "category": "FOM-Genetics"
  },
  {
    "id": 371,
    "question": "What is a Barr body?",
    "options": {
      "A": "An active X chromosome",
      "B": "An inactivated X chromosome",
      "C": "A heterochromatic autosome",
      "D": "A centrosome aggregate",
      "E": "A form of nuclear pore"
    },
    "answer": "B",
    "explanation": "A Barr body is the condensed, transcriptionally inactive X chromosome seen in female cells.",
    "category": "FOM-Genetics"
  },
  {
    "id": 372,
    "question": "Genomic imprinting is best described as:",
    "options": {
      "A": "Random X-inactivation",
      "B": "Expression from only one parental allele",
      "C": "Mutation of both alleles",
      "D": "Mitochondrial inheritance",
      "E": "Loss of heterozygosity"
    },
    "answer": "B",
    "explanation": "Genomic imprinting involves the monoallelic expression of a gene depending on whether it's inherited maternally or paternally.",
    "category": "FOM-Genetics"
  },
  {
    "id": 373,
    "question": "Which of the following inheritance types always skips generations?",
    "options": {
      "A": "Autosomal dominant",
      "B": "Autosomal recessive",
      "C": "Mitochondrial",
      "D": "X-linked dominant",
      "E": "Co-dominant"
    },
    "answer": "B",
    "explanation": "Autosomal recessive traits may skip generations if carriers do not manifest the phenotype.",
    "category": "FOM-Genetics"
  },
  {
    "id": 374,
    "question": "In an autosomal dominant pedigree, which pattern is expected?",
    "options": {
      "A": "Males only affected",
      "B": "Females only affected",
      "C": "Affected individuals in every generation",
      "D": "Only children of affected mothers inherit the trait",
      "E": "Only homozygotes show the trait"
    },
    "answer": "C",
    "explanation": "Autosomal dominant traits usually appear in every generation and affect both sexes equally.",
    "category": "FOM-Genetics"
  },
  {
    "id": 375,
    "question": "Which of the following is an example of co-dominance?",
    "options": {
      "A": "ABO blood group type AB",
      "B": "Recessive inheritance of CF",
      "C": "Mitochondrial diseases",
      "D": "X-inactivation",
      "E": "Autosomal trisomy"
    },
    "answer": "A",
    "explanation": "AB blood group demonstrates co-dominance where both A and B alleles are expressed equally.",
    "category": "FOM-Genetics"
  },
  {
    "id": 376,
    "question": "Incomplete dominance refers to:",
    "options": {
      "A": "Equal expression of both alleles",
      "B": "Suppression of the recessive allele",
      "C": "An intermediate phenotype between two parents",
      "D": "X-inactivation in females",
      "E": "Uniparental disomy"
    },
    "answer": "C",
    "explanation": "Incomplete dominance results in a blended phenotype, e.g., wavy hair from straight and curly-haired parents.",
    "category": "FOM-Genetics"
  },
  {
    "id": 377,
    "question": "Which condition would NOT be described as multifactorial?",
    "options": {
      "A": "Diabetes",
      "B": "Cancer",
      "C": "Cystic fibrosis",
      "D": "Hypertension",
      "E": "Asthma"
    },
    "answer": "C",
    "explanation": "Cystic fibrosis is monogenic, caused by mutations in the CFTR gene, unlike the polygenic/multifactorial others.",
    "category": "FOM-Genetics"
  },
  {
    "id": 378,
    "question": "Which description fits an autosomal recessive disorder?",
    "options": {
      "A": "Requires one mutant allele",
      "B": "Often affects every generation",
      "C": "Usually only affects males",
      "D": "Requires two mutant alleles",
      "E": "Always fatal"
    },
    "answer": "D",
    "explanation": "Autosomal recessive traits manifest only in individuals with two mutant alleles (homozygotes).",
    "category": "FOM-Genetics"
  },
  {
    "id": 379,
    "question": "Which of the following correctly describes trisomy?",
    "options": {
      "A": "Loss of one autosome",
      "B": "Loss of X chromosome",
      "C": "Presence of an extra chromosome",
      "D": "Mitochondrial inheritance",
      "E": "Epigenetic silencing"
    },
    "answer": "C",
    "explanation": "Trisomy is the presence of an additional chromosome, e.g., trisomy 21 in Down syndrome.",
    "category": "FOM-Genetics"
  },
  {
    "id": 380,
    "question": "Which concept explains how females express genes from only one X chromosome?",
    "options": {
      "A": "Mosaicism",
      "B": "Dosage compensation",
      "C": "Homologous recombination",
      "D": "Autosomal dominance",
      "E": "Telomere shortening"
    },
    "answer": "B",
    "explanation": "Dosage compensation ensures gene expression from one X chromosome is balanced between sexes, typically via X-inactivation.",
    "category": "FOM-Genetics"
  },
    {
    "id": 381,
    "question": "Which stem cell type can form both the embryo and extraembryonic structures?",
    "options": {
      "A": "Pluripotent",
      "B": "Multipotent",
      "C": "Unipotent",
      "D": "Totipotent",
      "E": "Mesenchymal"
    },
    "answer": "D",
    "explanation": "Totipotent cells can give rise to all cells of the embryo and extraembryonic tissues like placenta.",
    "category": "FOM-Genetics"
  },
  {
    "id": 382,
    "question": "Which best describes a pluripotent stem cell?",
    "options": {
      "A": "Forms only one tissue type",
      "B": "Can regenerate neurons only",
      "C": "Forms all embryonic cells but not placental cells",
      "D": "Only found in adult tissues",
      "E": "Can become any cell including placenta"
    },
    "answer": "C",
    "explanation": "Pluripotent cells can differentiate into all body cells but not extraembryonic structures.",
    "category": "FOM-Genetics"
  },
  {
    "id": 383,
    "question": "Which stem cell type is involved in tissue maintenance and repair in adults?",
    "options": {
      "A": "Totipotent",
      "B": "Pluripotent",
      "C": "Multipotent",
      "D": "Unipotent",
      "E": "Embryonic stem cell"
    },
    "answer": "C",
    "explanation": "Multipotent adult stem cells are responsible for maintaining and repairing specific tissues.",
    "category": "FOM-Genetics"
  },
  {
    "id": 384,
    "question": "What determines the fate of a differentiating cell?",
    "options": {
      "A": "Nutrient concentration",
      "B": "Extracellular pH",
      "C": "Presence of transcription factors",
      "D": "Centrosome duplication",
      "E": "Lysosomal activity"
    },
    "answer": "C",
    "explanation": "Cell-specific transcription factors drive differential gene expression, leading to cell fate determination.",
    "category": "FOM-Genetics"
  },
  {
    "id": 385,
    "question": "Which of the following is NOT a function of tight junctions?",
    "options": {
      "A": "Prevent leakage between epithelial cells",
      "B": "Allow ion passage between cells",
      "C": "Seal adjacent epithelial cells",
      "D": "Form physical barriers",
      "E": "Maintain cell polarity"
    },
    "answer": "B",
    "explanation": "Gap junctions allow ion passage; tight junctions create barriers to prevent leakage.",
    "category": "FOM-Genetics"
  },
  {
    "id": 386,
    "question": "Which junction directly connects the cytoplasm of two cells?",
    "options": {
      "A": "Tight junction",
      "B": "Desmosome",
      "C": "Hemidesmosome",
      "D": "Gap junction",
      "E": "Adherens junction"
    },
    "answer": "D",
    "explanation": "Gap junctions allow direct cytoplasmic exchange of ions and small molecules.",
    "category": "FOM-Genetics"
  },
  {
    "id": 387,
    "question": "Which cell junction provides mechanical strength and also acts as a signalling centre?",
    "options": {
      "A": "Tight junction",
      "B": "Gap junction",
      "C": "Desmosome",
      "D": "Adherens junction",
      "E": "Pseudopod junction"
    },
    "answer": "C",
    "explanation": "Desmosomes strongly anchor cells together and have roles in signalling pathways.",
    "category": "FOM-Genetics"
  },
  {
    "id": 388,
    "question": "Which form of cell death is a neat, programmed process involving macrophage engulfment?",
    "options": {
      "A": "Necrosis",
      "B": "Autolysis",
      "C": "Autophagy",
      "D": "Apoptosis",
      "E": "Pyroptosis"
    },
    "answer": "D",
    "explanation": "Apoptosis is a controlled process involving DNA fragmentation and phagocytosis by macrophages.",
    "category": "FOM-Genetics"
  },
  {
    "id": 389,
    "question": "Which of the following is most characteristic of necrosis?",
    "options": {
      "A": "Cell shrinkage",
      "B": "Membrane blebbing",
      "C": "DNA fragmentation",
      "D": "Swelling and bursting of the cell",
      "E": "Formation of apoptotic bodies"
    },
    "answer": "D",
    "explanation": "Necrosis is unregulated cell death involving swelling and lysis, triggering inflammation.",
    "category": "FOM-Genetics"
  },
  {
    "id": 390,
    "question": "Which sequence best describes the progression of apoptosis?",
    "options": {
      "A": "DNA replication → Cell lysis → Inflammation",
      "B": "Blebbing → Cell swelling → Apoptotic bodies",
      "C": "Cell shrinkage → DNA fragmentation → Apoptotic bodies → Phagocytosis",
      "D": "Necrosis → DNA repair → Macrophage recruitment",
      "E": "Mitosis → Cell death → Inflammation"
    },
    "answer": "C",
    "explanation": "Apoptosis involves cell shrinkage, cytoskeletal collapse, DNA fragmentation, blebbing, and clean engulfment.",
    "category": "FOM-Genetics"
  },
  {
    "id": 391,
    "question": "What term describes the external signal-based communication influencing cell fate?",
    "options": {
      "A": "Phagocytosis",
      "B": "Homeostasis",
      "C": "Paracrine signalling",
      "D": "Neurogenesis",
      "E": "Cytokinesis"
    },
    "answer": "C",
    "explanation": "Paracrine (and other chemical signalling types) are essential for directing cell differentiation decisions.",
    "category": "FOM-Genetics"
  },
  {
    "id": 392,
    "question": "Apoptosis differs from necrosis in that it:",
    "options": {
      "A": "Always triggers inflammation",
      "B": "Causes cell swelling",
      "C": "Is an unregulated process",
      "D": "Prevents leakage of cell contents",
      "E": "Occurs only in cancer cells"
    },
    "answer": "D",
    "explanation": "Apoptotic cells are neatly packaged into bodies, preventing inflammation unlike necrosis.",
    "category": "FOM-Genetics"
  },
  {
    "id": 393,
    "question": "Which structural change is NOT typical of apoptosis?",
    "options": {
      "A": "Cell shrinkage",
      "B": "Collapse of cytoskeleton",
      "C": "Chromosome duplication",
      "D": "Membrane blebbing",
      "E": "Nuclear collapse"
    },
    "answer": "C",
    "explanation": "Chromosome duplication is unrelated to apoptosis and occurs during the S phase of cell cycle.",
    "category": "FOM-Genetics"
  },
  {
    "id": 394,
    "question": "Which junction would most likely prevent leakage across an epithelial layer?",
    "options": {
      "A": "Desmosome",
      "B": "Gap junction",
      "C": "Adherens junction",
      "D": "Tight junction",
      "E": "Synapse"
    },
    "answer": "D",
    "explanation": "Tight junctions seal epithelial cells to form barriers against leakage.",
    "category": "FOM-Genetics"
  },
  {
    "id": 395,
    "question": "What ultimately removes apoptotic cells from tissues?",
    "options": {
      "A": "Natural killer cells",
      "B": "Neutrophils",
      "C": "Macrophages",
      "D": "Dendritic cells",
      "E": "Basophils"
    },
    "answer": "C",
    "explanation": "Macrophages engulf apoptotic bodies to prevent inflammation and promote tissue homeostasis.",
    "category": "FOM-Genetics"
  },
    {
    "id": 396,
    "question": "Approximately how much of the human genome is identical between individuals?",
    "options": {
      "A": "50%",
      "B": "75%",
      "C": "90%",
      "D": "99.9%",
      "E": "100%"
    },
    "answer": "D",
    "explanation": "Humans share approximately 99.9% of their genome; the remaining 0.1% contributes to individual variation.",
    "category": "FOM-Genetics"
  },
  {
    "id": 397,
    "question": "Which of the following is NOT a main source of genetic variation?",
    "options": {
      "A": "Sexual reproduction",
      "B": "Epigenetic processes",
      "C": "Mutation",
      "D": "Horizontal gene transfer",
      "E": "Random fertilisation"
    },
    "answer": "D",
    "explanation": "Horizontal gene transfer is not a typical source of variation in humans; the key sources are meiosis, mutations, and epigenetics.",
    "category": "FOM-Genetics"
  },
  {
    "id": 398,
    "question": "What are Copy Number Variations (CNVs) characterised by?",
    "options": {
      "A": "Balanced chromosomal content",
      "B": "Repeating nature, size, and numerical variation",
      "C": "Single base pair change",
      "D": "Presence of non-coding RNA",
      "E": "Aberrant gene silencing"
    },
    "answer": "B",
    "explanation": "CNVs involve large segments of DNA that are repeated and vary in number between individuals, possibly containing genes like CYP2D6.",
    "category": "FOM-Genetics"
  },
  {
    "id": 399,
    "question": "Which disease is strongly associated with a structural genetic variation?",
    "options": {
      "A": "Sickle cell anaemia",
      "B": "Huntington’s disease",
      "C": "Chronic myeloid leukaemia (CML)",
      "D": "Albinism",
      "E": "Phenylketonuria"
    },
    "answer": "C",
    "explanation": "CML is associated with the Philadelphia chromosome, a structural chromosomal abnormality (translocation).",
    "category": "FOM-Genetics"
  },
  {
    "id": 400,
    "question": "Which type of mutation is most common in the human genome?",
    "options": {
      "A": "Frameshift mutation",
      "B": "Copy number variation",
      "C": "Single nucleotide polymorphism (SNP)",
      "D": "Insertion of mobile elements",
      "E": "Large deletions"
    },
    "answer": "C",
    "explanation": "SNPs are the most frequent form of genetic variation, with approximately 5 million per human genome.",
    "category": "FOM-Genetics"
  },
  {
    "id": 401,
    "question": "Microsatellites are also known as:",
    "options": {
      "A": "Exons",
      "B": "CpG islands",
      "C": "Short tandem repeats (STRs)",
      "D": "Enhancer elements",
      "E": "Histone modifications"
    },
    "answer": "C",
    "explanation": "Microsatellites, or STRs, are short 2–6 bp repeated sequences used in forensics and known to cause disorders like Huntington’s disease.",
    "category": "FOM-Genetics"
  },
  {
    "id": 402,
    "question": "Which mechanism explains how mutations in non-coding DNA can affect gene expression?",
    "options": {
      "A": "Change in tRNA binding",
      "B": "Disruption of exon junction complex",
      "C": "Alteration in promoter or enhancer elements",
      "D": "Frameshift mutation",
      "E": "Suppression of translation"
    },
    "answer": "C",
    "explanation": "Mutations in non-coding regulatory regions like promoters or enhancers can alter gene transcription and expression.",
    "category": "FOM-Genetics"
  },
  {
    "id": 403,
    "question": "Which epigenetic change is associated with gene repression?",
    "options": {
      "A": "Histone acetylation",
      "B": "Histone phosphorylation",
      "C": "DNA methylation at CpG islands",
      "D": "Polyadenylation",
      "E": "Ribosome binding"
    },
    "answer": "C",
    "explanation": "CpG methylation leads to chromatin condensation and silencing of gene expression, particularly in tumour suppressor genes.",
    "category": "FOM-Genetics"
  },
  {
    "id": 404,
    "question": "What mutation causes the i allele in the ABO gene?",
    "options": {
      "A": "Missense mutation",
      "B": "Frameshift from guanine deletion",
      "C": "Stop codon bypass",
      "D": "Insertion in exon 1",
      "E": "Gain-of-function mutation"
    },
    "answer": "B",
    "explanation": "A G deletion causes a frameshift, resulting in a premature stop codon and a non-functional ABO enzyme in the i allele.",
    "category": "FOM-Genetics"
  },
  {
    "id": 405,
    "question": "Sickle cell disease is caused by:",
    "options": {
      "A": "A large chromosomal inversion",
      "B": "An A→T SNP in the beta-globin gene",
      "C": "Triplet repeat expansion",
      "D": "Loss of function in erythropoietin gene",
      "E": "Methylation of the globin gene promoter"
    },
    "answer": "B",
    "explanation": "An A→T transversion causes a valine-to-glutamic acid substitution, leading to HbS formation and sickling of RBCs.",
    "category": "FOM-Genetics"
  },
  {
    "id": 406,
    "question": "Which effect of HbS contributes directly to red cell sickling?",
    "options": {
      "A": "Lysosomal accumulation",
      "B": "Loss of iron binding",
      "C": "Hydrophobic interaction of valine with surface pocket",
      "D": "mRNA instability",
      "E": "Decreased membrane receptors"
    },
    "answer": "C",
    "explanation": "Valine on HbS interacts with a hydrophobic pocket on another beta-globin, promoting polymerisation and sickling.",
    "category": "FOM-Genetics"
  },
  {
    "id": 407,
    "question": "What is the goal of CFTR potentiator therapy?",
    "options": {
      "A": "Skip nonsense mutations",
      "B": "Prevent CFTR degradation",
      "C": "Enhance chloride channel opening",
      "D": "Trigger apoptosis of mutant cells",
      "E": "Promote immune clearance"
    },
    "answer": "C",
    "explanation": "Potentiators improve channel gating function by enhancing the open state of CFTR protein.",
    "category": "FOM-Genetics"
  },
  {
    "id": 408,
    "question": "Which CFTR mutation type causes protein misfolding and degradation?",
    "options": {
      "A": "Nonsense mutation",
      "B": "Missense mutation",
      "C": "ΔF508 deletion",
      "D": "Triplet expansion",
      "E": "Gene duplication"
    },
    "answer": "C",
    "explanation": "The ΔF508 mutation leads to misfolded CFTR, retained in the ER and degraded instead of being expressed on the cell surface.",
    "category": "FOM-Genetics"
  },
  {
    "id": 409,
    "question": "What is the most common form of epigenetic gene regulation?",
    "options": {
      "A": "Gene duplication",
      "B": "Methylation of cytosine residues",
      "C": "tRNA modification",
      "D": "Alternative splicing",
      "E": "Ubiquitination"
    },
    "answer": "B",
    "explanation": "Methylation of CpG sites, particularly in promoters, is a well-established mechanism of epigenetic silencing.",
    "category": "FOM-Genetics"
  },
  {
    "id": 410,
    "question": "Why is personalised medicine important?",
    "options": {
      "A": "It focuses solely on rare diseases",
      "B": "It generalises treatment for all patients",
      "C": "It tailors therapy based on individual genetic profiles",
      "D": "It excludes epigenetic factors",
      "E": "It is limited to oncology"
    },
    "answer": "C",
    "explanation": "Personalised medicine customises diagnosis and treatment strategies using the patient’s genetic makeup for optimal outcomes.",
    "category": "FOM-Genetics"
  },
  {
    "id": 411,
    "question": "Which of the following is true regarding non-coding DNA?",
    "options": {
      "A": "It is non-functional",
      "B": "It includes genes for structural proteins",
      "C": "It regulates gene expression via promoters and enhancers",
      "D": "It is mostly found in ribosomes",
      "E": "It only codes for tRNAs"
    },
    "answer": "C",
    "explanation": "Though non-coding, these regions regulate gene expression and include promoters, enhancers, and silencers.",
    "category": "FOM-Genetics"
  },
  {
    "id": 412,
    "question": "Which mutation class is most associated with triplet expansion disorders?",
    "options": {
      "A": "Frameshift",
      "B": "Indel",
      "C": "Microsatellite repeat",
      "D": "Splice site",
      "E": "Transversion"
    },
    "answer": "C",
    "explanation": "Triplet expansions of microsatellite repeats (e.g. CAG) underlie conditions like Huntington’s disease.",
    "category": "FOM-Genetics"
  },
  {
    "id": 413,
    "question": "Which treatment type promotes correct folding of mutant CFTR protein?",
    "options": {
      "A": "Potentiator",
      "B": "Read-through agent",
      "C": "Corrector",
      "D": "Stabiliser",
      "E": "Deacetylase inhibitor"
    },
    "answer": "C",
    "explanation": "Correctors help misfolded CFTR proteins reach the membrane by improving folding and trafficking.",
    "category": "FOM-Genetics"
  },
  {
    "id": 414,
    "question": "Which of the following does NOT directly contribute to structural variation?",
    "options": {
      "A": "Translocations",
      "B": "Copy number variation",
      "C": "Inversions",
      "D": "SNPs",
      "E": "Deletions"
    },
    "answer": "D",
    "explanation": "SNPs are sequence-level changes, not structural variations. Structural variants involve larger rearrangements.",
    "category": "FOM-Genetics"
  },
  {
    "id": 415,
    "question": "Which mechanism may allow read-through of a premature stop codon?",
    "options": {
      "A": "CFTR corrector",
      "B": "Gene editing",
      "C": "Translational read-through agent",
      "D": "Histone acetylation",
      "E": "Ubiquitin ligase"
    },
    "answer": "C",
    "explanation": "Translational read-through agents allow ribosomes to ignore premature stop codons, permitting full-length protein translation.",
    "category": "FOM-Genetics"
  },
    {
    "id": 416,
    "question": "At what day post-fertilisation does implantation typically begin?",
    "options": {
      "A": "Day 1",
      "B": "Day 3",
      "C": "Day 6",
      "D": "Day 12",
      "E": "Day 14"
    },
    "answer": "C",
    "explanation": "Implantation typically begins around day 6, when the blastocyst attaches to the uterine epithelium.",
    "category": "FOM-Embryology"
  },
  {
    "id": 417,
    "question": "Which cell layer contributes to the amniotic cavity during the second week of development?",
    "options": {
      "A": "Cytotrophoblast",
      "B": "Syncytiotrophoblast",
      "C": "Epiblast",
      "D": "Hypoblast",
      "E": "Yolk sac"
    },
    "answer": "C",
    "explanation": "The amniotic cavity forms within the epiblast, which is part of the bilaminar disc.",
    "category": "FOM-Embryology"
  },
  {
    "id": 418,
    "question": "Which structure gives rise to the extraembryonic mesoderm?",
    "options": {
      "A": "Trophoblast",
      "B": "Epiblast",
      "C": "Hypoblast",
      "D": "Primary yolk sac",
      "E": "Amniotic cavity"
    },
    "answer": "D",
    "explanation": "The extraembryonic mesoderm arises from cells associated with the yolk sac, forming between the trophoblast and Heuser’s membrane.",
    "category": "FOM-Embryology"
  },
  {
    "id": 419,
    "question": "What structure forms as the blastocoel expands within the blastocyst?",
    "options": {
      "A": "Zona pellucida",
      "B": "Morula",
      "C": "Inner cell mass",
      "D": "Blastocyst cavity",
      "E": "Neural groove"
    },
    "answer": "D",
    "explanation": "The fluid-filled blastocyst cavity, or blastocoel, expands as the blastocyst matures.",
    "category": "FOM-Embryology"
  },
  {
    "id": 420,
    "question": "What is the role of the zona pellucida in early development?",
    "options": {
      "A": "Nutrient absorption",
      "B": "Attachment to uterus",
      "C": "Prevention of premature implantation",
      "D": "Hormone secretion",
      "E": "Formation of amnion"
    },
    "answer": "C",
    "explanation": "The zona pellucida prevents the blastocyst from implanting in the fallopian tube during early travel to the uterus.",
    "category": "FOM-Embryology"
  },
  {
    "id": 421,
    "question": "Which week of development is known as the 'week of twos'?",
    "options": {
      "A": "Week 1",
      "B": "Week 2",
      "C": "Week 3",
      "D": "Week 4",
      "E": "Week 5"
    },
    "answer": "B",
    "explanation": "Week 2 features many binary structures: epiblast/hypoblast, amniotic/yolk sac, cytotrophoblast/syncytiotrophoblast, somatic/splanchnic mesoderm.",
    "category": "FOM-Embryology"
  },
  {
    "id": 422,
    "question": "During which week does the bilaminar disc form?",
    "options": {
      "A": "Week 1",
      "B": "Week 2",
      "C": "Week 3",
      "D": "Week 4",
      "E": "Week 5"
    },
    "answer": "B",
    "explanation": "The bilaminar embryonic disc, consisting of epiblast and hypoblast, forms in week 2 of development.",
    "category": "FOM-Embryology"
  },
  {
    "id": 423,
    "question": "What is the significance of lacunae forming in syncytiotrophoblasts?",
    "options": {
      "A": "Creation of the chorionic villi",
      "B": "Initiation of maternal blood flow to embryo",
      "C": "Formation of yolk sac",
      "D": "Development of neural tube",
      "E": "Delamination of mesoderm"
    },
    "answer": "B",
    "explanation": "Lacunae become filled with maternal blood, establishing uteroplacental circulation for nutrient and gas exchange.",
    "category": "FOM-Embryology"
  },
  {
    "id": 424,
    "question": "Which best describes Heuser’s membrane?",
    "options": {
      "A": "Layer that forms amniotic cavity",
      "B": "Derived from hypoblast and surrounds primary yolk sac",
      "C": "Part of the epiblast that gives rise to ectoderm",
      "D": "Forms primitive streak",
      "E": "Covers the inner surface of the chorionic cavity"
    },
    "answer": "B",
    "explanation": "Heuser’s membrane is a hypoblast-derived layer that surrounds the primary yolk sac during early development.",
    "category": "FOM-Embryology"
  },
  {
    "id": 425,
    "question": "Which of the following is formed first during embryogenesis?",
    "options": {
      "A": "Primitive streak",
      "B": "Neural groove",
      "C": "Blastocyst",
      "D": "Somites",
      "E": "Notochord"
    },
    "answer": "C",
    "explanation": "The blastocyst forms early around day 5–6, preceding other structures such as the primitive streak and neural groove.",
    "category": "FOM-Embryology"
  },
    {
    "id": 426,
    "question": "Which of the following events initiates gastrulation?",
    "options": {
      "A": "Closure of the neural tube",
      "B": "Fusion of the amniotic and yolk sacs",
      "C": "Formation of the primitive streak",
      "D": "Differentiation of trophoblast",
      "E": "Chorionic villus formation"
    },
    "answer": "C",
    "explanation": "Gastrulation begins with the formation of the primitive streak, marking the start of trilaminar germ layer development.",
    "category": "FOM-Embryology"
  },
  {
    "id": 427,
    "question": "Which embryonic germ layer gives rise to the heart and blood vessels?",
    "options": {
      "A": "Ectoderm",
      "B": "Endoderm",
      "C": "Paraxial mesoderm",
      "D": "Lateral plate mesoderm",
      "E": "Intermediate mesoderm"
    },
    "answer": "D",
    "explanation": "The lateral plate mesoderm splits to form somatic and splanchnic layers, giving rise to cardiovascular structures.",
    "category": "FOM-Embryology"
  },
  {
    "id": 428,
    "question": "What is the role of Hensen's node in development?",
    "options": {
      "A": "Establishes anterior-posterior axis",
      "B": "Induces formation of yolk sac",
      "C": "Differentiates trophoblast",
      "D": "Initiates implantation",
      "E": "Prevents neural tube closure"
    },
    "answer": "A",
    "explanation": "Hensen's node acts as the organiser, helping to define the body's axial orientation during gastrulation.",
    "category": "FOM-Embryology"
  },
  {
    "id": 429,
    "question": "Which of the following structures forms from paraxial mesoderm?",
    "options": {
      "A": "Kidneys",
      "B": "Somites",
      "C": "Limb buds",
      "D": "Dermis of ventral body wall",
      "E": "Endothelium of heart"
    },
    "answer": "B",
    "explanation": "Somites develop from paraxial mesoderm and differentiate into muscle, vertebrae, and dermis of the back.",
    "category": "FOM-Embryology"
  },
  {
    "id": 430,
    "question": "Neurulation is induced by signals from which structure?",
    "options": {
      "A": "Neural crest",
      "B": "Somites",
      "C": "Trophoblast",
      "D": "Notochord",
      "E": "Yolk sac"
    },
    "answer": "D",
    "explanation": "The notochord sends signals to the overlying ectoderm, inducing it to thicken and form the neural plate.",
    "category": "FOM-Embryology"
  },
  {
    "id": 431,
    "question": "Which structure defines the future mouth of the embryo?",
    "options": {
      "A": "Primitive node",
      "B": "Chorion",
      "C": "Oropharyngeal membrane",
      "D": "Cloacal membrane",
      "E": "Allantois"
    },
    "answer": "C",
    "explanation": "The oropharyngeal membrane is a bilaminar membrane that eventually breaks down to form the mouth opening.",
    "category": "FOM-Embryology"
  },
  {
    "id": 432,
    "question": "Failure of the cloacal membrane to rupture properly could result in:",
    "options": {
      "A": "Anencephaly",
      "B": "Imperforate anus",
      "C": "Gastroschisis",
      "D": "Spina bifida",
      "E": "Omphalocele"
    },
    "answer": "B",
    "explanation": "The cloacal membrane must rupture to form the openings of the urogenital and gastrointestinal tracts; failure leads to imperforate anus.",
    "category": "FOM-Embryology"
  },
  {
    "id": 433,
    "question": "Which developmental milestone occurs at the end of week 3?",
    "options": {
      "A": "Gastrulation begins",
      "B": "Zygote formation",
      "C": "Trilaminar disc is complete",
      "D": "Neural crest migration",
      "E": "Blastocyst hatching"
    },
    "answer": "C",
    "explanation": "By the end of week 3, gastrulation is complete and the embryo consists of a trilaminar disc with ectoderm, mesoderm, and endoderm.",
    "category": "FOM-Embryology"
  },
  {
    "id": 434,
    "question": "Which region of mesoderm gives rise to kidneys and gonads?",
    "options": {
      "A": "Paraxial mesoderm",
      "B": "Intermediate mesoderm",
      "C": "Lateral plate mesoderm",
      "D": "Axial mesoderm",
      "E": "Somitic mesoderm"
    },
    "answer": "B",
    "explanation": "Intermediate mesoderm gives rise to the urogenital system including kidneys, gonads, and associated ducts.",
    "category": "FOM-Embryology"
  },
  {
    "id": 435,
    "question": "Which event directly follows completion of neurulation?",
    "options": {
      "A": "Formation of bilaminar disc",
      "B": "Differentiation of neural crest cells",
      "C": "Primitive streak formation",
      "D": "Zona pellucida breakdown",
      "E": "Implantation"
    },
    "answer": "B",
    "explanation": "Following closure of the neural tube, neural crest cells migrate and differentiate into diverse tissues including peripheral neurons and facial bones.",
    "category": "FOM-Embryology"
  },
    {
    "id": 436,
    "question": "The neural crest is derived from which embryonic structure?",
    "options": {
      "A": "Paraxial mesoderm",
      "B": "Endoderm",
      "C": "Neural tube",
      "D": "Surface ectoderm",
      "E": "Neural folds"
    },
    "answer": "E",
    "explanation": "Neural crest cells originate at the tips of the neural folds during neurulation before migrating extensively.",
    "category": "FOM-Embryology"
  },
  {
    "id": 437,
    "question": "Which of the following does NOT derive from the neural crest?",
    "options": {
      "A": "Dorsal root ganglia",
      "B": "Adrenal medulla",
      "C": "Melanocytes",
      "D": "Cardiac muscle",
      "E": "Schwann cells"
    },
    "answer": "D",
    "explanation": "Cardiac muscle is derived from mesoderm, not neural crest. Neural crest contributes to diverse structures like ganglia and pigment cells.",
    "category": "FOM-Embryology"
  },
  {
    "id": 438,
    "question": "Which of the following is derived from ectoderm?",
    "options": {
      "A": "Muscles",
      "B": "Liver",
      "C": "Epidermis",
      "D": "Heart",
      "E": "Kidneys"
    },
    "answer": "C",
    "explanation": "The ectoderm gives rise to epidermis, nervous tissue, and related structures.",
    "category": "FOM-Embryology"
  },
  {
    "id": 439,
    "question": "Which embryonic germ layer gives rise to the lining of the respiratory tract?",
    "options": {
      "A": "Ectoderm",
      "B": "Mesoderm",
      "C": "Endoderm",
      "D": "Neural crest",
      "E": "Somatic mesoderm"
    },
    "answer": "C",
    "explanation": "The endoderm forms the epithelial lining of the respiratory, gastrointestinal, and urinary tracts.",
    "category": "FOM-Embryology"
  },
  {
    "id": 440,
    "question": "Which process transforms the flat embryonic disc into a 3D cylindrical body?",
    "options": {
      "A": "Neurulation",
      "B": "Gastrulation",
      "C": "Lateral and cephalocaudal folding",
      "D": "Somitogenesis",
      "E": "Blastulation"
    },
    "answer": "C",
    "explanation": "Lateral and cephalocaudal folding of the trilaminar disc results in a 3D tubular body form.",
    "category": "FOM-Embryology"
  },
  {
    "id": 441,
    "question": "What is the role of the allantois during early development?",
    "options": {
      "A": "Nourishment of embryo",
      "B": "Initiates neural tube formation",
      "C": "Formation of part of the umbilical cord",
      "D": "Formation of brain vesicles",
      "E": "Induces ectodermal thickening"
    },
    "answer": "C",
    "explanation": "The allantois contributes to early blood formation and the development of the umbilical cord.",
    "category": "FOM-Embryology"
  },
  {
    "id": 442,
    "question": "Which cavity will eventually contain the embryo suspended in amniotic fluid?",
    "options": {
      "A": "Chorionic cavity",
      "B": "Amniotic cavity",
      "C": "Blastocoel",
      "D": "Yolk sac",
      "E": "Decidual cavity"
    },
    "answer": "B",
    "explanation": "The amniotic cavity expands and surrounds the embryo, providing protection and cushioning in fluid.",
    "category": "FOM-Embryology"
  },
  {
    "id": 443,
    "question": "What is the origin of the chorion?",
    "options": {
      "A": "Syncytiotrophoblast + Cytotrophoblast + Extraembryonic mesoderm",
      "B": "Amnion + Yolk sac",
      "C": "Epiblast + Hypoblast",
      "D": "Neural crest cells",
      "E": "Decidua basalis"
    },
    "answer": "A",
    "explanation": "The chorion is composed of syncytiotrophoblast, cytotrophoblast, and associated extraembryonic mesoderm.",
    "category": "FOM-Embryology"
  },
  {
    "id": 444,
    "question": "Which of the following structures arises from somites?",
    "options": {
      "A": "Kidneys",
      "B": "Neural tube",
      "C": "Dermis of back",
      "D": "Yolk sac",
      "E": "Placenta"
    },
    "answer": "C",
    "explanation": "Somites give rise to dermis (especially of the back), axial muscles, and vertebrae.",
    "category": "FOM-Embryology"
  },
  {
    "id": 445,
    "question": "Which term describes the remnant of the primitive streak?",
    "options": {
      "A": "Oropharyngeal membrane",
      "B": "Tailbud",
      "C": "Neural groove",
      "D": "Notochord",
      "E": "Caudal eminence"
    },
    "answer": "E",
    "explanation": "The primitive streak regresses, leaving a remnant at the caudal end known as the caudal eminence.",
    "category": "FOM-Embryology"
  }
]
